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The current necessity of development new biological in vitro models that mimic 
the characteristics and the complexity of human tissue arises from the need to 
find a valid alternative to animal models to test and validate new products, and to 
screen substances and procedures for tissue repair and regeneration. In 
particular, in the cosmetics field, big multinational companies have developed and 
devised methods for the realization of testing platforms in large scale, since the 
European Regulations (Decree 76/768/EEC and the EU Cosmetic Regulation 
1223/2009) ban the putting on the market cosmetic products whose ingredients, 
or parts thereof, have been tested on animal models. in this scenario, researchers 
have been spent many efforts to develop innovative tissue engineering strategies 
to create 3D skin equivalent models that faithfully recapitulate the characteristics 
of human skin in terms of organization, complexity, architecture and responsivity 
to specific exogenous stimuli. 
The optimization of the process to produce these skin equivalent represents a 
crucial step to obtain i) tissue in large scale in order to allow the screening of a 
large number of molecules/exogenous factor ii) a high-fidelity replica of the native 
counterpart in order to evaluate the effect of molecules/exogenous factor on the 
mechanical properties and ECM composition organization and hydration. For this 
purpose, in my PhD work, after a deep study of the literature, it was developed a 
method of production of 3D skin equivalent models in large scale with great 
reproducibility.  
In the first part of the thesis, there is a description of the principal systems that 
composed the human skin and a summary about the main arguments of European 
Regulation related to cosmetics testing, the development of alternatives animal 
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tests and its principal applications. In the second chapter, we exploited a bottom-
up tissue engineering approach to build up the skin tissues. Such approach 
allowed to obtain skin tissues composed of endogenous extracellular matrix 
(ECM), produced by human dermal fibroblasts and by stratified epithelial cells that 
constitute a fully differentiated epithelium resembling the human epidermis. In  
the third chapter, we performed a morphological characterization of our 3D skin 
tissue by histological, biochemical and mechanical analysis in order to better 
describe the main features of this human skin equivalent models. Furthermore, to 
validate the skin produced as testing platform, we induced different kinds of 
damages (UVA, H2O2) and after evaluating the effect on the tissue, with the aim to 
study the effectiveness of molecules having antioxidant and photo-protective 
action. 
Finally, in the last part of thesis, we described firstly, a comparison between 3D 
skin models designed by us with the commercially available gold standard models 
produced by best international companies, and then a scale-up strategy in order 
to improve the production process of 3D-skin equivalent models with the 
prospective of realization of a start-up. In this last part, we described phases and 
all critical steps of human skin equivalent production passing from the realization 
of skin tissue in small scale to the large scale and the development of a working 
plan of all activities to better control step by step the quality and the effectiveness 
of final product.  
All results reported in my thesis strongly suggested a possible use of the 
developed skin tissues as a valid alternative to the use of animal models for the 





Skin models for cosmetics testing: an 
overview 
1.1 INTRODUCTION 
Over the last years, Tissue Engineering (TE) has become established in biomedical 
and scientific scenario as a new emerging field consisting of several 
interdisciplinary applications that combine the principles and methods of life 
science with those of engineering, aiming at repairing or regenerating portions or 
of whole biological tissue and organs (bone, cartilage, bladder, skin, cornea, blood 
cells, muscle, liver, pancreas, intestine, etc.) [1]–[4]. The purpose of TE research is 
very clear: establishing a new clinical technology that makes possible medical 
applications for diseases that have been too difficult to be cured by existing 
methods. Initially, it was thought that the principles of TE could be applied only 
virtually, but today it is known that many applications are widely used not only in 
tissue regeneration, but also in the industrial field [5], [6]. The classical approach 
of TE is based on the paradigm according to which, by three elements, which cells, 
scaffold and soluble factors, it is possible to induce the regeneration of damaged 
tissue, in attempting to replace traditional medical treatments that in some cases 
It cannot be applied [4]. 
The biological materials are made up of cells, cellular signaling and extracellular 
matrix (ECM). The cells are the core of the tissue that need an adequate systems 
of signal transduction and/or ECM to exert its functions. The ECM is a of collagen 
and elastin fiber network synthetized by the cells themselves and secreted in the 
extracellular space. This complex structure supports biological processes and cell 
proliferation as well as guarantees resistance and support to the tissue. Single 
4 
 
cells, without a three-dimensional guide, are indeed not able to organize a 3D 
tissue with its complex architecture, since the only cell proliferation is not 
sufficient. Single cells need a 3D support, defined “scaffold” whose main function 
is to support and control cellular processes, as well as the proliferation, 
differentiation and the synthesis of organic molecules and mediators, known as 
growth factors, which act in an autocrine and paracrine pathways on cellular 
processes [7]. 
As it is known from the literature, the first 3D tissue models made through the 
application of TE principles were skin equivalent, bone, cornea and cartilage, all 
tissues more frequently damaged [8]. In parallel with the new methods of 
regenerative medicine, several companies and industries, from the ‘90s, started 
off methods suitable for the implementation of tissue equivalent models as in 
vitro test systems in order to verify the safety of substances, active ingredients 
and cosmetic products [9]. The in vitro models became important tools in the 
pharmaceutical and cosmetics industries for research and development. The best 
model useful for these studies is the human skin, but the difficulties linked to 
samples availability, legal and bioethical issues related to the use of cadaver skin, 
biopsy material or cosmetic surgery, they have increased the need to develop 
innovative methods aimed to the realization of in vitro tissue equivalent models. 
Furthermore, the availability of tissues is limited not only by the sources, but also 
by the current regulations. Until the early 2000s in fact, all the tests performed by 
cosmetic companies before putting a finished product on the market, were 
carried out on animal models [10]. 
1.2 STRUCTURE AND FUNCTIONS OF HUMAN SKIN  
The skin is named also integumentary system and it is the continuous largest 
organ of the body and it performs many vital functions, including protection 
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against external physical, chemical, and biologic assailants, as well as prevention 
of excess water loss from the body and a role in thermoregulation [11]. The 
integumentary system is formed by the skin and its derivative structures (Figure 
1). The skin is composed of three layers: the epidermis, on the upper part, the 
dermis, and subcutaneous tissue [11]. The outermost level, the epidermis, 
consists of a specific population of cells known as keratinocytes, which synthesize 
keratin, a long, threadlike protein with a protective role. The middle layer, the 
dermis, is fundamentally made up of collagen, while the subcutaneous tissue 
contains small lobes of fat cells known as lipocytes. The thickness of these layers 
varies considerably, depending on the geographic location on the anatomy of the 
body. The palms and soles of the feet for example, have the thickest epidermal 
layer, measuring approximately 1.5 mm. The dermis is thickest on the back, where 










Figure 1. The structure of integumentary apparatus 
(Mayo’s Foundation).  
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1.2.1 Epidermis  
The epidermis is a stratified, squamous epithelium layer that is composed 
primarily of two types of cells: keratinocytes and dendritic cells. [13]. The 
epidermis includes also a number of other cell populations, such as melanocytes, 
Langerhans cells, and Merkel cells, but the keratinocyte cell type comprises the 
majority of the cells. The epidermis commonly is divided into four layers according 
to keratinocyte morphology and position as they differentiate into horny cells, 
including the basal cell layer (stratum germinativum), the squamous cell layer 
(stratum spinosum), the granular cell layer (stratum granulosum), and the 
cornified or horny cell layer (stratum corneum) [12], [13]. The lower three layers 















The epidermis is a dynamic tissue in which cells are constantly in unsynchronized 
motion, as differing individual cell populations pass not only one another but also 
melanocytes and Langerhans cells move toward the surface of the skin. [14]. The 
basal epidermal cells guarantee a continually renewing of all layers of epidermis 
and gives rise to derivative structures, such as pilosebaceous apparatuses, nails, 
and sweat glands [13]. 
Keratinocytes  
Keratinocytes derived from ectodermal compartment and the differentiation 
process that occurs as the cells migrate from the basal layer to the surface of the 
skin results in “keratinization”, a process in which the keratinocyte first passes 
through a synthetic and then a degradative phase [14]. During the keratinization 
phase, the cell builds up a cytoplasmic supply of keratin, a fibrous intermediate 
filament that serves as part of the cell’s cytoskeleton. Bundles of these keratin 
filaments converge on and terminate at the plasma membrane forming the 
intercellular attachment plates known as desmosomes. During the degradative 
phase of keratinization, cellular organelles are lost, and the cell finally is known as 
a horny cell or corneocyte. The process of maturation resulting in cell death is 
known as “terminal differentiation” [15]. 
 
Basal layer  
The basal layer, or stratum germinativum, represents the deepest layer of 
epidermis and it contains column-shaped keratinocytes that attach to the 
basement membrane with their long axis perpendicular to the dermis [13]. 
Epidermal stem cells in the basal layer are clonogenic cells with a long lifespan 
that progress through the cell cycle very slowly under normal conditions. 
Migration of a basal cell from the basal layer to the cornified layer in humans 
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takes at least 14 days, and the transit through the cornified layer to the outermost 
epidermis requires another 14 days [14].  
 
Spinous cell layer  
The spinous layer is 5–10 cells thick and is composed of a variety of cells that 
differ in shape, structure, and subcellular properties depending on their location. 
Parabasal spinous cells, for example, are polyhedral in shape and have a rounded 
nucleus, whereas cells of the upper spinous layers are generally larger in size, 
become flatter as they are pushed toward the surface of the skin, and contain 
lamellar granules that containing glycoproteins, glycolipids, phospholipids, free 
sterols, and a number of acid hydrolases, including lipases, proteases, acid 
phosphatases, and glycosidases [14]. Desmosomes are located in the intercellular 
spaces between spinous cells and they promote mechanical coupling between 
cells of the epidermis and provide resistance to physical stresses [13]. The 
desmosomal plaques are composed of six polypeptides found on the cytoplasmic 
side of the cell membrane that are important in the regulation of the calcium 
required for desmosomal assembly and maintenance [16]–[18]. Gap junctions, 
another type of connection between epidermal cells, forming an intercellular 
pore, in order to allow physiologic communication via chemical signals for cell 
metabolism, growth, and differentiation [19]. 
 
Granular layer  
The granular layer is the most superficial layer of the epidermis containing living 
cells holding abundant keratohyaline granules in their cytoplasm. These cells are 
responsible of keratinization phenomenon by synthesis and modification of 
specific proteins [14]. The keratohyaline has an enzymatic action in the production 
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of “soft” keratin in the epidermis by providing periodic cutting of keratin filaments 
[20]. Lysosomal enzymes are found at high levels in the stratum granulosum 
because the granular layer is a keratogenous zone of the epidermis and here, the 
dissolution of cellular organelles is prepared as the cells of the granular layer 
undergo the abrupt terminal differentiation process to a horny cell of the 
cornified layer [14].  
 
Cornified layer  
Horny cells (corneocytes) are anucleated cells that provide mechanical protection 
to the underlying epidermis and a barrier to prevent water loss and invasion by 
foreign substances [21]. The corneocytes, rich in protein and low in lipid content, 
are surrounded by a continuous extracellular lipid matrix have lost their nuclei 
during terminal differentiation [13], [14]. In The physical accordance to the 
position inner the cornified layer, biochemical properties of cells are vary: cells in 
the middle can bind water molecules than the deeper layers because of the high 
concentration of free aminoacids found in the cytoplasm of middle layer cells. 
Desmosomes undergo proteolytic degradation as the cells progress outward, 
contributing to the shedding of corneocytes during desquamation [15]. 
1.2.2 Dermis  
The dermis is an integrated system composed of three elements: fibroblasts, 
macrophages and adipocytes. Cells are embedded in a fibrous, filamentous and 
amorphous connective tissue that accommodates stimulus-induced entry by 
nerve and vascular networks. The dermis comprises the bulk of the skin and 
provides its pliability, elasticity and tensile strength and interacts with the 
epidermis in maintaining the properties of both tissues. The dermis does not 
undergo a series of differentiation events similar to epidermal differentiation, but 
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the structure and organization of the connective tissue components are 
predictable in a depth-dependent manner. The matrix of dermis is composed of 
collagen, glycosaminoglycans and elastic fibers, that vary in a depth-dependent 
manner and undergo turnover and remodeling phenomena in normal skin, in 
pathologic processes, and in response to external stimuli [14]. The main 
components of dermis developed from mesodermal compartment except for 
nerves, which, like melanocytes, that derive from the neural crest. Only by the 
12th week, fibroblasts are actively synthesizing reticulum fibers, elastic fibers, and 
collagen, while, a vascular network develops and fat cells have appeared beneath 
the dermis by the 24th week. Small collagen bundles composed the infant dermis 
whereas the adult dermis contains thicker bundles of collagen [15]. The dermal 
compartment can be divided in two specific regions: papillary region and reticular 
region, whereas the deepest layer is the hypodermis, which is primarily made up 
of adipose tissue. The papillary region is composed of loose areolar connective 
tissue; the reticular region lies under the papillary region and is usually thicker. 
Blood vessels that supply the capillaries of the papillary region run through the 
reticular layer [22]. 
Fibroblasts  
Fibroblasts represent the main cellular component of dermal compartment, and 
encompass any stromal cell that does not express markers for a more specific 
mesenchymal lineage [23]. Despite this imprecise definition, fibroblasts are an 
impressively heterogeneous and dynamic cell lineage. Depending on their resident 
depth of dermis, fibroblasts express different quantities of collagen and ratios of 
collagen type I and III [24]. Thanks to their plastic origin in nature, cells that share 
fibroblasts’ mesenchymal origin, including adipocytes and pericytes, are able to 
de-differentiate into fibroblasts with an appropriate stimulus [25]–[29]. Likewise, 
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fibroblasts themselves are capable of altering their cellular profile, with the most 
common transition being that into contractile myofibroblasts [23], [30]–[32]. For 
all these reasons, fibroblast is a malleable cell, capable of altering its function and 
physiology or even transforming into a new cell type, based on its location within 
the body [23]. The molecular mechanisms driving these alterations are probably 
due both to soluble signaling molecules and the resident molecular framework of 
the fibroblasts extracellular microenvironment [23], [33].  
 
Collagen  
Collagen is the main component of dermis; it is a fibrous structural protein for the 
entire body (tendons, ligaments, the lining of bones, and the dermis). Collagen 
bundles and elastic fibers play a role in maintaining the elastic and resistance to 
physical stresses and deformation of the skin. Collagen fibers undergo a 
continuous turnover where proteolytic enzymes, called collagenases, degrade 
bundles replaced quickly by new fibers [15]. Collagen synthesis and deposition in 
the ECM started from fibroblasts, that integrate the precursor molecule, named 
procollagen, a helical polypeptide chain, in order to assembly procollagen 
precursors into collagen fibrils. Collagen fibers are rich in glycine, hydroxyproline, 
and hydroxylysine alternating with typical sequences. The major constituent of 
the dermis is type I collagen that, with collagen III, co-polymerize to form 
extended mechanically stiff fibrils [34], [35]. Collagen fibers have a differential 
deposition in the papillary and deep reticular dermis [36], in fact, the architecture 
of these fibrils appears disorganized, composed into bundles which in turn are 
often oriented parallel to the dermal-epidermal junction (DEJ) or organized into 
basket-weave arrangements [37]. Type IV collagen is localized to perpendicularly 
oriented, found in the basement membrane zone anchoring fibrils which play a 
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key role in securing the dermis to the DEJ [38]; it represents the major structural 
component of anchoring fibrils with collagen type VII, which is produced primarily 
by keratinocytes [13], [15], [22] [39]. 
 
Elastin  
Elastic fibers are responsible for skin elasticity and they are synthesized mainly 
during development and growth by fibroblasts in skin. The elastic fiber consists of 
two distinct components: elastin and fibrillin-rich microfibrils. Elastin is 
synthesized as a 70 kDa monomer precursor and secreted as soluble tropoelastin 
monomers which are then cross-linked in the presence of extracellular microfibrils 
to form insoluble elastic fibers [40]. Elastogenesis is controlled by elastin binding 
chaperone and may bring the tropoelastin molecule to the microfibrillar scaffold 
that regulates the deposition and/or the orientation of tropoelastin monomers 
[41], [42]. Interaction between tropoelastin and microfibrils is mediated by ionic 
bonding involving non-oxidized lysine side chains of tropoelastin [43]. Microfibrils 
can assemble independent of elastin to form functional structure within the ECM, 
while, insoluble elastin has not been observed in the absence of microfibrils [42]. 
Size, orientation and function of elastic fibers may change over a lifetime [44]. 
 
Glycosaminoglycans  
The dermal ECM is not wholly composed of fibrous proteins but it contains also 
other components that plays an important role in skin biology as 
glycosaminoglycans (GAGs) [39]. GAGs are long, linear polysaccharide composed 
of repeats of specific disaccharide units [45]. Among GAGs, chondroitin-sulfate, 
dermatan-sulfate, keratan-sulfate, heparin-sulfate, heparin and hyaluronic acid, 
are involved in various structural and space-filling functions and many 
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physiological regulations [46]. The main role of GAGs is the capability to bind 
water molecules and to contribute to maintenance skin water content and skin 
hydration [46]–[48]. The glycosylation of core proteins contribute to various 
physiological functions, including collagen and elastic fibers formation, cell 
adhesion and migration [47]. Hyaluronic acid (HA) is a minor component of the 
normal dermis and it represents the key molecule in skin hydration by means of 
interactions with other skin components modulating skin moisture [46]. HA is 
composed of repeating alternating units of glucuronic acid and N-
acetylglucosamine, all connected by β-linkages, GlcAβ (1→ 3) GlcNAcβ (1→4). In 
particular HA regulates water balance and osmotic pressure and it acts as an 
organizer of the ECM, stabilizing molecular structures by electrostatic interactions 
[46]. 
1.2.3 Dermal-epidermal junction 
The dermal-epidermal junction (DEJ) is a high specialized component located at 
the interface between the epidermis and the dermis. The DEJ separates these two 
compartments and regulates the overall structural integrity of the skin system. 
This complex structure permits the transit of migrating cells as melanocytes and 
Langerhans cells but restricts the diffusion of molecules between two 
compartments supporting the polarity, proliferation, migration, and 
differentiation of epidermal keratinocytes [49]. In particular, DEJ is composed of 
four descriptive zones: the cell membranes of the basal keratinocyte which 
contain hemidesmosomes, the lamina lucida, an electron-lucent region seen by 
electron which anchoring filaments traverse; third, the lamina densa and finally 
the sub-basal lamina, which contains anchoring fibrils [49]–[51]. Each zones 
contains ubiquitous components, as laminin in the upper region, collagen type IV 
and heparan-sulphate proteoglycan predominantly in the lamina densa and type 
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VII collagen within the anchoring fibrils in the sub-basal lamina densa [50]. The 
regulation of the adhesive interactions of hemidesmosomes with the underlying 
basement membrane is essential in various biologic processes, such as wound 
healing, tissue morphogenesis and cancer development and progression [49], 
[50].  
1.3 TISSUE ENGINEERING OF THE SKIN  
In the vast scenario of in vitro tissue development by the application of TE 
approaches, the realization of skin models represents the most interesting 
innovation: in vitro generated skin models find growing interest as promising tools 
in basic research and clinical application in regenerative medicine and in the field 
of cosmetic testing. Skin equivalents, in fact, are employed from a side, in order to 
study tissue regeneration processes and mechanisms of pathogenesis (skin 
regeneration, wound healing phenomenon, genetic and structural alteration of 
epidermis) and from another side, as a useful screening platforms for the 
characterization and identification of compounds and active ingredients of 
cosmetic products, since abolishing the use of animal models. Although the 
demand for human tissue is growing, the lack of availability by the sources and the 
respective regulations have made the in vitro models important tools for research 
and development in the pharmaceutical and cosmetics industries. The clinical 
demand for tissue-engineered dermal and composite skin replacements continues 
to be high, despite there being a number of such products (Dermagraft, Apligraf) 
available today [52]. Limitations of these products include poor mechanical 




Although these in vitro models may serve as alternatives, they cannot completely 
satisfy the physiological or anatomical requirements found in in vivo models. 
Pharmaceutical and cosmetics industries developed strategies and innovative 
protocol for the realization of noncommercial in vitro human skin equivalents 
(HSE). The need for alternative models to assess dermal toxicity is great in 
biomedical research to test or evaluate the toxicity of numerous compounds. In 
order to reduce or replace animals in scientific research, ‘‘animal alternatives’’ are 
being pursued. For this purpose, HSE are employed to replace animal models with 
alternative test methods as three dimensional models of human skin. The 3D 
model has important advantages compared to monolayer cell culture and to 
simple epidermis model in efficacy testing: the possibility of long-term cultivation 
with repeated application of active principles and cosmetic formulations, the 
similarity to human skin allows to study dermis-epidermis interaction, 
characterization of keratinocytes differentiation and keratinization [54], [55]. In 
general, these in vitro models of skin consist of keratinocytes cultured over 
fibroblast-populated dermal matrices: briefly dermal fibroblasts are encapsulated 
within ECM components like collagen, fibrin, kitosan-glycosamminoglycan 
Figure 3. Apligraf skin model. 
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matrices or seeded onto decellularized dermis and cultured from a few days to a 
week. After this time, keratinocytes are seeded on top of the dermal equivalents, 
cultured under submerged conditions for few days and then the culture is 
exposed to the air (commonly defined air–liquid interface culture condition) in 
order to obtain epidermal differentiation, stratification and development of a 
cornified layer [56]–[58]. The various dermal substitutes used to mimic full-
thickness human skin include decellularized/de-epidermized dermis [56], [58] 
collagen type I [30], collagen-glycosaminoglycans [59], fibrin [60]–[62], fibroblast-
derived matrix [63] and synthetic polymers [60]. 
1.3.1. Alternative non-animal testing and european regulations 
The 7th amendment to the EU Cosmetics Directive prohibits to put animal-tested 
cosmetics on the market in Europe after 2013. Before the European regulation 
1238/2016, the Directive 76/768/CEE, established prohibitions about animal 
testing for cosmetics products: 
 the prohibition of testing of finished cosmetic products and ingredients on 
animal models (Experimental Prohibition); 
 the prohibition of finished cosmetic products containing ingredients or 
part of that they have been tested on animals (prohibition of placing on 
the market). 
The prohibition of placing on the market cosmetics products tested in animals 
became effective on 11 March 2013. In that context, the European Commission 
invited stakeholder bodies (industry, non-governmental organizations, EU 
Member States, and the Commission’s Scientific Committee on Consumer Safety) 
to identify scientific experts in five toxicological areas, i.e. toxicokinetic, repeated 
dose toxicity, carcinogenicity, skin sensitization, and reproductive toxicity for 
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which the Directive foresees that the 2013 deadline could be further extended in 
case alternative and validated methods would not be available in time. The 
selected experts were asked to analyze the status and prospects of alternative 
methods and to provide a scientifically sound estimate of the time necessary to 
achieve full replacement of animal testing. However, the experts were also of the 
opinion that alternative methods may be able to give hazard information, i.e. to 
differentiate between sensitizers and non-sensitizers ahead of 2017. For 
toxicokinetic, the timeframe was 5–7 years to develop the models still lacking to 
predict lung absorption and renal/biliary excretion, and even longer to integrate 
the methods to fully replace the animal toxicokinetic models. For the systemic 
toxicological endpoints of repeated dose toxicity, carcinogenicity and reproductive 
toxicity, the time horizon for full replacement could not be estimated. In early 
2003, the 7th amendment the European Union’s Cosmetics Directive (76/768/EEC) 
was adopted stipulating an immediate end to animal testing in the EU for 
cosmetic products and a complete ban of animal testing for ingredients by 11 
March 2009, irrespective of the availability of alternative methods. The European 
Centre for the Validation of Alternative Methods (ECVAM), hosted by the Institute 
for Health and Consumer Protection of the European Commission’s Joint Research 
Centre, was asked to coordinate this activity. ECVAM, existing since 1991, has 
invested considerable time and resources in coordinating and promoting the 
development, validation and use of alternative methods. The most favorable 
outlook in terms of the time estimated for full animal replacement (5 years or 
less) was in the area of skin irritation. Test methods for skin corrosion, skin 
absorption/penetration and phototoxicity were already adopted into legislation at 
that time. Prospects for the mid to long-term (over 5 and up to 15 years) included 
the areas of eye irritation, acute toxicity, skin sensitization, genotoxicity and 




Toxicokinetic is the endpoint that informs about the penetration into and 
fate within the body of a toxic substance, including the possible 
emergence of metabolites and their absorption, distribution, metabolism 
and excretion (ADME). While toxicokinetic is an intrinsic part of an in vivo 
animal study, when developing an alternative approach based on in vitro 
studies, toxicokinetic becomes an absolutely crucial and indispensable first 
step in translating the observations in vitro to the human in vivo situation. 
Toxicokinetic studies are important for safety assessment of a cosmetic 
ingredient, testing for systemic toxicity is only necessary if the ingredient 
penetrates into the body following dermal, oral, or inhalation exposure 
and if internal exposure potentially exceeds critical levels, i.e. the internal 
Threshold of Toxicological Concern (TTC). Toxicokinetic studies are also 
necessary to evaluate the possible range of target doses at the cell or 
tissue level that can be expected from realistic external human exposure 
scenarios to cosmetics. This information is crucial for determining the dose 
range that should be used for in vitro testing. Kinetics in the in vitro system 
and dose–response information is also crucial to translate in vitro results 
to the (human) in vivo situation. 
 
 Skin sensitization 
Skin sensitization represents the toxicological endpoint associated with 
chemicals that have the intrinsic ability to cause skin allergy, termed 
allergic contact dermatitis (ACD) in humans. The mechanisms at the basis 
of the induction of skin sensitization are rather complex but relatively well 
understood and involve the following key steps: skin bioavailability, 
haptenation (binding to proteins), epidermal inflammation, dendritic cell 
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activation, dendritic cell migration and T-cell proliferation. Skin 
sensitization (and ACD) appears only after repeated exposure. All 
predictive tests conducted to identify substance causing sensitization 
historically has been based on animal testing. In recent years, non-animal 
alternative methods have been developed and evaluated to identify skin 
sensitization hazard potential. a range of non-animal test methods that 
address the above-mentioned key mechanisms involved in skin 
sensitization would be necessary to yield an alternative measure of skin 
sensitizer potency. 
 
 Repeated dose toxicity 
The term “repeated dose toxicity” comprises the general toxicological 
effects occurring as a result of repeated daily dosing with, or exposure to, 
a substance for a part of the expected lifespan (sub-chronic exposure) or, 
in case of chronic exposure, for the major part of the lifespan of the 
experimental animal. The onset and progression of this toxicity is 
influenced by the interplay between different cell types, tissues and 
organs, including the concomitant contribution of toxicokinetic, hormonal 
effects, autonomic nervous system, immunosystem and other complex 
systems. Current repeated dose toxicity studies provide information on a 
wide range of endpoints because changes in many organs and tissues are 
taken into account. They allow evaluation of an integrated response and 
its quantitative (dose–response) aspects, making its replacement very 
challenging. For this purpose, alternative methods have been developed in 
order to evaluate quantitative risks based on the perturbation of a 
biological systems, or molecular pathways leading to toxicity. The aim of 
evaluation of repeated dose toxicity is defining quantitative safety 
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assessment related to repeated dose toxicity of cosmetic ingredients. The 
best approach is based on combining and interpreting data on multiple 
targets obtained from a variety of alternative methods and on the 
extrapolation between exposure routes. In conclusion, in the last years, 
the progress of (basic) research and development paved the way to 
transfer basic research results into practical and robust alternative test 
methods that allow adequate safety assessment and risk management.  
 
 Carcinogenicity 
Carcinogenesis is a long-term process characterize by a complex sequence 
of events, biological interactions and aberrant molecular pathways that 
could be triggered by chemical substances depending to mode of action 
and target organs. The 2-year cancer assay in rodents is widely regarded as 
the “gold standard” to evaluate the cancer hazard and potency of a 
chemical substance. It is clear that the animal testing ban under the 7th 
amendment of the Cosmetics Directive will have a strong impact on the 
ability to evaluate and conduct a quantitative risk assessment for potential 
carcinogenicity of new cosmetic ingredients. This impact is not only due to 
the ban on the cancer assay itself, but mainly to the ban on in vivo 
genotoxicity testing, any repeated dose toxicity testing, and other tests 
such as in vivo toxicokinetic studies and in vivo mechanistic assays. 
 
 Reproductive toxicity 
Reproductive toxicity is probably the most difficult endpoint to be 
replaced, since it has not only to provide an understanding of the many 
mechanisms and their interactions which are essential for male and female 
fertility but also an understanding of the development of the entire human 
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being during its prenatal life and for this reason only animal models are 
hitherto accepted as adequately representing the complexity and 
providing an assessment of the complex interaction of chemicals on the 
reproductive system. Despite this, in the last decades, some non-animal in 
vitro tests have been developed and validated that address specific 
aspects, such as embryotoxic or endocrine disrupting effects, of the overall 
reproductive system; in fact, only selected mechanisms, which lead to 
reproductive toxicity, can be mimicked in vitro. The available tests are used 
as screening tools or for providing additional or supporting mechanistic 
information, but no single alternative method or set of methods is yet 
available that could replace the current animal tests used for assessing 
reproductive toxicity of chemical substances and support safety 
assessments. 
 
 Conclusions  
Thanks to recent advances in cell-based research including use of stem cells, and 
the development of two-dimensional and three-dimensional cell (co)-cultures, are 
facilitating the production of much more sophisticated structures more similar to 
tissues in the body which can be used as complex system to study molecular 
pathways, cellular behavior, short and long term effects of chemicals and active 
compound. These 3D tissue model promise the development of a more predictive 
risk assessment, based on a better understanding biological events triggered by a 
chemical. It is important to say that, each alternative method may not be able to 
generate all required information, but their combination that might provide a 
sufficient basis for a complete safety assessment for active principles and 
chemical compound. [10]. 
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1.3.2. Insights from in vitro skin models for clinical applications 
The first attempts to create in vitro artificial skin models date back to the 70's, 
when Rheinwald and his research group, managed to grow human primary 
epidermal cells in serial culture on a layer of lethally irradiated 3T3 murine 
fibroblasts. This first attempt was unsuccessful, and Rheinwald understood the 
importance of cellular crosstalk between keratinocytes and fibroblasts [64]. 
Subsequently, cultured epidermal autografts (CEAs) were tested but they showed 
several limitations depending on the wound site and status, age of the patient, 
and knowledge and experience of the operator [65]–[69]. Only in 1981 Bell et al. 
[70] developed a dermo-epidermal in vitro system that was tested on animals, and 
after this first experiments, the technique of realization was perfected, in order to 
obtain the commercial model named Apligraf, which was fabricated using human 
allogeneic fibroblasts and keratinocytes. Thanks to advances in TE regeneration 
protocols, several dermo-epidermal skin substitutes, consisting of human 
autologous keratinocytes and fibroblasts in bovine collagen, were applied in 
severe burn patients to induce skin regeneration, demonstrating the importance 
of epithelial–mesenchymal interactions and the relevance of cross-talk between 
fibroblasts and keratinocytes for the establishment of a functional basement 
membrane [71], [72]. In the 1980s there were developed acellular matrices based 
on collagen and GAGs, giving birth to the actual model commercially available as 
Integra Artificial Skin (Figure 4) (commonly referred to as Integra) that 
represented the major step in tissue engineering of skin and it paved the way to 
new and more complex dermo-epidermal skin model, in order to optimize clinical 





Based on these studies, various companies and start-ups have developed in vitro 
skin tissue equivalent models for pharmaceutical, cosmetic and chemical 
compound screening and testing. These commercially available skin tissue 
equivalents for in vitro testing offer significant advantages over the traditional 
monolayer co-cultures but also differ in important ways from natural skin tissue: 
organotypic cultures predominantly utilize mitotically-active early passage 
fibroblasts derived from human foreskins, abdomen, forearm or breast tissues 
which proliferate within the dermal matrix resulting in 3–4 fold increase over a 3 
week culture period [60], [73]. Further, studies also reveal the importance of 
fibroblast-keratinocyte crosstalk for the generation of a well-organized basement 
membrane, and for the optimal keratinocytes differentiation [56]. Studies on 
Figure 4. Schematic representation of Integra Skin model. 
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organotypic cultures on type I collagen and de-epidermized dermis have 
demonstrated the role of keratinocyte-fibroblast interactions that influence the 
formation of basement membrane and which in turn can influence the 
keratinocyte phenotype [58], [74]–[76]. In fact, in organotypic cultures, a 
functional basal membrane was observed by the presence of specific markers as 
collagen type IV and VII, laminin-5, laminin-10/11, expressed only in the presence 
of fibroblasts that release soluble factors like EGF, KGF and GM-CSF [55], [56]. 
Several attempts are tested to optimize such variables as timing of keratinocyte 
addition to the co-culture, and fibroblast seeding densities inner collagen matrices 
[58]. As explained already, organotypic culture of full-thickness skin equivalents 
principally involves the following steps: seeding and culture of fibroblasts 
onto/within dermal matrices followed by keratinocyte seeding on the surface of 
matrices and culture at air–liquid interface. Similarly, we observed contraction 
phenomenon of collagen-based dermal matrix with and without the presence of 
fibroblasts, while contraction of the fibrin-based dermal matrix was minimal 
irrespective of the presence or absence of fibroblasts. Experiments with scaffold-
reinforced fibrin-based dermal matrices and extended culture periods of up to 12 
weeks have previously been reported [60], [61], highlighting the inherent 
properties of different dermal matrices and the potential enhancements that may 
be made to culture models under the right conditions. Several studies and 
investigations on HSEs suggest the presence of a complex 3D system whit all 
molecular and cellular pathway typical of native skin compartment: investigations 
suggest the existence of receptors in epidermal and/or dermal regions, they have 
been primarily focused on skin keratinocytes and information on their role and 
expression among the heterogeneous dermal fibroblasts is limited. Other studies 
have demonstrated the presence of neurohormone receptors and 
neurotransmitter systems in non-neuronal skin cells which are involved in skin 
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homeostasis and inflammation like acetylcholine (nicotinic and muscarinergic), 
adrenergic, histamine, opioid, cannabinoid, kinin, prostanoid, vasoactive intestinal 
peptide, somatostatin and neuropeptide receptors. Experiments accomplished on 
in vitro HSEs demonstrated that the exposure of dermal fibroblasts to nicotine 
produces an increase in cell cycle and apoptosis related regulators and an 
upregulation of MMP-1 and collagen type-I suggesting an alteration in ECM 
turnover [77]. In summary, with the advent of organotypic models our knowledge 
of skin biology and of the roles of fibroblasts/fibroblast-keratinocyte crosstalk has 
grown significantly. However, all in vitro models of native skin developed during 
this years, lack of all aspects of the complexity of the in vivo counterpart, for 
instance, barrier functions, innervation, a continuous blood supply, presence of 
skin appendages, and interactions with immune cells [56]. A several group of 
organotypic 3D system are employed as skin substitutes for clinical applications. It 
is possible to dived engineered skin substitutes in two large groups of application: 
large and deep burn wounds, or chronic situations, as disabling scars, and chronic 
ulcers, that can be ideally replaced by an adequate skin graft [78]. 
Skin autografts are harvested from uninjured areas and then applied to the 
excised or debrided areas of the wounded skin of the same individual previous an 
adequate tissue preparation in order to agree the merge between the capillary 
network of the wound with that of the skin graft. However, many problems arise 
from skin autografts: if a dermal substitute reaches a threshold thickness [79], 
vascularization is too slow to assure nutrition of the overlying epidermis resulting 
in epidermal necrosis or graft loss. For this reason, most dermal substitutes 
thicker than 1 mm are applied using a two-step approach in order to avoids 
epidermal necrosis, as the dermal substitute is given sufficient time to vascularize 
[65]. Other problems liked to skin transplant may be the lack of pigmentation and 
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elasticity, contraction and low mechanical proprieties of tissue, the lack of 
protection against UV ray exposition. Therefore, bioengineered HSEs could be 
used to provide a more permanent solution. Several commercial products were 
developed during the last 30 years. Most of them were designed for permanent 
use, some of them as temporary substitutes. All skin substitutes are fabricated 
using a similar approach, using cells of different origins (autologous, allogenic or 
xenogeneic) and polymers as biodegradable scaffold for cell attachment and 
proliferation. In the vast scenario of HSEs for clinical application, it is possible to 
classified them into epidermal, dermal and dermo-epidermal substitutes. 
Epidermal substitutes contain autologous keratinocytes often grown in the 
presence of murine fibroblasts [65] and can be classified into several types: 
acellular skin substituted and cellular autologous skin substitutes [80]. Examples 
are Biobrane, employed in the late 1970, is now used as temporary substitute, 
composed of nylon mesh, which acts as a “dermis” and a silicon membrane which 
acts as an “epidermis” and it is used as a temporary coverage for superficial or 
mid dermal partial thickness wounds, burns, donor sites and congenital diseases 
such as epidermolysis bullosa; Integra Skin Substitute developed by Yannas and 
Burke [80], [81] is a bi-layered skin substitute made of a silicone membrane water 
resistant; the dermal part is made of bovine collagen and shark chondroitin-6-
sulphate glycosaminoglycan that allows the whole vascularization within 2-3 
weeks from the application; Alloderm, is essentially formed from acellular matrix 
derived from a cadaveric dermis adequately processed without epidermal layer. 
However, this acellular matrix represents a good natural niche for fibroblast and 
endothelial cells to generate neodermis [82]. After application to prepared 
dermis, these substitutes are colonized and vascularized by underlying cells [65]. 
Cellular allogenic substitutes include Transcyte, Dermagraft, Apligraf. 
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Trancyte is a tissue substitute made from a nylon mesh and allogenic fibroblasts 
from neonatal foreskin embedded into the mesh and allowed to grow for 3-6 
weeks to obtain a cellular matrix which enhances tissue regeneration.; Dermagraft 
is similar to Trancytes but lacks the silicon layer and also contains a fibroblasts 
mixed in a polyglycolic acid matrix in a bag of circulating nutrients [83], while, 
Apligraf is an example of an organotypical skin substitute composed of both 
dermis and epidermis fabricated by mixing living fibroblasts from neonatal 
foreskin with bovine collagen type I and neonatal foreskin keratinocytes seeded 
on the surface of dermal compartment for 4 days in order to allow cell 
proliferation. High calcium concentration and the air-liquid interface culture 
system allowed cellular differentiation and keratinization of epithelium [84]. In the 
1998, FDA (Food and Drug Administration) approved the clinical use of Apligaf for 
treatment of venous and diabetic ulcers [81], [85] and for the conventional 
treatment of non-infected partial or full thickness venous ulcers which have not 
responded to conventional treatment. Cellular autologous skin substitutes include 
tissue systems employed as a temporary coverage of skin surface for the 
treatment of large wound regeneration by autologous keratinocytes for the 
permanent skin coverage [65], [80]. 
Among cellular autologous substitutes, most tissue systems belong to the 
category of cultured epidermal autograft, also called CEA (Epicel, Epidex) for 
which keratinocytes obtained from skin biopsy of patient, are grown to stratified 
cell sheets in order to obtain the final product in 3 weeks [65], [86], [87]. Once 
applied to the pre-treated dermal wound bed, CEAs can be employed directly or in 
combination of other methods [65]. Cultured skin substitutes (CSS), are tissue 
systems based on both epidermal and dermal components, with a minimal risk of 
infection transmission, and they act as a permanent coverage. The most 
28 
 
commonly used type is a hyaluronic acid derived substitute. Hyaluronic acid 
facilitates the growth and movement of dermal cells and controls matrix 
hydration [80]. Actually, skin substitutes commercially available are classified on 
the basis of tissue composition:  epidermal, dermal, and full-thickness models. 
Epidermal models 
Several companies offer epidermal HSEs including Genzyme’s Epicel based on the 
use of a cultured keratinocytes obtained from a small biopsy. Keratinocytes are 
cultured aseptically for a period of several weeks to expand the cell population 
into many skin grafts. The resulting grafts are sheets of skin approximately 50 cm2 
and two to eight cell layers thick [64]. 
 
Dermal models 
Dermal skin replacements add greater mechanical stability and prevent the 
wound from contracting. The most commonly used are Transcyte, Dermagraft, 
Alloderm and Strattice and finally Integra Dermal Regeneration Template [56].  
 
Full thickness models 
Full-thickness models of HSEs are composed of both epidermal and dermal layers; 
keratinocytes and fibroblasts, either autologous or allogeneic, are utilized to 
prepare the bilayer structures. These full-thickness skin substitutes are more 
complete skin systems and they are very close to native skin mimicking the 
principal features and proprieties. In fact, primary keratinocytes cultured for few 
weeks on fibroblasts, epidermal cells can proliferate and differentiate 
recapitulating histological structure of the epidermis in vivo. Fibroblasts provide 
an ample support for keratinocytes [56] Apligraf is an example of bilayered skin 
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model, while a new product called PermaDerm is a can act as a permanent cover 
of large burns and injuries. It uses keratinocytes and fibroblasts seeded into a 
collagen sponge. 
1.3.3. Commercially available human skin equivalents for in vitro 
applications 
Among HSE commercially available, various skin models have been developed as 
platform for chemical and pharmacological applications in order to substitute 
animal models. Also in this case, HS for cosmetics testing belong to different 
groups: epidermal or dermal models and full-thickness model [78]. These 3D skin 
model are employed to study safety of different substances and chemicals, in 
terms of corrosiveness, phototoxicity, irritation. Actually, the implementation of 
3D in vitro HSE is required by international companies to: 
 test the efficacy of newly developed formulations and products and thus to 
use them for claim support; 
 differentiate compounds that cause reversible and irreversible toxicity without 
resorting to in vivo animal testing; 
 provide accurate and measurable mechanistic information that can be utilized 
to determine whether a molecule or compound can be altered to reduce 
irritation or toxicity, without loss of efficacy; 
 objectively compare the toxicity and efficacy of newly-developed compounds 
with those already in use in the market place for the same purpose; 
 evaluate the long-term stability or shelf-life of finished products or raw 
materials; 




HSE can be utilized to test drug permeation of cosmetics and personal care 
products applied topically on skin surface. The SC (corneous layer) is a major 
barrier to the uptake of drug molecules into and through the human skin, and the 
mechanistic principles for drug transport in the skin models are rather similar, so 
for this purpose it is important for cosmetic and pharmaceutical companies to 
have a reliable in vitro screening system to test the number of drugs/active 
ingredients that permeate into the epidermis, dermis, and across the membrane. 
In recent years, companies such as L’Oréal and SkinEthic have invested heavily in 
the development of skin models for pharmaceutical, cosmetic and chemical 
compounds testing, but from several studies revealed that actual available skin 
models have a less efficient barrier function than the native human skin. Drug 
permeability in cultured skin models is higher than in intact human skin in vitro, 
sometimes the difference is even 2–3 orders of magnitude [78]. The permeation 
barrier of skin models is generally less developed and more permeable to 
molecules than native counterpart. One of most highly developed applications of 
commercial reconstructed epidermis models is in vitro prediction of the 
cutaneous irritancy of topically applied products and active compounds. The 
cutaneous uptake of chemicals applied topically, is the first step in the induction 
of skin damage since keratinocytes are known to play a crucial role in the initiation 
and regulation of epidermal inflammation [88]. The use of three-dimensional 
human keratinocyte cultures is the logical choice for the skin irritation tests 
because of the test material will be applied topically on the surface of the 
corneous layer in order to mimic exposure conditions and concentrations of the in 
vivo application. Typically, skin models are pre-treated with tested chemical by 
incubation, then treated with drug by a topical application during the whole 
experiment. Irritation markers are either released into the culture medium under 
the viable epidermis or they can be detected from keratinocyte cells with different 
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techniques (MTT, Alamar Blue as viability tests or LDH enzyme activity to evaluate 
cell membrane integrity). The process of alternative methods validation is 
regulated by ECVAM (European Centre for the Validation of Alternative Methods) 
and it involved in three principal phases: pre-validation (protocol refinement; 
phase I), protocol transfer between laboratories (phase II), and protocol 
performance (i.e. the reproducibility and predictive ability of the tests; phase III) 
and formal validation study (to meet the criteria of test sensitivity and specificity 
>60% for correct classification, based on statistical data analysis) [78]. 
Some 3D in vitro reconstructed human skin models were already developed in the 
1990’ including the EpiSkin model (L’Oréal) and EpiDerm model (MatTek 
Corporation), and subsequently, additional in vitro skin models were included to 
the commercial market, as EST1000 skin model (Cell System), Phenion full-
thickness skin model (Henkel), Straticell model (Straticell), StrataTest model 
(Stratatek), and more recently introduced Labcyte model. 
 
Episkin and SkinEthic RHE skin models 
The EpiSkin model (Figure 5a) was developed in 1991 and it is composed of a 
collagen lattice mixed with human fibroblasts, surfaced with a film of type IV 
collagen, with a fully differentiated epithelium. In 1997 this model was acquired 
by L’Oréal [89]. The SkinEthic model (Figure 5b) was fabricated in 1990, by seeding 
human keratinocytes on inert filters, which are exposed to the air-liquid interface 
in order to allow differentiation of epidermis [90]. Actually, both models have 
been scientifically validated for skin corrosion and irritation assessment by 
ECVAM. In fact, in 2007, ECVAM announced the validation of EpiSkin as a full 
replacement method for assessing the skin irritancy potential of chemicals. In 
addition, both models are used for screening acute and chronic irritation of 
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topically applied formulation and testing phototoxicity [91], genotoxicity, barrier 
function and metabolism of cosmetic compounds [92]. 
 
 
EpiDerm and EpiDermFT skin models 
The EpiDerm in vitro reconstructed skin model, fabricated by MatTek Corporation, 
is composed of human epidermal keratinocytes that develop a fully-differentiated 
epithelium with a basement membrane and stratum corneum, after air-liquid 
interface culture system on a polycarbonate filters. This 3D model was introduced 
to the commercial market in 1993 and later, the company, introduced also a full-
thickness model called EpiDermFT composed of an epidermis completely 
differentiated ion a dermis compartment, obtained mixing human dermal 
fibroblasts and exogenous bovine collagen (Figure 6a). Later, MatTek introduced a 
melanocyte containing epidermal model called MelanoDerm. EpiDerm models are 
employed by several industries in product development, safety assessment and 
drug discovery. The most important supplication are skin irritation, skin corrosion, 
and in particular, in vitro skin irritation data collected using this model, correlate 
well with human dermal irritation effects caused by compounds and chemicals, 
with pre-validation studies performed on phototoxicity and dermal penetration. 
Several additional applications using EpiDerm models include cosmetic products 




testing, skin metabolism, genotoxicity, nanotoxicity and pharmacology. Also 
MelanoDerm is one of innovative model fabricated by MatTek Corporation 
employed for several applications; MelanoDerm System consists of normal, 
human-derived epidermal keratinocytes (NHEK) and melanocytes (NHM) cultured 
to form a multilayered, highly differentiated model of the human epidermis. The 
NHM within co-cultures undergo melanogenesis leading to tissue pigmentation. 
The cultures are grown on tissue culture inserts at the air-liquid interface, allowing 
for topical application of skin lighteners or self-tanning agents. MelanoDerm 
provides a useful in vitro means to evaluate cosmetic and pharmaceutical agents 
designed to modulate skin pigmentation. Actually, the same company realized a 
new pathological model, named Psoriasis, a diseased 3D model of psoriasis 
produced from normal human epidermal keratinocytes and psoriatic fibroblasts 
harvested from psoriatic lesions (https://www.mattek.com/products/psoriasis/). 
The EST1000 skin model  
The EST1000 skin model is an in vitro 3D RHE produced by Cell System (Troisdorf), 
became epiCS in 2012. This skin system is fabricated stating from normal human 
keratinocytes that form a multilayered, highly differentiated model of the human 
epidermis (Figure 6b). Due to the skin barrier function of the epidermis, liquid, 
creamy and solid substances can be applied topically-onto the stratum corneum to 
closely mimic the in vivo situation. Substances can also be applied systemically by 
adding to the cell culture medium (http://reconstructed-human-
epidermis.com/overview/epics/). The model is used in a wide range of regulatory 
toxicology tests as irritation, corrosion and phototoxicity analysis and actually, 
was validated and approved for skin corrosion testing according to the OECD 
guideline 431 [93]. In 2013 the company launched the pigmented RHE "epiCS-M" 
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available with melanocytes from donors of three different photo-types: 
Caucasian, Afro-American and Asian-Caucasian. 
 
The Phenion Full-thickness skin model  
This model produced by Henkel (Germany), was introduced commercially in 2006. 
It consists in human fibroblasts isolated by biopsy are grown in an artificial matrix 
equivalent (Figure 6c). After the development of this dermal equivalent, 
keratinocytes obtained from the same donor are seeded on the top of the first 
compartment. Within several days an epidermal tissue featuring all typical 
epidermal layers, including a multilayered stratum corneum, develops. This model 
was employed for skin irritation, photoxicity, dermal adsorption , and genotoxicity 
studies [94]–[96]  
 
Other skin models  
The StratiCELL skin model was fabricated by the company Straticell (Les Isnes) and 
is a reconstituted human epidermis with and without pigmentation, composed of 
normal human keratinocytes and melanocytes cultured on a polycarbonate 
membrane in a well-defined serum-free medium at the air-liquid interface in 
order to allow keratinocytes differentiation. Actually, this 3D skin system is 
preparing for catch-up skin irritation validation and the models were also 
Figure 6. Histological images of most important commercially available human skin 
models. a) EpiDermFT; b) EST1000; c) Phenion FT. 
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evaluated for usefulness in nanotoxicology testing. Additional specific safety 
applications of the StratiCELL skin model are currently being evaluated 
(genotoxicity and phototoxicity). This model represents a relevant tool for safety 
and dermato-cosmetic activity testing, for penetration and absorption studies and 
for providing insights into mechanisms of action of an active or product. Recently, 
it was fabricated a new skin model (MEL/001) using melanocytes from african or 
caucasian donors in order to reproduce the reconstitution of dark tanned and 
light tanned pigmented tissues, respectively. This model represents a relevant tool 
to investigate and characterize molecular pathways involved in skin 
melanogenesis, de/pro-pigmentation as well as to study new active ingredients 
and to evaluate photo-protection (http://www.straticell.com/en/In-Vitro-Skin-
Models/in-vitro-reconstituted-epidermis.php). 
The LabCyte skin model (EPI-model) is produced by Japan Tissue Engineering 
Corporation and it consists of human epidermal cells seeded on inserts. After 
human epidermal cells proliferation, the exposure to the air-liquid interface 
solicits keratinization, creating a cultured epidermis model similar to the human 
epidermis. The EPI-model has undergone validation for skin corrosion and skin 
irritation in accordance with the OECD test guideline 431 and 439 [97]. The 
Vitrolife-SKIN skin model is produced by Gunze Corporation (Kyoto) and is 
commercially available as a kit containing 24 collagen sponges without cells and 
culture medium. The models are not ready to use and it need to be prepared in 
the laboratory, cultivating cells in sponges for several days in order to obtain a 3D 
skin model composed of a dermis and an epidermis with cornified layers as 
described in the literature. Recently, this model was validated for corrosion and 
obtained the JACVAM (Japanese Centre for the Validation of Alternative Methods) 
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validity statement that the Vitrolife-SKIN corrosion assay complies with the OECD 
guideline (http.//jacvam.jp/files/effort/01001/01_001_05_en.pdf.2008), [98].  
The StrataTest skin model is developed by the company StrataTech (Madison), 
and it consists of a fully-stratified human skin tissue enriched of dermal and 
epidermal components. The epidermal compartment is generated by the terminal 
differentiation of a spontaneously immortalized keratinocytes cell line (NIKS) [99]. 
The dermal counterpart contains normal human fibroblasts embedded in a fibrous 
collagen matrix [100]. Unlike other skin models, StrataTest requires keratinocytes 
from the same source, in order to obtain a consistent, reproducible test platform. 
Several tests described the biological response to chemical compound treatments 
[100] antibiotics formulations [102]. In particular NIKS cells are able to be 
genetically modified by non-viral methods to generate stably-transfected clones 
[103]. Data collected with skin irritation tests are comparable to native skin in 
vivo, and for these reasons the model is preparing for catch-up skin irritation 
validation. 
In addition to the skin model described above, which can be considered the most 
used models in industry today, several other in vitro 3D skin systems are 
fabricated. The company BIOalternatives, has developed an in-house 
reconstructed epidermis model, called EPI-Ba, mostly used for pre-clinical efficacy 
studies [104]. The company commercializes a “3D epidermal kit” which contains 
all necessary materials and reagents, including epidermal cells, to reconstitute a 
3D epidermal model in the laboratory [105], provides 3D tissue models ‘on 
demand’, including both epidermal and dermal-epidermal models using its 
proprietary chemically defined medium 
(http://www.sterlab.com/ingenierie_tissulaire/laboratoire_ingenierie_tissulaire.h
tml). Finally, the UK-based biotech company Evocutis (Innovenn) has developed a 
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full-thickness skin equivalent called LabSkin, consisting of a fully differentiated 
epidermis on top of a dermal compartment composed of fibroblasts embedded in 
a fibrin matrix. The model also allows microorganisms to be grown on its surface, 
mimicking infection or the skin natural microflora. This configuration ensures 
available assays include assessments for antimicrobial and pre-biotic activity, 
penetration, anti-ageing and anti-inflammatory properties. Actually, the 
applications of LabSkin have extended to wound healing studies researching 
active compound and ingredients efficacy (http://www.innovenn.co.uk/labskin/). 
Conclusions 
Commercially available 3D skin systems have become reliable tools in toxicity and 
efficacy testing for both pre-clinical and regulatory purpose. This overview of the 
most used skin models focused the attention on different testing applications 
including skin corrosion, skin irritation, phototoxicity, dermal adsorption, skin 
sensitization and genotoxicity tests [98]. All these 3D skin models were resumed in 





Table 1. Most important 3D human skin model commercially available today.  
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A novel approach for skin tissue engineering: 
endogenous human skin equivalent models 
2.1 INTRODUCTION 
Actually, the existing in vitro skin models reported in literature and widely 
described in the previous chapter, are employed in large scale for several 
applications and are currently the most used by cosmetic and pharmaceutical 
industries [1]–[3]. Due to the success and the efficacy, a number of research 
groups have developed the skills and new methods to characterize these 3D skin 
system in order to compare all features to the native skin [4], [5]. From these 
studies, however, it showed that, although these 3D skin models represent a valid 
system mimicking the most basic characteristics of human skin, and they respond 
effectively to chemical compounds and active substances to which they are 
exposed, they have non-negligible limitations. According to the authors, in fact, 
the models commercially available are essentially based on cellularized fibrillar 
exogenous collagen matrices, often enriched in fibrin and glycosaminoglycans 
(GAGs), totally lack of structural complexity without an adequate evaluation of 
dermal compartment, since an endogenous ECM is completely absent [1]. Another 
limitation verified of these models is the absence of desquamation events of the 
stratum corneum; in fact, the native skin undergoes to a continuous cellular 
recycling of epithelial tissues thanks to stem cells pull, but in this case the 
outermost layer does not exfoliate, but, on the contrary, it seems tend to thicken 
over the time. Finally, all these 3D skin models have an ineffective barrier function 
of epithelial layer due to an inadequate lipids content that does not confer the 
impermeability, a fundamental characteristic to exert protection against specific 
substances which cannot penetrate in the underlying dermis [1]. In conclusion, 
53 
 
even if this models are widely used as in vitro dermal substitutes, they represent 
too simplified models to mimic the complex structure of dermis made up on cells 
embedded in a structured extracellular matrix (ECM) composed by collagen, 
elastin and GAGs. For these reasons, an exogenous bovine collagen cannot mimic 
correctly such a complex network as ECM, and it is not able to allow the 
recapitulation of pathways that in vivo play a fundamental role in phenomena 
such as aging, photoaging or other events in which the structural proteins of ECM 
are involved. In the light of these considerations, my work fits in this scenario and 
tries to make available an equivalent skin model able to reproduce the complexity 
and characteristics of native counterpart, and in the same time, a 3D innovative 
skin platform with an endogenous ECM that mimics the structure of dermal 
compartment. 
ECM, in fact, is the non-cellular component present within all tissues and organs 
provides the principal means by which mechanical information is communicated 
between tissue and cellular levels of function. The ECM allows not only the 
physical support for the cellular constituents but also a substrate for crucial 
biochemical and biomechanical cues that are required for tissue morphogenesis, 
differentiation and homeostasis. These mechanical signals play a central role in 
controlling cell fate and establishing tissue structure and function. The ECM is a 
highly dynamic system that is constantly enzymatically or non-enzymatically 
remodeled; thanks to its physical and biochemical characteristics it lends the 
biochemical and mechanical properties of each organ, such as tensile and 
compressive strength and elasticity, mediating protection by a buffering action 
that maintains extracellular homeostasis and water retention. In fact, ECM 
microstructure and mechanical properties are considered among the major 
signaling sources regulating cellular behavior, in particular, differentiation by 
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signaling pathways involved in the phenomenon known as mechanotransduction 
process [6]. In this scenario, the aim of my work was the development of a human 
skin equivalent in vitro model that is able to reproduce the mean features of 
native counterpart exceeding all limitations of others commercially available 
models, in order to employ this organotypic tissue system as a complex and 
reliable testing platform that best replace the animal models. In particular, the 
innovation of our human skin equivalents (HSE), resides in an innovative approach 
that replaces all the exogenous matrices with a totally endogenous ECM produced 
by human dermal fibroblasts in a dynamic culture system. The endogenous ECM 
takes part to the dermal compartment that mimics the native human dermis. On 
the top of dermis, there is the epithelial compartment, completely differentiated 
consisting of human keratinocytes adequately stratified at air-liquid interface 
culture condition. The production of our HSE is trigged by a complex multistep 
process according to an innovative bottom-up approach: starting from small pre-
assembled modules, we fabricated a 3D tissue model perfectly organized and 
architecturally defined. The current traditional tissue engineering strategies 
employ the classical top-down approach, which cells are seeded on a 
biodegradable polymer scaffold, in an attempt to recreate the tissue 
microarchitecture through the synthesis of the ECM and often, by means of the 
perfusion of molecular mediators, such as growth factors and mechanical 
stimulation substances, which must be added to the system. However, the top-
down approaches fail to effectively recreate the intricate microstructural 
characteristics of biological tissues [7]. To overcome the top-down approach 
limitations, in order to re-create biomimetic structures, through the bottom-up 
approach, we designed modular units that can be used as "building blocks" to 
obtain more complex engineered tissues for more dimensions with microscale 
structural features that perfectly reproduce the natural organization of the tissue 
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[8]–[10] (Figure 1). These building blocks, named HD-µTP, are modular units that 
we assembled in a specific device in order to develop endogenous human dermis 
equivalents (HDE), that subsequently, are enriched in human keratinocytes 
seeded on the surface of dermis, obtaining a complete human skin model, 
composed of dermis and epidermis reproducing with high fidelity all features of 





Figure 1. Bottom-up & top-down approaches. In the bottom-up approach there are 
multiple methods for creating modular tissues, which are then assembled into 
engineered tissues with specific micro-architectural features. In the top-down 
approach, cells and biomaterial scaffolds are combined and cultured until the cells 
fill the support structure to create an engineered tissue (by courtesy of Costantino 




2.2 MATERIALS AND METHODS 
2.2.1 Porous scaffold preparation 
Gelatin Porous Microbeads (GPMs) were prepared according to a modified double 
emulsion technique (O/W/O) [10]. Gelatin type B (Sigma Aldrich) was dissolved 
into 10 ml of water containing TWEEN 85 (6% w/v) (Sigma Aldrich). The solution 
was kept at 60°C. Toluene containing SPAN 85 (3% w/v) (Sigma Aldrich) was 
continuously added to the aqueous gelatin solution (8 % w/v) to obtain primary oil 
in water emulsion. The added toluene formed droplets in the gelatin solution until 
saturation. Beads of gelatin containing droplets of toluene were produced 
through the addition of excess toluene (30 ml). The overload of toluene allowed 
the obtaining of a double emulsion (O/W/O). After cooling below 5°C, 20 ml of 
ethanol was added to extract toluene and stabilize GPMs. The resulting 
microspheres had a diameter of 50-200 µm and they were washed and filtered 
with acetone and then dried at RT. Microspheres were separated selectively by 
using commercial sieves (Sieves IG/3EXP). GPMs with 75-150 µm size range were 
recovered and further processed. Microbeads morphology were examined by 
means of Scanning Electron Microscopy (SEM). 
2.2.2 Crosslinking of GPMs 
GPMs were stabilized by means of chemical treatment with D-(+)-Glyceraldehyde 
(GAL) (Sigma Aldrich) in order to make them stable in aqueous environment at 
body temperature (37°C). In particular, GPMs were dispersed into acetone/water 
solution containing 4% of GAL and mixed at 4°C for 24 h. The crosslinked 
microspheres were washed and filtered with acetone and then dried at RT. GPM 
were sterilized by absolute ethanol sub-immersion for 24 h before use. 
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2.2.3 Cell source  
Primary cells were extracted from human tissue biopsies surplus obtained by 
“Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (AORN) A. 
Cardarelli/Santobono/Pausillipon at Urology and Biotechnology Centre AORN” 
according to the project “Realization of human skin equivalent in vitro after 
approval of ethical committee”. 
2.2.4 Fibroblasts and keratinocytes isolation and culture 
Fibroblasts. Primary human fibroblasts were isolated from human breast biopsy 
(25 years old) using a standardized procedure. Briefly, the tissue was scraped in 
order to remove subcutaneous fat, incubated for 1 h with penicillin/streptomycin 
solution (Microgem) 2% in PBS and 50 µg/ml of gentamycin solution (Lonza) in 
PBS at 4°C alternatively. Finally, biopsy was divided into pieces incubated 
overnight in 1.8 U/ml of dispase solution (Life Technologies) prepared in PBS at 
4˚C. After dispase digestion, dermal sheets were separated from epidermis with 
forceps. For isolation of human dermal fibroblasts (HDF), dermal pieces were 
scraped and put in 30 ml collagenase A solution (Roche) at concentration of 2,5 
mg/ml for 40 minutes at 37°C. Pieces were suspended in a little volume of 
Minimum Essential Medium with Earle’s salts (Microgem) supplemented with 10% 
fetal bovine serum (FBS), 100 mg/ml L-glutamine, 100 U/ml 
penicillin/streptomycin (P/S), and 0, 1 mM non-essential amino acids. In this way, 
HDF will migrate on the surface of the Petri Dishes. HDF were maintained at 37°C 
in humidified atmosphere containing 5% CO2 and propagated in monolayer 
culture onto 150 cm2 tissue culture flasks in culture medium (Minimum Essential 
Medium with Earle’s salts) containing 20% FBS, 100 mg/ml L-glutamine, 100 U/ml 
P/S, and 0,1 mM non-essential amino acids with a cell density of 8x103/cm2. HDF 
were maintained at same conditions and used from 5 to 9 passages.  
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Keratinocytes. Human keratinocytes were isolated from human foreskins after 
routine phimosis surgery with the informed consent of the patient, following the 
procedure:  
Day 1: separation of dermis from epidermis. Foreskin samples derived from 
phimosis surgery were transported in saline solution in sterility condition and 
store at 4°C. The biopsy was rinsed 3 times with PBS, and incubated at 4°C for 1 h 
in different antibiotics solution, as P/S solution (Microgem) 2% and 50 µg/ml of 
gentamycin solution (Lonza), prepared in PBS, alternatively. Between an 
incubation and the other, the tissue was scraped in order to remove 
subcutaneous fat from the dermis side leaving intact the epithelium. Finally, after 
the last incubations, the sample was cut into strips of about 3 mm width. Strips 
were transferred into new small Petri Dish, wash with PBS and incubated at 4˚C 
with about 20-30 ml of dispase solution 1.8 U/ml prepared in PBS (Life 
Technologies) over night (for max 16 h).  
Day 2: keratinocyte extraction. Once digestion completed, dispase enzymatic 
activity was inactivated by washing with cold PBS for 3 times. Skin strips were 
transferred in a Petri dishes in order to separate epidermis from dermis with 
tweezers. For keratinocytes extraction, epidermis strips were cut in small pieces 
and transferred into 10 ml of pre-heated Trypsin/EDTA solution at 0,05% (Lonza) 
for 5 minutes at 37°C in water bath. The enzyme reaction was stopped after 5 
minutes by using FBS and KGM2 with 5% FBS. In order to allow the mechanical 
separation of cells from epithelial keratins, pieces were resuspended by vigorous 
pipetting for 5 minutes. The cell suspension was filtered by a nylon cell strainer 
with a filter pore size of 100 µm (Falcon) in order to separate cells from residual 
tissue fragments. Cells were counted and centrifuged at 1200 rpm for 5 minutes. 
Primary keratinocytes were maintained in culture in tissue flasks with a cellular 
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density of 2x104/cm2. After 4 h from seeding, medium was changed and again 
changed every 2 days. Let cell culture up 70% of confluence before trypsinization. 
Primary keratinocytes were grown in KGM2 (Promocell) culture medium. The 
growth medium contains the base medium, separate vial of calcium chloride and 
other supplement mix that are: BPE (bovine pitutary extract), hEGF, insulin 
(recombinant human), hydrocortisone, epinephrine and transferrin. The 
formulation is optimized for initial seeding of 5000 cells/cm² up to sub-confluence. 
During this time, basal medium was supplemented with 0.1% transferrin, 0.1% 
epinephrine, 0.1% hydrocortisone,0.1% insulin, 0.1% H-EGF, 0.4% BPE, 5% FBS, 
1%P/S and calcium chloride at 0.06 μM. All cells were grown at 37° C in 5% CO2 
atmosphere. 
2.2.5 HD-μTP precursors fabrication 
HDF of passages 5-9 and GPMs crosslinked at 4% were used to start human dermis 
µ-tissue precursor fabrication (HD-µTP). Before using dry GPM were sterilized by 
absolute ethanol sub-immersion for 24 h. Successively, in order to remove 
completely the ethanol several washings in PBS were performed. Before cell 
seeding PBS was removed and replaced with the culture medium. HD-μTP 
cultivation was initiated by inoculating HDF with scaffold at initial concentration of 
10 cells/bead. The culture suspension (9.5x106 HDF and 172 mg of microbeads) 
was loaded dynamically in spinner flasks (Integra Bioscience) and stirred 
intermittently at 30 rpm (5 minutes stirring and 30 minutes static incubation) for 6 
h post-inoculation, and then continuously agitated at 30 rpm. The rate of 
disappearance of free cells from inoculated cultures was determined as an 
indication of cell attachment to microcarriers. During the intermittent stirring 
phase culture sample (500 μl) was taken each hour and allowed to settle for 1 
minute in an eppendorf tube. The microcarrier-free supernatant was introduced 
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into a hemocytometer for cell counting. After counting the free cells in the 
medium with a hemocytometer, the number of cells adhering to microbeads 
(cell/microbead ratio) was evaluated. The growth medium was replenished on the 
first day and every 2 days until the end of experiments (9 days in total). From the 
2nd day 50μg/ml of ascorbic acid (TCI) was added. HD-μTP samples were taken for 
assay at day 1, 3, 6 and 9. About 1 ml aliquots were collected at day 1, 3, 6 and 9 
from spinner culture for the cell adhesion assay on the microcarriers. Briefly, 300 
μl of the same aliquots was transferred to a cell culture dish (w/2 mm grid Nunc) 
for microcarrier counting, the experiment was performed in triplicate. After that 
the microcarriers suspension was placed in the 1.5 ml eppendorf tube, gently 
washed twice with PBS, and then treated with trypsin solution (Lonza) to allow 
cell harvesting. Finally, the detached cells were counted using a hemocytometer. 
After 9 days, microtissues precursor were transferred into maturation chamber in 
order to provide the assembly of microtissues and the fabrication of macrotissue 
by using a bottom up approach as previously described [9]. 
2.2.6 3D Human dermis equivalent model: HD-μTP molding  
In order to obtain a compact 3D human dermis equivalent system, the HD-µTP 
suspension was withdrawn from the spinner flask and transferred and cultured in 
an assembling chamber. First of all, HD-μTP suspension was transferred from the 
spinner flask to a 50 ml centrifuge tube and, after settling, loaded by pipetting 
into the maturation chamber to allow their molding in disc-shaped construct (1 
mm in thickness, 5 mm in diameter). During the filling procedure, the maturation 
chamber was accommodated on a device connected with a vacuum pump to 
make the process faster and to assure that weren’t any bubble in the maturation 
space. The maturation chamber had a “sandwich-like” structure: in the middle, 
there was a silicon mold with blank spaces, where HD-μTP were loaded and 
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assembled. The silicon mold was delimited on both the top and bottom sides by 
two stainless steel rigid grids characterized by a porous mesh (18 lm) that was 
able to retain the µTPs but to allow the flow of nutrients present in culture 
medium. Two polytetrafluoroethylene (PTFE) rings were placed on the grids on 
both sides of the system that was sealed by stainless steel screws and bolts. The 
system was autoclavabled in each part. Furthermore, four assembling chamber 
was placed on the bottom of a bioreactor (Bellco) and completely surrounded by 
culture medium. The spinner was operated at 60 rpm and the medium was 
changed every 2 days and supplemented with ascorbic acid 50 µg/ml (TCI). After 6 
weeks of culture the HD-µTP were assembled thanks to collagen deposition and 
ECM assessment and gelatin microscaffold carrier were degraded by the action of 
specific enzyme as metalloproteinases and gelatinase that take part to ECM 
remodeling during the maturation phase. Maturation of 3D-HDE was carried out 
in dynamic conditions by placing the chamber on the bottom of a bioreactor 
operated at 60 rpm at 37°C, 5% CO2 and humidity 90%. 
2.2.7 3D Human skin equivalent model fabrication  
In order to obtain 3D full thickness human skin model, primary human 
keratinocytes obtained from biopsy were seeded on human dermis equivalent 
surface and subsequently it was induced cell proliferation and differentiation in 
specific culture condition. In this phase the culture medium was composed of 
KGM2 0.1% transferrin, 0.1% epinephrine, 0.1% hydrocortisone,0.1% insulin, 0.1% 
h-EGF, 0.4% BPE, 5% FBS, 1%P/S and calcium chloride at 0.06 μM. For healthy 
epidermal reconstruction, surfaces of 3D human dermis equivalent model 
obtained during the maturation phase, were coated with human fibronectin 
solution (Sigma Aldrich) at concentration of 50 µg/ml prepared in sterile PBS with 
a minimal volume (about 10 µl/sample). It is important to allow to dry samples 
62 
 
under hood flow for at least 45 minutes at RT. During this time, keratinocytes 
were washed 3 or 4 times with PBS/EDTA 0,01M for 5 minutes and cellular 
colonies were detached using trypsin/EDTA (Lonza) for 5 minutes at 37°C. Cells 
were gently resuspended in culture medium enriched of 5% of FBS in order to 
stop trypsin enzymatic reaction, and subsequently counted and centrifuged at the 
appropriate numbers (150,000 cells/samples of 5 mm diameter) at 1200 rpm for 5 
minutes. Cellular pellet was resuspended in a small volume needed for plating 
onto dermis surface (150,000 cell in a minimal volume of 10-15 µl). It is important 
do not touch the drops on dermis surfaces for about 10 minutes in order to allow 
cell attachment. Dermis samples were incubated at 37°C for 2,5/3 h adding a 
culture medium drops each 10 minutes to allow keratinocytes survival and 
adhesion. We prepared a control in Petri dishes in order to check cell adhesion. 
When cells on control Petri dishes were attached, 3 h after seeding, the medium 
was added first on the bottom of the well and after the rest of volume gently into 
the insert submerging whole samples. During the submerged phase, keratinocytes 
proliferate on dermis surface. The day after the seeding, culture media enriched 
of FBS 5% was substituted with KGM2 3% FBS, and after 2 days, with KGM2 0% 
FBS. Human skin equivalent samples remained in submerged conditions for about 
6 days from seeding. After 6 days of submerged conditions, the cultures were 
raised to the air/liquid interface for 14 days. In this phase, the culture medium 
contains the base medium with 0.1% transferrin, 0.1% epinephrine, 0.1% 
hydrocortisone, 0.1% insulin, 1% P/S, without EGF and BPE and with calcium 




2.2.8 Characterization of HD-µTP 
Histological analysis  
Morphological analysis of HD-µTP were performed on histological section of 
samples at 9th days of dynamic culture in spinner flask. In order to evaluate 
collagen deposition and 3D organization of HD-µTP, samples were fixed with 10% 
neutral-buffered formalin fixative for 2–4 h at RT and rinsed twice with PBS buffer 
solution. After the fixation and dehydration procedure, samples were embedded 
in paraffin to be sectioned and stained. 5 µm transverse sections of samples were 
stained using hematoxylin-eosin solutions (Bio-Optica), Masson’s Trichrome 
(Sigma Aldrich) following standard procedure and analyzed by an optical 
microscope (BX53; Olympus). 
 
Collagen structure by Second Harmonic Generation (SHG) imaging 
Second harmonic generation (SHG) imaging has recently emerged as a 
noninvasive tool for high-resolution imaging of fibrillar type I collagen in tissues. 
Simultaneous interaction of two near-infrared (NIR) photons with non-
centrosymmetric structures can result in emission of a single photon at exactly 
half the wavelength of the excitation light. In particular, collagen type I produces a 
very robust SHG signal with a nonlinear excitation wavelength between 700 and 
1064 nm, allowing a window of detection from 350 to 532 nm. Because individual 
collagen fibrils are the source of the SHG signal, this method has the potential to 
spatially resolve collagen organization at the submicrometer level and provide 
information regarding physiological changes in collagen structure that correlate 
with tissue function.  
The samples for SHG imaging were fixed with were fixed in 4% paraformaldehyde 
solution and rinsed in twice in PBS and observed in their 3D structure. SHG 
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imaging in our samples were performed using a Confocal Leica TCS SP5 II 
femtosecond laser scanning system (Leica), coupled to a tunable compact mode-
locked Ti:sapphire laser (Chamaleon Compact OPO-Vis, Coherent). The samples 
were observed by using λex = 840nm (two photons) and λem = 415-425nm. The SHG 
images, having a size of 200μmx200μm, were acquired with a resolution of 12 bit, 
1024x1024 pixel by using a HCX IRAPO L 25X N.A. 0.95 water immersion objective. 
2.2.9 Characterization of 3D human dermis equivalent models 
Histological analysis 
For characterization of dermis structures, morphological analysis of 3D human 
dermis equivalent models was performed on histological section of samples at 6th 
weeks of maturation phase in bioreactor culture system. Samples were fixed with 
10% neutral-buffered formalin fixative for 2–4 h at RT and rinsed twice with PBS 
buffer solution. After the fixation and dehydration procedure, samples were 
embedded in paraffin to be sectioned and stained. 5 µm transverse sections of 
samples were stained using hematoxylin-eosin (Bio Optica) solutions, analyzed by 
an optical microscope (BX53; Olympus).  
 
Collagen structure by Second Harmonic Generation imaging 
In order to evaluate collagen assembly and composition, second harmonic 
generation (SHG) imaging was performed ad described previously for the 
characterization of HD-µTPs. The samples were prepared in the same manner and 
visualized using Confocal Leica TCS SP5 II femtosecond laser scanning system 
(Leica), coupled to a tunable compact mode-locked Ti:sapphire laser (Chamaleon 
Compact OPO-Vis, Coherent). The samples were observed by using λex = 840nm 
(two photons) and λem = 415-425nm. The SHG images, having a size of 
65 
 
200μmx200μm, were acquired with a resolution of 12 bit, 1024x1024 pixel by 
using a HCX IRAPO L 25X N.A. 0.95 water immersion objective. 
2.2.10 Characterization of 3D human skin equivalent models 
Histological analysis 
For visualization of dermis and epithelial structures, morphological analysis of 3D 
human skin equivalent models was performed on histological section of samples 
at 14th days air-liquid interface culture conditions. Samples were fixed with 10% 
neutral-buffered formalin fixative for 2–4 h at RT and rinsed twice with PBS buffer 
solution. After the fixation and dehydration procedure, samples were embedded 
in paraffin to be sectioned and stained. 5 µm transverse sections of samples were 
stained using hematoxylin-eosin (Bio Optica) solutions, analyzed by an optical 
microscope (BX53; Olympus). 
 
Immunofluorescences and immunohistochemistry 
3D skin tissues at 14th days of air-liquid interface culture conditions were rinsed 
gently in PBS and fixed with 10% neutral-buffered formalin fixative for 2–4 h at RT 
and rinsed twice with PBS buffer solution. After the fixation and dehydration 
procedure, samples were embedded in paraffin. Immunofluorescences were 
performed on 7 µm paraffin-embedded tissue sections in order to observe 
organization of 3D skin system and epithelial differentiation. Histological sections 
were deparaffinized and permeabilized with 0.2% Triton X-100 (Sigma Aldrich) in 
PBS and incubated with PBS/BSA (Bovine Serum Albumin, Sigma Aldrich) 6% as 
blocking solution for 2 h in wet conditions. Subsequently, the slices were 
incubated overnight with primary antibody for Versican (1:50, policlonal, Abcam), 
Keratin 10 (1:500, polyclonal, Covance), P63 (1:50, monoclonal, Abcam) Loricrin 
(1:1000, polyclonal, Covance), Involucrin (1:400, polyclonal, Covance), Laminin 5 
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(1:100, monoclonal, Abcam), Keratin 14 (1:500, polyclonal, Covance) after citrate 
antigen retrieval, to detect epithelial markers, at 4°C in wet conditions. Tissue 
sections were rinsed with PBS and incubated with secondary antibodies for 1 h at 
RT. The secondary antibodies used were: Alexa Fluor 546 donkey anti-rabbit (Life 
Techologies) and Alexa Fluor 488 goat anti-mouse IgG H&L (Abcam). Nuclei were 
stained with DAPI (4',6-diamidino-2-phenylindole, 1:10000) diluted in PBS for 15 
minutes at RT. Immunohistochemical analysis were performed for Keratin 19 
(1:50, Abcam) in accordance with protocol of Mouse and Rabbit Specific (ABC) 
Detection IHC kit (Abcam, UK). 
 
2.3 RESULTS  
2.3.1 HD-µTP assembly assessment  
The spinner flasks were loaded with 9,5x106 cells and 172 mg of microbeads, 
corresponding to 10 cells per bead with an initial cellular density of 70,000 
cells/ml and in a minimal volume of 135 ml The first 6 h of the seeding phase were 
characterized by intermittent stirring to improve the cell-to-bead distribution and 
to obtain a lower proportion of unoccupied beads [11]. The disappearance of free 
cells from the inoculated spinner cultures was considered to indicate the 
attachment of cells to the microcarriers. Before proceeding with the loading of 
HD-µTP in the blank spaces of maturation chamber it was necessary to evaluate 
the aggregation of HD-µTP and deposition of an initial collagen matrix around and 
inside microcarriers. At 9th day of dynamic culture in spinner flask, HD-µTP 
appeared as 3D small compact aggregates composed of cells, evenly distributed 
around and inside the microbeads (Figure 2a). Masson Trichrome staining 
revealed the histological composition of HD-µTP, which aggregates of porous 
microbeads were surrounded by collagen (blue) and cells (violet) that proliferated 
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exploiting the maximal available surface given by the interconnected porosity of 
GMPs (Figure 2b and c). Collagen deposition was confirmed by SHG signal (grey) 
(Figure 2c). 
 
2.3.2 3D human dermis equivalent characterization  
After HD-µTP assembly in the maturation chamber (Figure 3a and b), at the end of 
about 6 weeks of culture in the bioreactor (Figure 3c), we obtained an 
homogeneous and compact 3D human dermis equivalent model that preserved 
the shape and size after the removal from the chamber. The 3D dermis model was 
compact and intact with a smooth surface showing a significant elasticity and 
Figure 2. HD-µTP analysis. a) HD-µTP at optical microscope (Mag 4X); Masson 
Trichrome staining which showed cells around and inside microbeads (violet) 
and the ECM assembled (blue) surrounding 3D cell aggregates (b and c, Mag. 
20X and 40X respectively); d) SHG signal: collagen fibers were assembled 
around cells and held together microscaffolds and cells in a 3D µTP construct. 
Bars in a-c) are 100 µm; bar in d) is 50 µm. 
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firmness, furthermore, it appeared ductile, flexible, strong and resistant to torsion 
stress and at the pull (Figure 3d). 
 
It was interesting to highlight that after 6 weeks of culture the tissue is completely 
made-up of endogenous ECM which composition and morphology were assessed 
by performing histological analysis and evaluation of SHG signal by Two-Photon 
technology microscope. The Figure 4 showed histological images of hematoxylin-
eosin staining concerning 3D-HDE at 6 weeks of maturation. In Figure 4a and 4b it 
was possible to observe the ECM as a continuous network in its composition along 
the thickness of the samples with fibroblasts completely embedded in collagen 
matrix and the elongated nuclear morphology underlines the good condition of 
the cells in their own ECM. The collagen fibrils structure was observed by using 
MPM that allow to visualize unstained collagen structure by exploiting SHG (Figure 
4c in grey). 
 
Figure 3. a) HD-µTP of 9th day of culture loaded in the maturation chamber; b) 
maturation chamber sealed with grids, PTFE rings, screws and bolts; c) bioreactor 
loaded with 4 maturation chambers sealed; d) 3D human dermis equivalents 




2.3.3 3D human skin equivalent characterization  
In order to develop a 3D full thickness human skin models, 3D dermis tissues were 
extracted from chambers and prepared for keratinocytes seeding (Figure 5a). 3D 
full proliferation and differentiation of primary keratinocytes were triggered 
modulating calcium concentration during the culture time and employing typical 
culture condition. During the submerged phase, 3D-HSE were fully covered by 
medium in a low calcium concentration, in order to allow cellular proliferation. 
After 6 days, samples were places in air-liquid condition: 3D-HSE were wet by 
lower medium in the well at high calcium concentration and the exposition to the 
air allows epidermal differentiation of keratinocytes on dermis surface (Figure 5b) 
[12]–[14].  
Figure 4. 3D human dermis model histological analysis. a) H&E staining on tissue 
section which showed dermal fibroblasts (violet) with their elongated nuclei 
perfectly embedded in and endogenous ECM (pink) with no trace of scaffold 
microbeads; b) H&E staining observation with a major magnification; c) SHG 
signal: stretched collagen fibers assembled to form compact and complex 




In order to evaluate the epithelial differentiation at the end of human skin 
equivalent process, different epithelial markers were detected by histological 
staining, immunofluorescence and immunohistochemistry. The epidermal 
compartment at 14th day of air-liquid interface culture condition was assessed by 
H&E staining which showed a good differentiation of all epithelial layers, from 
basal stratum to corneous one. The epidermis was firmly anchored to dermis 
compartment through the basal membrane between both compartments. The 
epidermis was well integrated to the 3D dermal system which was compact, 
homogenous and rich of an endogenous matrix produced by cells and assembled 
during the maturation phase. The dermis compartment was devoid of gelatin 
microscaffold at the end of production process thanks to metalloproteinases 
remodeling (Figure 6a) [15]–[17]. As already described by Casale et al. [18] it was 
interesting to observe also the presence of appendage-like structures that 
originated in the basal layers of the epidermis and descended into the dermis 
Figure 5. 3D-HSE fabrication. a) 3D human dermis equivalent coated with human 
plasma fibronectin under hood flow; b) 3D human dermis equivalent in a 
transweel insert after keratinocytes seedng. 
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(Figure 6b). Similar structure in vitro were reported only by adding in the 
epidermal compartment hair buds or multipotent stem cells from neonatal mice 
able to grow into hair after mice grafting [19], [20]. We found “folliculoid” 
structures in our model, by using dermal and epidermal human adult cells, leading 
us to hypothesize that the produced 3D-HSE provide a physiological environment 
able to preserve the stem cells population obtained by extraction procedure, and 
to address the fate of such adult cells toward the genesis of appendage-like 
structures. We characterized these follicle-like structure by performing histology 
and immunofluorescence for the main epidermal and follicle markers and these 
results confirmed that our 3D human skin models well recapitulated the in vivo 
counterparts. Histological analysis showed a typical multilayered epithelium 
evenly distributed over the 3D human dermis equivalent surface. In particular, the 
basal and suprabasal layers displayed the presence of keratin 14 and keratin 10, 
respectively, while p63-positive staining of the cells in the germinative layer 
confirmed the maintaining of their staminal state [21]; laminin 5 appeared as a 
continuous thin line and it  was used as a marker of the dermo-epidermal junction 
(DEJ). Finally, the terminal differentiation of epidermis was demonstrated by the 
expression of loricrin as typical signals was detected in the stratum corneum. The 
follicle-like structure appeared as finger-shaped projections associated with the 
basal layer of the epidermis that descended into the dermis and were positive for 
versican, a proteoglycan expressed in vivo in the dermal sheath surrounding bulge 
epithelial cells and in the core of the bulb region, indicating hair follicle 
development and cycling. It is known from literature that versican is a 
proteoglycan expressed in the epithelial tissue and in the dermis matrix, where it 
works as a modulator of cell proliferation and migration [22]. We found a spot 
signal of versican in the ECM, while in the epidermal compartment is visible as a 
homogenous signal that surround the follicle-like structure (Figure 6d, e, f, g). 
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Most importantly, keratin 19, a follicular stem cell marker, was found in the basal 
epidermal layers and in the follicle-like structures displaying a stronger signal the 
peripheral cells than in the inner cells (Figure 6c) [23]. 
 
  
Figure 6. Histological analysis of 3D human skin equivalent model. a) H&E staining 
showed dermis and epidermis compartment separated by basal membrane. The 
dermis was highly cellularized, composed of dermal fibroblasts (violet) well 
distributed completely embedded in the endogenous ECM, assembled by cells 
themselves (pink); b) H&E staining of a follicle-like structure invagination inner the 
dermal compartment; it was clear the epidermal origin of follicle-like structure and 
the penetration of this structure inner the dermis; c) Immunohistochemistry for 
keratin19 (K19) (brown) with counter staining by using Mayer's hematoxylin;  
immunolabeling for epithelial markers as keratin 10 (K10) and p63, loricrin, versican, 
markers of stratified epithelial layers,  and p63, typical marker used to evaluate the 
stemness of cell population , and Laminin 5, expressed by germinative layer at DEJ 
(d, e, f, g respectively). Cells was stained with DAPI. Bars in a-c) are 100 µm; bars in a-




Actually, international cosmetic and pharmaceutical industries began to develop 
methods and skills for the realization of in vitro skin models in large scale for 
cosmetic testing and several applications [1], [2], [4].Therefore, studies conducted 
for the characterization of these 3D skin models commercially available, revealed 
that they although resembled native human skin, showed several limitations: 
indeed, these 3D skin models did not show a continuous cellular recycling of 
epithelial tissues, typical of native human epidermis, they exerted an ineffective 
barrier function for the inadequate lipids composition of the epidermal 
compartment and finally they lacked of a functional endogenous ECM as a stromal 
microenvironment able to support epidermal differentiation and stratification [1]. 
First of all, we realized a 3D human dermis equivalent model in vitro completely 
made up of endogenous extracellular matrix by HD-µTP aggregation in a 
maturation chamber after 5 weeks in dynamic culture conditions. Then, with the 
standardization of keratinocytes seeding procedure, we developed a full-thickness 
3D human skin equivalent model in vitro having a thickness of 1 mm and a surface 
of 19,2 mm2 completely made up of endogenous extracellular matrix. This model 
represents a real innovation in tissue engineering as an efficient 3D system that 
mimics all characteristics and features of native human skin. 3D-HSE allowed to 
overcome several problems and limitations associated with the 3D nature of the 
organotypic culture, such as difficulties in regulating distinct behavior of different 
cell types in the same construct [24]. Our 3D human skin system was obtained by 
setting the optimal conditions for keratinocyte extraction as well as their 2D 
expansion it is possible to preserve keratinocytes stemness and their capability to 
differentiate generating a full development epidermal layer, leading to the success 
of the epidermal compartment. By combining a dermal equivalent made up of 
completely endogenous ECM with keratinocytes cultured in serum-free conditions 
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and without feeder layer during the 2D expansion, 3D human skin models 
produced and assembles an endogenous ECM by primary fibroblasts that works as 
an optimal microenvironment with its mechanical features, providing support and 
anchorage for cells and chemical interactions, necessary for keratinocytes 
proliferation and differentiation. Finally, this human skin equivalent model can be 
employed as an effective alternative animal testing in order to substitute animals 




2.5 REFERENCES  
[1] F. Netzlaff, C.-M. Lehr, P. W. Wertz, and U. F. Schaefer, “The human 
epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology 
and their suitability for testing phototoxicity, irritancy, corrosivity, and substance 
transport,” Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. 
Verfahrenstechnik EV, vol. 60, no. 2, pp. 167–178, Jul. 2005. 
[2] C. Faller, M. Bracher, N. Dami, and R. Roguet, “Predictive ability of 
reconstructed human epidermis equivalents for the assessment of skin irritation 
of cosmetics,” Toxicol. Vitro Int. J. Publ. Assoc. BIBRA, vol. 16, no. 5, pp. 557–572, 
Oct. 2002. 
[3] T. Hu, R. E. Bailey, S. W. Morrall, M. J. Aardema, L. A. Stanley, and J. A. 
Skare, “Dermal penetration and metabolism of p-aminophenol and p-
phenylenediamine: application of the EpiDerm human reconstructed epidermis 
model,” Toxicol. Lett., vol. 188, no. 2, pp. 119–129, Jul. 2009. 
[4] A. Coquette, N. Berna, A. Vandenbosch, M. Rosdy, and Y. Poumay, 
“Differential expression and release of cytokines by an in vitro reconstructed 
human epidermis following exposure to skin irritant and sensitizing chemicals,” 
Toxicol. Vitro Int. J. Publ. Assoc. BIBRA, vol. 13, no. 6, pp. 867–877, Dec. 1999. 
[5] A. El Ghalbzouri, P. Hensbergen, S. Gibbs, J. Kempenaar, R. van der Schors, 
and M. Ponec, “Fibroblasts facilitate re-epithelialization in wounded human skin 
equivalents,” Lab. Investig. J. Tech. Methods Pathol., vol. 84, no. 1, pp. 102–112, 
Jan. 2004. 
[6] D. P. Bottaro, A. Liebmann-Vinson, and M. A. Heidaran, “Molecular 
signaling in bioengineered tissue microenvironments,” Ann. N. Y. Acad. Sci., vol. 
961, pp. 143–153, Jun. 2002. 
76 
 
[7] J. W. Nichol and A. Khademhosseini, “Modular tissue engineering: 
engineering biological tissues from the bottom up,” Soft Matter, vol. 5, no. 7, p. 
1312, 2009. 
[8] F. Urciuolo, G. Imparato, C. Palmiero, A. Trilli, and P. A. Netti, “Effect of 
Process Conditions on the Growth of Three-Dimensional Dermal-Equivalent Tissue 
Obtained by Microtissue Precursor Assembly,” Tissue Eng. Part C Methods, vol. 17, 
no. 2, pp. 155–164, Feb. 2011. 
[9] G. Imparato, F. Urciuolo, C. Casale, and P. A. Netti, “The role of 
microscaffold properties in controlling the collagen assembly in 3D dermis 
equivalent using modular tissue engineering,” Biomaterials, vol. 34, no. 32, pp. 
7851–7861, Oct. 2013. 
[10] C. Palmiero, G. Imparato, F. Urciuolo, and P. Netti, “Engineered dermal 
equivalent tissue in vitro by assembly of microtissue precursors,” Acta Biomater., 
vol. 6, no. 7, pp. 2548–2553, Jul. 2010. 
[11] Y. C. Ng, J. M. Berry, and M. Butler, “Optimization of physical parameters 
for cell attachment and growth on macroporous microcarriers,” Biotechnol. 
Bioeng., vol. 50, no. 6, pp. 627–635, Jun. 1996. 
[12] M. Rosdy and L. C. Clauss, “Terminal epidermal differentiation of human 
keratinocytes grown in chemically defined medium on inert filter substrates at the 
air-liquid interface,” J. Invest. Dermatol., vol. 95, no. 4, pp. 409–414, Oct. 1990. 
[13] M. Pruniéras, M. Régnier, and D. Woodley, “Methods for cultivation of 
keratinocytes with an air-liquid interface,” J. Invest. Dermatol., vol. 81, no. 1 
Suppl, p. 28s–33s, Jul. 1983. 
[14] S. T. Boyce and R. G. Ham, “Calcium-regulated differentiation of normal 
human epidermal keratinocytes in chemically defined clonal culture and serum-
free serial culture,” J. Invest. Dermatol., vol. 81, no. 1 Suppl, p. 33s–40s, Jul. 1983. 
77 
 
[15] A. Page-McCaw, A. J. Ewald, and Z. Werb, “Matrix metalloproteinases and 
the regulation of tissue remodelling,” Nat. Rev. Mol. Cell Biol., vol. 8, no. 3, pp. 
221–233, Mar. 2007. 
[16] I. Stamenkovic, “Extracellular matrix remodelling: the role of matrix 
metalloproteinases,” J. Pathol., vol. 200, no. 4, pp. 448–464, Jul. 2003. 
[17] V. M. Kähäri and U. Saarialho-Kere, “Matrix metalloproteinases in skin,” 
Exp. Dermatol., vol. 6, no. 5, pp. 199–213, Oct. 1997. 
[18] C. Casale, G. Imparato, F. Urciuolo, and P. A. Netti, “Endogenous human 
skin equivalent promotes in vitro morphogenesis of follicle-like structures,” 
Biomaterials, vol. 101, pp. 86–95, Sep. 2016. 
[19] D. Larouche, K. Cuffley, C. Paquet, and L. Germain, “Tissue-engineered skin 
preserving the potential of epithelial cells to differentiate into hair after grafting,” 
Tissue Eng. Part A, vol. 17, no. 5–6, pp. 819–830, Mar. 2011. 
[20] S. B. Mahjour, F. Ghaffarpasand, and H. Wang, “Hair follicle regeneration in 
skin grafts: current concepts and future perspectives,” Tissue Eng. Part B Rev., vol. 
18, no. 1, pp. 15–23, Feb. 2012. 
[21] Y. Zheng, X. Du, W. Wang, M. Boucher, S. Parimoo, and K. S. Stenn, 
“Organogenesis From Dissociated Cells: Generation of Mature Cycling Hair 
Follicles From Skin-Derived Cells,” J. Invest. Dermatol., vol. 124, no. 5, pp. 867–
876, May 2005. 
[22] D. R. Zimmermann, M. T. Dours-Zimmermann, M. Schubert, and L. 
Bruckner-Tuderman, “Versican is expressed in the proliferating zone in the 
epidermis and in association with the elastic network of the dermis,” J. Cell Biol., 
vol. 124, no. 5, pp. 817–825, Mar. 1994. 
[23] D. Larouche, C. Hayward, K. Cuffley, and L. Germain, “Keratin 19 as a stem 




[24] B. Liu, Y. Liu, A. K. Lewis, and W. Shen, “Modularly assembled porous cell-





Chapter 3.  
Endogenous 3D human skin equivalent as a 
novel testing platform 
3.1 INTRODUCTION 
In this chapter, we deeply characterized our 3D endogenous human dermis and 
skin equivalent models demonstrating its effectiveness as responsive tissue 
system to external stimuli and to active compounds. We conducted a study on the 
Extracellular matrix (ECM) in order to evaluate its organization, composition and 
its dynamic changes during the assembling phase. 
In fact, ECM, is not a merely “passive” matrix holding cells and tissues in place, but 
it has a functional importance as a dynamic repository for morphogens, cytokines 
and growth factors, which in vivo regulate several cellular processes recapitulating 
those found in the native tissues [1]–[4]. We observed cellular damage response 
as collagen and epithelial compartment re-arrangement and photo-protectants 
efficacy under simulated solar exposure. Our 3D human skin models best 
recapitulated a native 3D environment which the endogenous ECM explain a 
central role. 
It is reasonable to argue that the 3D matrix commonly used as human skin 
equivalent (HSE) models include de-cellularized/de-epidermized dermis [5], [6], 
collagen type I [7], collagen-glycosaminoglycans [8], fibrin [9], fibroblast derived 
matrix [10], [11] , and synthetic polymers [12] do not mimic the complexity of 
native dermal compartment and its regulatory functions [5]. However, despite the 
success in generating 3D-HSE with a multilayered and differentiated epidermis, 
the complete recapitulation of the skin functionality, the rete ridge profile of the 
dermis-epidermis junction and the formation of a complete and functional skin 
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system have not been attained yet [13]. The functionality of our skin models is 
associated to the endogenous complex ECM network enriched of structural and 
elastic components. In fact, a functional and responsive ECM was composed of 
principal components as collagen, elastic fibers and glycosaminoglycans (GAGs) 
which, in turn, are synthesized, assembled and remodeled by cells.[1], [14], [15]. 
Dermal collagen and elastic fibers are ECM protein complexes produced by 
fibroblasts and involved in skin support and elasticity [16], while GAGs have 
various structural and physiological regulatory functions in the skin, including 
tissue water maintenance due to their water holding capacity [17]. Collagen 
comprises approximately 70-80% of the dry weight of the dermis is responsible for 
skin’s tensile strength. The elastic fibers network occupies approximately 2-4 % of 
the dermis volume, provides resilience and suppleness. GAGs are composed of 
specific repeating disaccharide units attached to a core protein as proteoglycans, 
widely distributed throughout the skin; hyaluronic acid is the GAG most 
represented in the human skin [18]. GAGs bind up to 1000 times their volume and 
the skin hydration is highly related to their content and distribution [18], [19].  
It is known that the ageing phenomenon altered texture and structure of skin by 
molecular alterations in protein, lipids and water. Changes in dermal structural 
proteins have been investigated: changes in the amount and architecture of 
collagen, elastin and GAGs have been described in intrinsic ageing (chronological) 
and extrinsic ageing (related to the photo-exposition and photo-damage) [18], 
[20]. In the chronologically aged skin, the rate of collagen synthesis, collagen 
solubility, density and thickness of collagen bundles all decrease [18], [20] while 
also the UV exposition has a significant consequences on collagen network and 
tissue homeostasis [2], [21]. Therefore, in the intrinsic ageing, elastin exhibits 
numerous age-related changes, including fragmentations and slow degradation of 
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elastic fibers with a decrease in number and diameter. On the contrary, the 
photo-exposition generates abnormal localization of fibers in the upper dermis, 
with an elastotic accumulation [16], [18]. Regarding GAGs and hyaluronic acid 
(HA), recent studies document that the total level remains constant in the dermis 
with the ageing. The major age-related change is the increasing avidity of HA. Such 
intercalated HA may have diminished the ability to take on water of hydration. 
These events, parallel to the progressive cross-linking of collagen, contributing to 
dehydration, atrophy and loss of elasticity [17], [20], [22]. However, in photo-aged 
skin, GAGs and HA increase, with a paradoxical increase of total water, even if 
photo-damaged skin appears dry and wrinkled. Probably, proteins became more 
hydrophobic and folded and GAGs are clumped on elastotic material with a minor 
interaction with water molecules [17], [18], [20]. 
In the first part of this chapter, in order to evaluate changes and evolution of ECM 
composition and proprieties during the time, we performed a quantitative assay 
for quantification of collagen, elastin and GAGs content in our 3D human dermis 
and skin equivalent. Our results confirmed a dynamic maturation of our model 
during the assembling phase, with a progressive increase of structural and 
functional components of ECM.  
In the second part of this chapter, among the oxidative stresses, we put the 
attention on photo-damage UVA-induced both on dermal and epidermal 
compartment of our organotypic models. In particular, the UVA-induced oxidative 
stress in epidermal compartment determinates stem cell damage that, in turn, is 
responsible of epidermal senescence [23], [24], with an irregular pigmentation, 
wrinkles, laxity, loss of hydration [25]. The penetration of UVA radiations into the 
skin can initiate detrimental photochemical reactions able to remodel the ECM by 
increasing matrix-metalloproteinase (MMPs), reducing structural collagen and 
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affecting cell signaling and phenotype [26], [27]. The capability to restore totally 
or partially the physiological conditions of the tissue depends on several 
parameters, including the threshold dose, time exposition, age and type of skin 
UVA exposed [28]. In this study, we observe the feasibility of using our 
endogenous human skin equivalent to confirm the well-known photo-protective 
effect of retinoic acid on UVA induced damages and a powerful crosstalk between 
dermal and epidermal compartment, by a mutual interaction between fibroblasts 
and keratinocytes. In fact, the realization of our endogenous full thickness HSE 
presenting responsive endogenous dermal ECM, biologically active epidermal cells 
and physiological wettability able to sustain a topical administration [29], 
recapitulating the complex homeostatic equilibrium and dynamical reciprocity 
between the cellular and extracellular space, as an essential tool to perform a 
complete study of in vitro photo-repair. Such results suggest a possible regulatory 
role of the dermis in our 3D-HSE, highlighting that it represents an instructive 
environment, in which the inductive signals and germinative phenotypes of the 
basal keratinocytes can be preserved, raising some doubts on the use of 




3.2 MATERIALS AND METHODS 
3.2.1 3D Human skin equivalent model realization 
The development of 3D endogenous HSE were performed by bottom-up tissue 
engineering strategy widely described in the previous chapter (see chapter 2). 
Briefly, primary human dermal fibroblasts extracted by human biopsy were sub-
cultured into 150 cm2 tissue flasks in culture medium (Minimum Essential Medium 
with Earle’s salts, Microgem) containing 20% fetal bovine serum (FBS), 100mg/ml 
L-glutamine, 100 U/ml penicillin/streptomycin (P/S), and 0,1 mM non-essential 
amino acids) with a density of 8x103 cell/cm2 and maintained at 37 °C, 5% CO2 and 
humidity 90%. Human dermal microtissue precursor (HD-μTP) were produced by 
seeding HDF of passages 5-9 on gelatin porous microcarriers crosslinked at 4% 
with D-(+)- Glyceraldehyde (Sigma Aldrich), in a spinner flask (Integra Bioscience) 
for 9 days and then transferred into the maturation chamber to allow their 
molding in disc-shaped tissue-construct such as Human Dermis Equivalent (HDE) 
(1 mm in thickness, 5 mm in diameter) as previously described. Maturation of HDE 
was carried out until 6 weeks in dynamic conditions by placing the maturation 
chamber on the bottom of a bioreactor (Bellco) operated at 60 rpm at 37 °C, 5% 
CO2 and humidity 90%. The medium was changed every 2 days and at each 
medium change ascorbic acid (TCI) was added at a concentration of 50µg/ml. At 
the end of the optimal maturation time, chambers were opened and HDE were 
extracted and prepared for primary keratinocytes seeding. As described in the 
chapter 2, human keratinocytes were obtained from biopsy and cultured into 150 
cm2 tissue flasks with a density of 2x104 cell/cm2 in culture medium KGM2 
(Promocell) composed of 0.1% transferrin, 0.1% epinephrine, 0.1% 
hydrocortisone,0.1% insulin, 0.1% H-EGF, 0.4% BPE, 5% FBS, 1% P/S and calcium 
chloride at 0.06 μM and maintained 37 °C, 5% CO2 and humidity 90%. 3D-HDE 
were prepared for keratinocytes seeding by a human fibronectin coating for 45 
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minutes and during this time, keratinocytes were washed and trypsinized. Cells 
were counted (150,000 cells/samples of 5 mm diameter), seeded on the human 
dermis models surface and maintained in submerged culture conditions for 6 days 
in order to allow cell adhesion and proliferation. After 6 days of submerged 
conditions, the cultures were raised to the air/liquid interface for 14 days in 
culture medium with a different composition (0.1% transferrin, 0.1% epinephrine, 
0.1% hydrocortisone, 0.1% insulin, 1% P/S, without EGF and BPE and with calcium 
chloride at 1.88 μM) in order to induce and stimulate differentiation and 
stratification of epidermis. 
3.2.2 Quantitative biochemical assay of ECM components in 3D HDE and 
HSE during the culture time 
Quantitative extraction of main components of ECM was performed on our 
endogenous 3D models (both HDE and HSE) during the time of culture in order to 
evaluate the contribute of collagen, elastin and GAGs in the ECM composition. 
These measurements were obtained for our 3D skin system and compared with 
human breast skin data. 3D-HDE samples were collected at different time of 
maturation as 4, 5, 6 and 9 weeks of culture, while 3D-HSE samples were collected  
at the end of air-liquid interface time culture. All data were compared with human 
breast skin (25 years old) samples. Samples were prepared for protein extraction 
according to manufacturing procedures, using the extraction assay dye-binding 
methods designed for the analysis of collagen (Sircol Soluble Collagen Assay), 
elastin (Fastin Assay) and GAGs (Blyscan Assay) content. All assay kits were 
purchased from Biocolor, UK. 
Sircol soluble collagen assay procedure: The Sircol Assay is a quantitative method 
of pepsin-acid extraction of soluble collagens. This assay is suitable for monitoring 
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collagen produced and in vitro ECM and recovered from soft tissues, cartilages 
and fluids.  
3D-HDE samples at 4, 5, 6 and 9 weeks of maturation time culture, and 3D-HSE 
were weighed and then incubated with a pepsin solution 0,1 mg/ml in acetic acid 
0,5 M (pepsin-acid extraction buffer) overnight at 4°C to solubilize collagen of 
ECM. 100 µl of each sample were used for quantitative tests. It was prepared:  
- reagent blanks using 100 µl of extraction buffer; 
- collagen standards using aliquots containing 10, 20, 30, 40 and 50 µg of the 
collagen reference standard provided from the kit, and make each 
standard up to 100 µl using the same extraction buffer; 
- test samples using 100 μl of volume of lysed samples 
To each tube was added 1 ml of Sircol Dye Reagent in order to fully saturate the 
collagen molecules within a 100 μl sample volume. Tubes were mixed by inversion 
and placed in a gentle mechanical shaker for 30 minutes to allow the formation 
collage-dye complex. Samples were centrifuged at 12000 rpm. for 10 minutes and 
carefully drained by inversion. 750μl ice-cold Acid-Salt Wash Reagent were added 
gently on to the collagen-dye pellet to remove unbound dye and then samples 
were centrifuged again at 12000 rpm for 10 minutes. In order to allow collagen 
release from collagen-dye complex, 250 µl were added to all samples and mixed 
with a vortex mixer. When all of the bound dye was dissolved (after 5 minutes), 
the samples are ready for measurement. Finally, 200 μl of each sample were 
transferred to individual wells of a 96 micro well plate, and the measurement of 
absorbance was obtained by setting the microplate reader (Pelkin Elmer) to 
555nm. Each sample was normalized with the reagent blanks and it was 
determined the µg of collagen/mg wet samples using the collagen standards. 
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Fastin elastin assay procedures: The Fastin Elastin Assay is a quantitative method 
for the analysis of elastin extracted from mammalian sources by 5,10,15,20-
tetraphenyl-21H,23H-porphine tetra-sulfonate (TPPS).  
3D-HDE samples at 4, 5, 6 and 9 weeks of maturation time culture and 3D-HSE 
were weighed and then incubated with 750 μl of 0,25 M oxalic acid at 100°C for 1 
h. After the first extraction, samples were centrifuged at 10000 rpm for 10 
minutes and liquids were pipetted off and retained for the quantitative analysis. 
The residual tissue was heated again with 750 μl of 0,25 M oxalic acid at 100°C for 
1 h. Up to three heat extractions should be initially used to check that complete 
solubilization of the tissue elastin has occurred. 100 µl of each sample were used 
for quantitative tests.  
It was prepared:  
- reagent blanks using 100 µl of extraction buffer; 
- elastin standards using aliquots containing 12,5, 25, 50, 75 µg of the elastin 
reference standard provided from the kit, and make each standard up to 
100 µl using the same extraction buffer; 
- test samples using 100 μl of volume of lysed samples 
According to kit procedure, to each tube was added 1 ml of an equal volume of 
Elastin Precipitating Reagent in order to fully saturate the elastin molecules within 
a 100 μl sample volume. Tubes were mixed by inversion and leaved for 15 minutes 
to complete precipitation of elastin. Samples were centrifuged at >10000 x g for 
10 minutes and liquids were drained. To all samples was added 1 ml of Dye 
Reagent and were mixed by inversion and leaved for 90 minutes on a gentle 
shaker. After, test tubes were centrifuged at >10000 x g for 10 minutes. When 
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liquids were pipetted off, the elastin-dye complex could be observed as a reddish-
brown deposit in the bottom and inside lower wall of the tube.  
To each tube was added 250 μl of Dye Dissociation Reagent to release the dye 
into solution with the aid of a vortex mixer. Finally, 200 μl of each sample were 
transferred to individual wells of a 96 micro well plate, and the measurement of 
absorbance was obtained by setting the microplate reader (Pelkin Elmer) to 513 
nm (blue-green color). Each sample was normalized with the reagent blanks and it 
was determined the µg of elastin/mg wet samples using the collagen standards. 
Blyscan GAGs assay procedures: The Blyscan Assay is a quantitative method for 
the analysis of sulfated proteoglycans and GAGs. The dye label used in the assay 
was 1, 9-dimethylmethylene blue and the dye is employed under conditions that 
provide a specific label for the sulfated polysaccharide component of 
proteoglycans or the protein free sulfated glycosaminoglycan chains.  
3D-HDE samples at 4, 5, 6 and 9 weeks of maturation time culture, and 3D-HSE 
were weighed and incubated with papain extraction reagent composed of 400 mg 
sodium acetate (Sigma Aldrich), 200 mg EDTA (Sigma Aldrich), disodium salt 
(Sigma Aldrich) and 40 mg cysteine HCl (Sigma Aldrich) dissolved in 50 ml of a 0.2 
M sodium phosphate buffer, (Na2HPO4-NaH2PO4), pH 6.4 and 250 µl of papain 
suspension (Sigma Aldrich), containing 5 mg of the enzyme. 1 ml of Papain 
extraction reagent was added to test samples and heated at 65° C for 3 h. Samples 
were centrifuged at 10,000 x g for 10 minutes and supernatants were collected for 
Blyscan assay protocol. It was necessary: 
- reagent blanks using 100 µl of extraction buffer; 




Make each standard up to 100 μl using the same solvent as the Reagent blanks. 
The standards and the reagent blank are used to produce a calibration curve.  
According to kit procedure, to each tube was added 1 ml of an equal volume of 
Blyscan dye reagent in order to fully saturate the elastin molecules within a 100 μl 
sample volume. Tubes were mixed by inversion and leaved for 30 minutes on a 
gentle shaker. During this period a sulphated glycosaminoglycan-dye complex will 
form and precipitate out from the soluble unbound dye. Test tubes were 
centrifuged at 12000 rpm for 10 minutes. Carefully, tubes were inverted and 
drained, and was added 500 µl od Dissociation reagent in order to allow dye 
release. When all of the bound dye had been dissolved, (usually within 10 
minutes), samples were centrifuged at 12000 rpm for 5 minutes to remove foam. 
200 μl of test samples were transferred to individual wells of a 96 micro well 
plate. Avoid rapid pipetting as foaming can cause abnormal absorbance readings 
setting microplate reader (Pelkin Elmer) to 656 nm. Each sample was normalized 
with the reagent blanks and it was determined the µg of GAGs/mg wet samples 
using the collagen standards. 
3.2.3 Histological evaluation of ECM components in 3D-HDE and HSE 
during the culture time 
In order to estimate the main components contents of ECM by an ultrastructural 
analysis, immunofluorescence and histological staining on tissue slices were 
performed. 3D-HDE samples at 6 weeks of maturation time culture, and 3D-HSE at 
the end of air-liquid interface culture, were fixed with 10% neutral-buffered 
formalin fixative for 2–4h at RT and rinsed twice with PBS buffer solution. After 
the fixation and dehydration procedure, samples were embedded in paraffin to be 




Elastin content was estimated by immunofluorescence for α-tropoelastin on 
frozen section both of 6 weeks 3D-HSE and HSE at the end of air-liquid interface. 
The samples were fixed in a solution of 4% paraformaldehyde for 30 minutes at 
RT, rinsed twice with PBS buffer solution and soaked into a sucrose water solution 
(2M). After 24 h samples were included in Tissue Tek (Killik) in a suitable mold 
(Peel-A, Ted Pella INC) and submerged in liquid nitrogen vapors for 1 minute and 
then stored at -80°C. All samples were cut in slices 5 μm in thickness by using a 
cryomicrotome (Leica CM 1850). The cut was oriented so as to view the cross 
section of the samples.  
Picrosirius red staining 
To estimate collagen content, tissue section was stained with Sirius Red (PSR) 
(Sigma Aldrich) following standard procedure and analyzed by an optical 
microscope (BX53; Olympus).  
Polarized light images of samples stained with PSR alone were acquired with an 
inverted microscope (BX53; Olympus) with a digital camera (Olympus DP 21). A 
linear polarizer was placed between the light source and the specimen, while the 
analyzer was installed in the light path between the specimen and the camera. It 
is known that the color of collagen fibers stained with PSR and viewed with 
polarized light depends upon fiber thickness; as fiber thickness increases, the 
color changes from green to red. For quantitative analyses PSR images were 
analyzed by using imageJ software. In order to quantitatively determine the 
proportion of mature (red) and immature (green) collagen fibers, we resolved 
each image into its hue, saturation and brightness (HSB) components by using 
ImageJ software “color threshold” function. Only the hue component was 
retained and a histogram of hue frequency was obtained from the resolved 8-bit 
hue images, which contain 256 colors. We used the following hue definitions; red 
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0-51, green 52-120 [29], [30]. The analysis was performed on 20 PSR stained 
sections of sample. About 5 region of interests (ROIs) were examined for each 
section. 
Immunofluorescence analysis 
For the evaluation of GAGs content, an immunofluorescence for hyaluronic acid, 
the most represented component of GAGs molecules, was performed on paraffin 
embedded 6 weeks 3D-HDE and on 3D-HSE tissue slices. Histological sections were 
deparaffinized and permeabilized with 0.2% Triton X-100 (Sigma Aldrich) in PBS 
and incubated with PBS/BSA (Bovine Serum Albumin, Sigma Aldrich), 6% as 
blocking solution for 2 h in wet conditions. Sections on slices were incubated with 
primary anti-hyaluronic acid antibody (1:50, sheep polyclonal, Abcam) overnight 
at 4°C. Secondary antibody used was 546 Rabbit Anti-Sheep IgG H&L (Abcam). 
Secondary antibody was diluted 1:500 in PBS/BSA 6%. Nuclei were stained with 
DAPI (1:10000, Invitrogen) incubated for 15 minutes at RT. 
The assessment of elastin content was performed by mean immunofluorescence 
for α-tropoelastin on frozen section of our samples. Histological section was 
permeabilized with 0.01% Triton X-100 in PBS/BSA 3% for 1h at room 
temperature. Subsequently, the slices were incubated with an alkylation reaction 
solution composed of Tris-buffer 20 mM/DTT 50 mM/Guanidine-HCl 6 M for 15 
minutes. Tissue slices were then incubated with iodoacetamide solution 100 mM 
in order to protect –SH free groups of elastin cysteines. Subsequently, tissue slices 
were rinsed and incubated with primary antibody anti-α tropoelastin (1:50, 
policlonal, EPC) for 3 h at RT. The secondary antibody was incubated for 2 h at RT. 
The secondary antibody used was Alexa Fluor 568 goat-anti rabbit (Life 
Technologies) was diluted 1:500 in PBS/BSA 3% blocking solution. Nuclei were 
stained with DAPI and Sytox Green (1:10000, Invitrogen). 
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3.2.4 Mechanical analysis of 3D HDE and HSE models by means of non-
destructive nanoindentations methods  
Nano-indentation tests were performed on 3D-HSE at the end of air-liquid 
interface and on 3D-HDE samples after 4, 5, 6, 9 weeks of maturation by means of 
Piuma Nano-Indenter (Optics).  
Indentation is a versatile, quantitative and non-destructive technique for 
measurements of the mechanical behavior of tissue [31], [32]. Based on the 
indentation of surfaces using probes with a well-defined geometry, the elastic and 
viscoelastic constants of examined materials can be determined by relating 
indenter geometry and measured load and displacement to parameters which 
represented stress and deformation [33]. In particular, indentation instruments 
commercially available have led to the optimization of testing and analyzing 
methods for deriving materials elastic and plastic proprieties, such as elastic 
modulus and hardness. For these reasons, the constitutive response of soft tissue 
and biomaterials differs from that of linearly elastic and isotropic engineering 
materials. First, the former generally exhibit non-linear stress-strain (σ-ε) behavior 
[33], [34]; second, their mechanical response is often characterize by a significant 
time-dependence, which is typically described by empirical parameter viscoelastic 
models [33], [35], [36]; third, these materials are likely to be both microscopically 
and microscopically anisotropic, especially in case of biological tissue [33], [37].  
Piuma is a displacement-controlled nanoindenter machine including a controller, 
an optical fiber and a spherical probe. The probe is attached to a spring cantilever 
that it is connected to the end of optical fiber in order to measure the cantilever 
deflection. The applied indentation depth (piezo motor movement) and the actual 
indentation depth are different. The applied indentation depth is a combination of 
the cantilever deflection and the actual indentation depth; therefore, the actual 
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indentation depth is calculated by subtracting of the measured cantilever 
deflection from the displacement of the probe from the point of contact [31]. The 
analysis of spherical nano-indentation data is generically based on the Hertz 
model, assuming a linear elastic and isotropic material response [33], [38], [39]. In 
order to characterize material viscoelastic proprieties and to study the analysis of 
spherical nano-indentation data, we used the Hertz model and a variant of the 
nano-epsilon method (εM) [33]. In this method for strain rate viscoelastic material 
characterization of soft biomaterial (as biological tissue), it was introduced a new 
definition of indentation stress (σind) and strain (εind) that allowed us to obtain 
indentation-stress curved at constant strain rate from load-displacement 





 εind=  
4ℎ
3𝑅(1−𝜐2)
  (2) 
where P was the load, R the radius of spherical indenter tip, ah h was the 
penetration depth. 
The ratio σind/εind directly returns the sample modulus E. Each sample was 
indented using a cantilever with a stiffness of 59.2 N m-1, the indentation depth 
was about 10 mm during each indentation test in different areas of the sample. 
The tip radius was 77 µm and the connected optical fiber measured the cantilever 




3.2.5 Induction of damage on 3D-HDE and HSE samples  
Irritant tests were performed on our 3D human skin platforms following H2O2 
treatment and UV exposure and the extent of damage was evaluated by mean 
cytosolic ROS (Reactive Oxygen Species) assay. 
Reactive oxygen species (ROS) are chemical compound that are formed upon 
incomplete reduction of oxygen and includes the superoxide anion (O2–), 
hydrogen peroxide (H2O2) and the hydroxyl radical (HO•). ROS mediate the 
toxicity of oxygen because of their greater chemical reactivity with other 
molecules regard to oxygen. In fact, ROS operate in signaling through chemical 
reactions with specific atoms of target proteins that lead to covalent protein 
modifications [40]. The effectiveness of our 3D-skin system was tested by 
hydrogen peroxide treatment as a stress substance, and by UV exposition and 
cellular damage was evaluated by cytosolic ROS assay. It was used an antioxidant 
substance as the ascorbic acid and retinoic acid that act as protectant and 
scavenger of ROS.  
Oxidative stress by means of H2O2  
For stress induced by hydrogen peroxide, samples of 3D-HDE at 6 weeks of 
maturation, were extracted from maturation chamber the day before the 
experiment in order to allow contraction of ECM. The day of experiment control 
samples were incubated with ascorbic acid 250 µM for 2 h. After the incubation, 
samples were washed with PBS and incubated with 10 µM CM-DCFDA (5--6)-
chloromethyl-2,7 dichlorodihydrofluoresceine diacetate, (ROS indicator, 
Invitrogen) at 37°C for 60 minutes protect from the light. After incubation, the 
samples were washed in PBS and incubated with H2O2 400 µM for 30 minutes in 
optimal cell condition. Subsequently, samples were incubated with appropriate 
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medium and maintained at 37°C and finally were collected at 5 minutes from 
treatment. Samples were divided into three groups: 
 Control (not H2O2 treated and not protected); 
 H2O2 (H2O2 treated and not protected); 
 H2O2 Asc. Ac. (H2O2 treated and ascorbic acid protected); 
 
Photo-damage by UVA irradiation  
For the cellular stress induced by UV light exposition, 3D-HSE samples were 
exposed to UVA radiations by using a UVA lamp in order to simulate solar 
exposure. The samples were accommodated in transwell and irradiated in PBS 
solution for 15 minutes at final power of 20 Joule/cm2. The UVA lamp (3UVP lamp 
115V 60Hz, Thermo Scientific) was mounted on a stable support allowing an 
exposure distance of 2 cm from the sample surface. Samples sterility was 
guaranteed by performing irradiation under the biological hood. 
 
 
Antioxidant and photo-protective compounds 
For our experiments 3D-HSE samples were exposed to UVA radiations and retinoic 
acid solution 1 µM as positive control was used. Treatment with the protectant 
was performed 4 h before UVA exposure by adding 900 μl retinoic acid in the 
insert of transwell and 5 μl on the top of epidermal layer for the topic and 
systemic application and by adding 5μl on the top of epidermal layer for only 
topically application. To avoid the formation of phototoxic products, immediately 
before performing UVA irradiation, culture medium was withdrawn and 
substituted with fresh PBS solution. At the end of 4 h of pre-treatment, samples 
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were incubated with CM-DCFDA (5--6)-chloromethyl-2,7 
dichlorodihydrofluoresceine diacetate, (ROS indicator, Invitrogen) 10 µM at 37°C 
for 60 minutes protect from the light in order to estimate the rate of oxygen 
species induced by UV radiations. Samples were divided into three groups:  
 
 Control (not UVA exposed and sunscreen not treated); 
 UVA (UVA exposed and sunscreen not treated); 
 UVA Ret T&S (UVA exposed and topic&systemic retinoic acid treated); 
 UVA Ret Top (UVA exposed and topic retinoic acid treated);  
At the end of UVA exposures PBS solution was removed and fresh medium with or 
without retinoic acid was added.  
The UVA-induced damage and the protecting effects of retinoic acid were 
evaluated 6 and 72 h after UVA exposure for all samples.  
Histological analysis  
For the evaluation of extent of ROS induced damage, samples were prepared for 
embedding in Tissue Tek (Killik Bio-optica) after fixation in a solution of 4% 
paraformaldehyde for 30 minutes at RT and soaked in a sucrose water solution 
(2M) for 24 h before the inclusion. All samples were cut in slices of 5 μm in 
thickness by using a cryomicrotome (Leica CM 1850), nuclei stained with 4',6-
diamidin-2-fenilindolo (DAPI, 1:10000, Invitrogen). Tissue slices of samples treated 
with H2O2 and UVA exposed were directly closed with 50 % Glycerol solution 
(Sigma Aldrich). 
To quantitatively analysis, images were processed by using ImageJ software and 




For the evaluation of cellular damage UVA-induced on epithelial and dermal 
compartment of 3D-HSE, mature and immature collagen morphology was 
assessed by staining 5 µm transverse sample sections with PSR staining (Sigma 
Aldrich).  
All images were acquired with an inverted microscope (BX53; Olympus) with a 
digital camera (Olympus DP 21). For the PSR images analysis, A linear polarizer 
was placed between the light source and the specimen, while the analyzer was 
installed in the light path between the specimen and the camera. Quantitative 
imaging analyses were performed as previously reported [41].  
Immunofluorescences analysis 
For immunofluorescences analyses, the 5 µm thick slices were incubated for 3 h at 
room temperature with primary antibodies followed by incubation with the 
appropriate secondary antibody for 2 h at RT. The primary monoclonal antibodies 
used in this study include: anti-matrix metalloproteinase-1 antibody (1:200, 
polyclonal, Abcam), anti-matrix metalloproteinase-9 antibody (1:200, monoclonal, 
Abcam), anti-ki67 antibody (1:50, polyclonal, Abcam), anti-p63 monoclonal 
antibody (1:50, monoclonal, Invitrogen), anti-active Caspase-3 antibody (1:150, 
monoclonal, Abcam) and anti-keratin 10 antibody (1:500, polyclonal, Covance). 
The secondary antibodies used were: Alexa Fluor 568 goat anti-rabbit, Alexa Fluor 
568 goat anti-mouse, Alexa Fluor 488 goat anti-mouse and goat anti-rabbit (Life 
Technologies), all secondary antibodies were diluted 1:500 in PBS/BSA 3%. The 
cell nuclei were detected by DAPI staining (1:10000, Invitrogen) or by Sytox Green 
staining (1:10000, Invitrogen). The samples were investigated by using optical 
microscope (BX53; Olympus). To quantitatively analyze MMPs, p63, ki67 and 
active caspase-3 in each sample, images were processed by using ImageJ software 
and the signal was normalized to the cell number. Cells were counted by using the 
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software function “Analyze particles”. The analysis was performed on 3 
independent experiments, 30 stained sections for samples were analyzed and 10 
regions of interests (ROIs) were chosen. 
 
Second harmonic generation imaging and texture analysis  
Sample slices 50 µm thick were prepared for SHG imaging. Samples were 
investigated by confocal microscopy (TCS SP5 II Leica, Milano, Italy) combined 
with a MPM where the NIR femtosecond laser beam was derived from a tunable 
compact mode-locked titanium: sapphire laser (Chamaleon Compact OPO-Vis, 
Coherent) as widely described in the chapter 2. The SHG images, with a size of 200 
x 200 µm, were acquired with a resolution of 12 bit, 1024x1024 pixel by using a 
40X N.A. 1.25 objective. To quantitatively assess the collagen-related changes, we 
performed GLCM texture analysis by using ImageJ plug-in “Texture” on SHG 
images. The analysis was performed on 3 independent experiments as reported in 
the previous paragraph. A running neighbor index allowed calculation of a GLCM 
matrix per neighbor index per SHG image. In detail, we evaluated the correlation 
feature; if the correlation fell off sharply with pixel distance, the collagen matrix 
presented distinct, linear fibrils; if it remained elevated as pixel distance was 
increased, the collagen matrix showed a less defined fibrillar structure. In this 
work, we calculated the correlation curve for distances ranging from 1 to 200 
pixels (corresponding to 1-40 µm) in the horizontal and vertical direction of each 
optical section that covered a length of interest of 40 µm. In such spatial windows 
the distance at which the correlation function fell off represented the correlation 
length of the texture. In particular the correlation curve was calculated vs. the 
neighbor index and the correlation length was obtained by fitting data with an 




Data is expressed, as mean ± SD. Differences between groups were determined 
using a one-way analysis of variance with ANOVA tests. Significance between 
groups was established for p < 0.01. 
 
3.3 RESULTS AND DISCUSSION 
3.3.1 Biochemical, mechanical and histological analysis of 3D-HDE and HSE 
during the culture time 
In order to evaluate main ECM components during the culture time, biochemical 
quantitative assays were performed both on endogenous 3D-HDE and 3D-HSE, at 
different weeks of maturation. We quantified the µg of collagen, α-elastin and 
GAGs for each mg of wet sample. Since primary fibroblasts used for the 
fabrication of dermal compartment were extracted from breast human biopsy, 
quantitative analysis was performed also on breast human skin in order to 
evaluate the efficiency of quantitative test. We assessed by histological evidences 
that the contribution of epithelial layer was negligible (about 0,004 %) compared  
to the dermal compartment and we weighted all samples entirely, including the 
epithelium. As showed in the Figure 1, collagen, elastin and GAGs amounts  
followed a similar trend: all main ECM components increased during the culture 
time, from 4 to 6 weeks of maturation. These data suggested that fibroblasts of 
dermal compartment assembled and organized ECM enriching it of structural and 
elastic proteins during the maturation phase. Furthermore, it was interesting to 
observe a depletion of collagen and elastin (Figure 1a and b) and an increment of 
total GAGs in HDE 9 WK samples (Figure 1c). After 14 days of air-liquid interface 
(HSE 6+3 WK samples) all ECM components levels returned to values similar to 










The increment of ECM components content was confirmed also by histological 
analysis performed on 5 weeks 3D-HDE and 3D-HSE samples, stained for PSR, in 
order to evaluate collagen content, and immunolabelled for hyaluronic acid and 
α-tropoelastin to evaluate GAGs and elastin amount, respectively. The Figure 2 
showed the progressive increment of protein content over the time for 5 weeks 








Figure 1. Quantitative assay for main ECM components. Total collagen (a), elastin 
(b) amd GAGs content in our 3D-HDE and HSE over the time of culture. Breast 





In order to better study the evolution of our samples over the time and the 
culture conditions, we evaluate also mechanical proprieties of ECM by nano-
indentations analysis. The skin behaves as a viscoelastic material, which 
biomechanical function depends on the concentrations, configurations and type 
Figure 2. Biochemical quantitative analysis on histological sections of ECM components. 
Collagen fibers staining with PSR, immunolabelling for α-tropoelastin and hyaluronic acid 
on 5 weeks 3D-HDE and on 3D-HSE (A and B; C and D; E and F, respectively). Bars in A,B, 
E, F are 100µm; bars in C, D are 50 µm. Quantitative evaluation by imaging analysis using 
ImageJ software for each histological section (G, H, I). (*, # p<0.001). 
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of components within its matrix, as collagen, elastic fibers and sulfated GAGs [43]. 
Nano-indentation is a non-destructive technique that achieves measurement of 
the mechanical behavior of soft tissue [31]. In particular, the probe of Piuma 
directly in contact with the surface, pushed onto material and then retracted, 
recording load (P) and penetration depth (h) over the time (t). Among all 
mechanical tests known, the main limitation of nano-indentation is the inability to 
obtain information about biomaterial bulk, but despite these handicaps, we 
employed  this method for viscoelastic characterization of our tissues since we 
were interested to the superficial mechanical proprieties using a non-destructive 
method, with the possibility to follow the dynamic changes of mechanical 
characteristics over the time also under sterile conditions, avoiding sacrificing the 
sample. The observation emerged from quantitative assays and histological 
analysis, were confirmed by the nano-indentation data (Figure 3) that revealed, as 
we expected, an increasing of Young’s Modulus both of 3D-HDE and 3D-HSE 
samples analyzed over the time of culture, from 4 to 9 weeks in maturation 














Taken together, these data suggested an evolution of ECM assembling during the 
culture period, from 4 weeks to the end of process, at 14 days of air-liquid 
interface (HSE 6+3 WK). It was interested to observe an increasing trend of ECM 
components amount that dynamically changed over the time. Quantitative assays 
showed also a depletion of collagen and elastin content from 6 weeks to 9 weeks 
in 3D-HDE samples, and, on the contrary, an increase of total GAGs content. These 
results could be suggested the establishment of a stress condition or of an ageing 
phenomenon for long time culture inside the maturation chamber which probably 
leaded to a remodeling of ECM. In fact, as it is known from the literature, elastin 
and collagen fibers represent the major components of the ECM but many 
degradative mechanisms are thought to operate systemically as a consequence of 
Figure 3. Mechanical proprieties of 3D human dermis and 
skin equivalent model over the time and the culture 
conditions. Young’s Modulus (E) was expressed in kPa. (*, 
# indicated not significantly differences). 
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a stress conditions or age-related phenomena leading to a progressive 
degradation and fragmentation of the collagenous and elastic fibers network, with 
significant changes in ECM structure and composition [45] [46]. On the contrary, 
GAGs increased during the time until reaching the maximum content (about 2,5 
µg/mg of wet samples) at 9 weeks, before returning to lower values, similar to 
those of 5 and 6 weeks HDE samples. This trend might be explained considering 
the establishment beginning of a stress condition associated to the long-time 
culture inside the maturation chamber over 6 weeks. In fact, GAGs content and 
hyaluronic acid amount underwent an increase in pathological conditions, as 
photo-damage, wound healing, acute and chronical inflammation [17]–[21]. In 
HSE 6+3 WK samples, all ECM components returned to values close to 5 and 6 
weeks of maturation. Probably we could suggest a functional cross-talk between 
fibroblasts and keratinocytes: keratinocytes of the epithelial compartment 
participated to ECM assembly triggered by dermal fibroblast by a regulation of 
protein organization and deposition allowing the improvement of ECM 
proprieties. The mutual interaction between keratinocytes and fibroblasts and the 
assembly of basal membrane, could contribute to improvement of ECM 
composition and organization with a gradual increment of synthesis of matrix 
constituents [48], [49]. On the other hand, observing data of mechanical 
proprieties, we could assess that our samples followed not only a dynamic and 
progressive assembling of ECM components, but also a progressive increasing of 
tissue stiffness, as revealed by nano-indentation test. 
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3.3.2 Reactive Oxygen Species (ROS) production in damaged and 
protected 3D human dermis and skin platforms  
Radical oxygen species (ROS) formation is a common start point in many pathways 
associated with UVA-induced damage [50] and substances with an oxidative 
effects as hydrogen peroxide [51].  
In order to evaluate the effect of oxidative stresses on our dermal and epidermal 
models, and the effectiveness of our skin system as a testing platform, a cell 
damage test was performed and the extent of the damage was evaluated by ROS 
cytosolic assay. We conducted two experiments which we evaluate the effect of 
two type of oxidative stresses: hydrogen peroxide (H2O2) treatment and UV 
radiations exposition. Cellular response induced by stress stimuli, was evaluated 
on samples both treated and protected by compounds with a known antioxidant 
and photo-protective effect, as ascorbic acid and retinoic acid [52], [53]. Inside the 
molecular mechanism, after oxidation reaction, an antioxidant might be 
regenerated by reduction, or it might be broken down and therefore need to be 
replaced ant they allow the chemical conversion of oxygen radicals in less reactive 
and toxic derivative [53]. Regarding the photo-protectants, we tested retinoic 
acid, a lipophilic molecule well known for its anti-aging and anti-UVA effects [54].  
 
Oxidative stress induced by H2O2 and treatment with antioxidant product on 3D 
human dermis equivalent model  
As shown in Figure 4, analyzing the fluorescence signal given by the presence of 
cytosolic ROS, a physiological level of intrinsic stress in control samples of HDE 
was observed. (Figure 4a and b). The intrinsic stress of the sample in basal 
conditions could be associated to the mechanical action exerted by the grid on the 
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surfaces of the specimen during the maturation phase. Anyway, the cytosolic ROS 
signal in control samples was is very low compared to stressed sample with H2O2  
(Figure 4b and c). Samples exposed to oxidative stress and treated with 250 mM 
of ascorbic acid showed a lowering of cellular damage compared to stressed and 
not treated samples, although not entirely comparable to that baseline. These 
data highlighted not only the responsiveness of our 3D human dermis equivalent 
model to an oxidative insult, but also its effectiveness as a useful testing platform, 














Figure 4. Analysis of the cytosolic ROS signal after treatment with H2O2 
and antioxidant product: a) intrinsic basal stress in the CTRL sample; b) 
ROS signal due to cellular damage after treatment with H2O2; c) ROS 
signal following treatment with H2O2 and antioxidant ascorbic acid; 
Nuclei were visible in blue, ROS signal in green; d) Trend of the 
fluorescence signal of intracellular ROS  in the different samples 
analyzed. (* p<0,001). Bars are 200 µm. 
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Oxidative stress induced by UVA exposure and treatment with antioxidant 
product on 3D human skin equivalent platform 
We investigated the generation of cytoplasmic ROS induced in photo-exposed and 
photo-protected samples 5 minutes and 6 h after UVA exposure (Figure 5). Time 
slots having a duration raging from few minutes to few hours are usually 
investigated in previous works dealing with oxidative stress damages [55] [56]. 
Both dermal fibroblasts and epidermal keratinocytes (nuclei stained dye in red) 
produced a significant increase of ROS (green signal) after 5 minutes of UVA 
exposure in compare to control samples associated to cellular damage (Figure 5a 
and b). Quantitative investigations of fluorescent images showed that ROS (Figure 
5c) per cells in 3D-HSE not treated with retinoic acid (UVA) 5 minutes and 6 h after 




























In samples treated with retinoic acid, the ROS production decreased only when 
both topic and systemic treatment (T&S) (p<0.001) was applied. Topical 
application (T) alone was not able to reduce oxidative stress significantly. Topic 
application was introduced to mimic the application of compounds and formulas 
on the native skin. The damage UVA-induced is well known to affect more the 
Figure 5. ROS production. ROS production 5 minutes post-
irradiation in: (a) 3D-HSE non-irradiated and not treated with 
retinoic acid (CTRL); (b) 3D-HSE UVA-irradiated and not treated 
with retinoic acid (UVA). Nuclei are visible in red and ROS signal 
in green. Bars are 50µm. (c) Quantitative analyses of 
fluorescent images of ROS assay for cell performed 5 minutes 
and 6 h post-irradiation; (*, **, #p < 0.01). 
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cytoplasmic molecule than the structural proteins of the dermis that are likely 
protected by their amino-acid composition [57]. 
Early effect of 3D-HSE exposure to UVA was a rise in ROS, which are scavenged by 
an intrinsic antioxidant defense system as suggested by the decreasing of ROS 
expression between 5 minutes and 6 h in UVA-exposed samples. These functional 
tests conducted on our 3D skin systems allowed to evaluate the effectiveness of 
our models as a testing platform. We tested the cellular response after an 
oxidative stress induced by H2O2 and UVA exposure, and the effect of antioxidant 
compound on our platform as scavenger substance of reactive oxygen molecules. 
Our results show not only the cellular response to several types of oxidative 
stress, but also the effectiveness as testing platform of protective compounds. 
These evidences pave the way to the possibility to have an in vitro skin system 
useful to investigate the cellular damage induced by an oxidant stress and the 
effect of protectant compounds, presenting important consequences not only in 
dermatology but also in cosmetology science with the  possibility to investigate in 
vitro cosmetic function previously assessable only in vivo. 
 
3.3.3 Effect of UVA photo-degradation on cellular and tissue senescence in 
our 3D human skin equivalent models 
In order to focus the attention on photo-damage UVA exposure-induced, we put 
the attention on epidermal and dermal response of endogenous human skin 
model insulted with 20 Joule/cm2 of UVA radiations. In fact, we observed that the 
UVA-induced oxidative stress in epidermal compartment induces stem cell 




Depletion of proliferative activity UVA-induced on 3D-HSE 
First of all, we observed that UVA exposure induces a depletion of epidermal 
proliferation index obtained by the quantification of cellular proliferation by 
immunolabeling of Ki-67 as a marker of proliferative activity of epithelial cells [58]. 
The proliferation index was evaluated in photo-exposed and photo-protected 
samples at 6 and 72 h (Figure 6) In the control samples, proliferating Ki-67 
keratinocytes (red signal) were mainly localized at basal layers (Figure 6a and b), 
while, in photo-exposed samples, the distribution of Ki-67 positive keratinocytes 
was restricted only at a few basal cells (Figure 6c and d). Meanwhile the Ki-67 
signal in the epidermis of T&S and T samples were similar to the control sample in 
both the time points evaluated (Figure 6e-h). Imaging analysis was performed on 
immunofluorescent images to evaluate Ki-67 positivity per epidermal cell. A 
decrease of Ki-67 signal was found in photo-exposed samples compared to the 
control at both time points. Moreover, both T&S and T samples show the same 


























Caspase-3 activation by UVA exposure in 3D-HSE 
Cellular damage UVA-induced was evaluated also in term of inducing apoptosis. In 
fact, UVA exposition causes not only the depletion of proliferation rate of 
epidermal keratinocytes but also the enhancement of apoptotic events. To 
Figure 6. Epidermal proliferation index evaluation. Ki67 
immunofluorescences 72 h post-irradiation in: (a, b) 3D-HSE non-
irradiated and not treated with retinoic acid (CTRL,); (c, d) 3D-HSE 
UVA-irradiated and not treated with retinoic acid (UVA).; (e, f) 3D-
HSE UVA-irradiated and treated with retinoic acid in topical and 
systemic application (UVA Ret T&S); (g, h) 3D-HSE UVA-irradiated 
and treated with retinoic acid in topical application (UVA Ret T). 
For each sample is reported immunostaining and merge with 
nuclear staining. Bars are 25 µm. (I) Quantitative analyses of ki67 
immunofluorescences performed 6 and 72 h post-irradiation; (*, 
**, #, ## p < 0.01). 
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determine the activation of caspase-3 during UVA-damage and retinoic acid 
photo-protection we used antibodies that specifically recognize the cleaved, 
activated form of caspase-3 (Figure 7). In both modalities of photo-protection 
treatment, as well as in the control sample, was possible to observe that the 
immunostained cells were distributed at patches in the transition zone between 
the granular and cornified layers of the epidermis (Figure 7a). These 
immunolocalization was described also for native skin suggesting that caspase-3 is 
activated late during keratinocyte differentiation [59]. On the contrary, in photo-
exposed samples the localization of activated form of caspase-3 is evident also in 
cytosol of basal cells involving more epidermal layers than in photo-protected and 
control samples (Figure 7b). Quantitative investigations of immunofluorescent 
images highlight that an early apoptotic stage in photo-exposed samples occurred 
only 6 h after UVA damage. Consequently, only at this time point it is possible to 

























Adult epidermal stem cell depletion by UVA exposure in 3D-HSE 
Immunopositivity to p63 in photo-exposed and photo-protected samples was 
evaluated in order to study its essential role for the proliferative potential of stem 
cells in stratified epithelia [60] [61]. The distinguishing feature of adult stem cells 
is their extraordinary capacity to divide prior to the onset of senescence. While 
stratified epithelia such as skin, prostate, and breast are highly regenerative and 
account disproportionately for human cancers, genes essential for the 
proliferative capacity of their stem cells remain unknown. Here we analyzed p63, 
a gene whose deletion in mice results in the catastrophic loss of all stratified 
Figure 7. Active-Caspase 3 production. Active Caspase 3 production 72h 
post-irradiation in: (a) 3D-HSE non-irradiated and not treated with 
retinoic acid (CTRL); (b) 3D-HSE UVA-irradiated and not treated with 
photo-protectant (UVA). Nuclei are visible in blue and Caspase 3 signal 
in green. Bars are 50µm. (c) Quantitative analyses of 
immunofluorescence of Caspase 3 performed 5 minutes and 6 h post-
irradiation; (* p < 0.01). 
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epithelia. We demonstrated that p63 is strongly expressed in epithelial cells with 
high clonogenic and proliferative capacity and that stem cells lacking p63 undergo 
a premature proliferative rundown. Additionally, we showed that p63 is 
dispensable for both the commitment and differentiation of these stem cells 
during tissue morphogenesis. Together, these data identify p63 as a key, lineage-
specific determinant of the proliferative capacity in stem cells of stratified 
epithelia. In the epidermis of control samples, p63 was confined to almost all the 
cells of the basal layer, and gradually decreased in the cells of the suprabasal 
layer. No p63 expression was found in the granular layer, where cells were 
immunopositive to K10, and in spinous layer, where terminal cells differentiation 
occurred (Figure 8a and b). UVA exposure induced a decrease of p63 positive cells 
in suprabasal layer more than in the basal layer (Figure 8c and d) meanwhile the 
photo-protected samples shown a distribution of p63 nuclear signal similar to the 
control sample (Figure 8e-h). Quantitative investigations of immunofluorescent 
images of photo-exposed samples show significantly lower number of p63-
positive epidermal cells than in the control sample. Adult epidermal stem cell 
maintenance was preserved in photo-protected sample at both the time points 
evaluated and at both modalities of treatment, confirming the effectiveness of 



























Figure 8. Epidermal stemness index evaluation. P63 (green 
signal) and K10 (red signal) immunofluorescences 72h post-
irradiation in: (a,b) 3D-HSE non-irradiated and not treated with 
retinoic acid (CTRL); (c, d) 3D-HSE UVA-irradiated and not 
treated with retinoic acid (UVA); (e, f) 3D-HSE UVA-irradiated 
and treated with retinoic acid in topical and systemic 
application (UVA Ret T&S); (g, h) 3D-HSE UVA-irradiated and 
treated with photo-protectant in topical application (UVA Ret 
T). DAPI nuclear staining (blue signal) was used for cells-K10 co-
localization Bars are 50 µm. (I) Quantitative analyses of P63 




Mutual interaction between MMPs and collagen in dermal compartment of 
Endo-HSE after UVA exposure 
In order to estimate the damage extent in dermal compartment after UVA 
exposition, immunofluorescence and histochemical analyses were performed 
evaluating the expression and localization of matrix-metalloproteinase-1 (MMP-
1), matrix-metalloproteinase-9 (MMP-9) and collagen type I (coll 1) in the tissue at 
the two-time points in photo-exposed and photo-protected sample respectively. 
As shown in the Figure 9, at 72 h after exposition radiations there were high levels 
of the MMPs and low content of collagen I featured the photo-exposed samples 
compared to control and photo-protected samples (Figure 9A-N). Indeed MMP-1, 
a key member of matrix metalloproteinase family in initiating collagen type 1 
degradation, and MMP-9, gelatinase able to continue the enzymatic degradation 
of interstitial collagens, are the major collagenolytic enzymes responsible for 
collagen destruction in photodamaged native human skin as well as in 3D-HSE 
UVA-exposed [62]. Quantitative imaging analysis showed that MMP-1 per 
fibroblast in 3D-HSE irradiated with UVA but not treated with retinoic acid at 6 h 
and 72 h after UVA irradiation increased respectively 1,8 and 2,2 times compared 
to the control samples. Our results confirmed the photo-protectant actions of 
retinoic acid in decreasing the MMP-1 production in both T&S and T photo-
protective treatment at 6 and 72h, respectively, compared to UVA exposed 
samples (p<0.001). Moreover, not statistically differences were reported in photo-
protected sample at 6 and 72 h compared to the control samples (Figure 9O). 
Upregulation of MMP-9 in the photo-exposed samples at 6 and 72 h was reported 
respectively 1.9 and 2.2 times compared to the control. MMP-9 production 
response in photo-protected sample was pushed down to the values of the 
control in both time points evaluated in the two different treatments performed 
Figure 9P). It is interesting to observe that the collagen I (mature collagen in red) 
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stained with PSR detected in photo-exposed samples decreases of 1.6 and 1.5 
time, respectively, compared to control samples. On the contrary in the photo-
protected sample at both modalities of treatment, the retinoic acid preserved the 
collagen I degradation from enzymatic cleavage maintaining the amount of 
collagen I at same level of controls (Figure 9Q). 
Figure 9. MMPs and endogenous collagen I productions. (A-D) MMP-1 
immunofluorescences in all type of samples investigated 72 h post-irradiation; (E-H) 
MMP-9 immunofluorescences in all type of samples investigated 72 h post-
irradiation; (I-N) Collagen I histochemical staining (Picro Sirius Red) at linear light 
polarized of all samples investigated 72h post-irradiation. Sytox Green staining was 
used in immunofluorescent images. Bars are 100µm for all images. (O-Q) 
Quantitative analyses of immunofluorescences and histochemical staining 
performed 6 and 72 h post-irradiation; (*, **, #, ## p < 0.01). 
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To study collagen remodeling after UVA exposure the unstained collagen structure 
was visualized by exploiting SHG. By performing grey-level co-occurrence matrix 
(GLCM) texture analysis, we evaluated the correlation length as a parameter 
indicating the roughness of the collagen matrix [2], [63], [64]. Rough textures, or 
low correlation length, is synonymous of fine structure, with well-defined collagen 
bundles and narrow distribution of the bundle diameter. This is the condition of 
young and healthy dermis. Ageing, and photoaging, induces collagen 
degeneration, causing changes in the textural features of the collagen matrix. As a 
consequence, correlation length tends to increase because of collagen matrix 
coarsening [62]. SHG imaging was performed on treated and on non-treated 
Endo-HSE in order to highlight the responsiveness and structural changes in 
collagen organization. All the samples were observed at the two-time points, but 


















By comparing the SHG images of photo-exposed 3D-HSE samples it is possible to 
note the different organization of the endogenous collagen between control and 
photo-protected samples. In detail, in all images is possible to detect an intense 
SHG signal indicating a dense matrix, with tight collagen bundles. In particular, in 
the photo-exposed samples, the fibrils show marked clumping, indicating a loss of 
the fine structure and structural organization, while the samples treated with 
retinoic acid have a collagen structure very similar to the control. In order to make 
Figure 10. SHG imaging and GLCM analyses. (A–D) SHG images of 3D-
HSE 72h post-irradiation show the morphology of collagen 
organization in: (A) non irradiated and not treated with retinoic acid 
samples (CTRL); (B) UVA-irradiated and not treated with retinoic acid 
samples (UVA); (C) UVA-irradiated and treated with photo-
protectant in topical and systemic application (UVA Ret T&S); (D) 
UVA-irradiated and treated with photo-protectant in topical 
application samples (UVA Ret T); Bars are 25 μm. (E,F) GLCM 
analyses on SHG images allow quantification of the coarsening 
collagen network in 3D-HSE, 6 and 72 h post-irradiation. 
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such an observation objective, the correlation curve was calculated at both time 
points for all samples and its behavior was reported (Figure 10E-F). UVA exposed 
samples but non-treated with retinoic acid were characterized by the highest 
correlation values, indicating a collagen matrix coarsening due to UVA exposure. 
In contrast, the photo-protected samples presented correlation curves very 
similar to those of the control. The correlation lengths calculated in a window of 
40 μm is reported in Table 1: according to the behavior of the correlation curve, 
photo-exposed samples presented the highest correlation length at both time 
points compared to the control (p < 0.01). Moreover not statistically differences 
were present in the correlation length of T&S and T retinoic acid treatments 












Table 1.: Values represent average ± SD of correlation 
length for the following samples: samples non-UVA-
irradiated and not treated with photo-protectants (CTRL); 
samples UVA-irradiated and not treated with photo-
protectants (UVA); samples UVA-irradiated and treated 
with photo-protectant in topical and systemic application 
(UVA Ret T&S); samples UVA-irradiated and treated with 
photo-protectant in topical application (UVA Ret T). 
Statistical significance was determined using the Anova 
method (in Endo-HSE samples, p < 0.01 for CTRL vs UVA, 




In particular, these data highlighted UVA radiations effects associated to cellular 
damage on dermal and epidermal compartment. The effect of cellular damage 
UVA-induced was evaluated on our 3D endogenous skin equivalent models, which 
showed the advantage to present a dermis compartment composed of fibroblasts 
that are embedded in their own matrix presenting several of the complex 
macromolecules that characterize the native ECM [58]. 
This fundamental feature makes the dermis not a merely “passive” matrix holding 
cells and tissues in place, but a dynamic repository for morphogens, cytokines and 
growth factors, which in vivo regulate diverse cellular processes. Such unique 
feature affects also the development of epidermis that, in contrast to that of HSE 
model based on fibroblast populated collagen, is characterized by a convoluted 
profile of DEJ and superior barrier epithelial functions correlate with higher 
density of p63-positive cells with a germinative potential [65].  
Moreover we immunoquantified p63, Ki67 and caspase 3 in the epidermal layers 
in order to investigate the effect of UVA on cellular senescence [59], [60] . We 
found that p63 and Ki67 were downregulated in UVA samples and that the T and 
T&S treatments with the retinoic acid maintaining the level of p63 and Ki67 to 
those of the control. The UVA-response caused the depletion of staminal and 
proliferative potential of both the basal cells and a subset of daughter cells locate 
in suprabasal epidermal layer. Meanwhile the caspase 3 was up-regulated only at 
short time point of UVA exposure, suggesting an attempt of a rapid restoration in 
basal cells of epidermal tissue. T and T&S application of retinoic acid was able to 
restore the situation of control samples. These findings are compatible with the 
hypothesis that, in proliferating basal stem cell pool, cellular senescence is 
important for the response to single UVA exposure in order to cope a repair 
mechanism that sacrifices the germinative capability of basal stem cells through 
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p63 and Ki67 downregulation. Our model potentially allows to investigate several 
phenomena involving germinative cells and here, for the first time, we quantified 
the early induction of cellular senescence after UVA exposure and the cellular and 
structural damage both in dermis and epidermal compartment. In fact, we found 
that the combined production of the MMP9 and MMP1 by fibroblasts leads to a 
strong degradation of collagen in photo-exposed samples, while due to the 
protective action of retinoic acid both in T and T&S samples, collagen degradation 
is preserved. Moreover, in accordance with a study performed in vivo on photo-
aged skin [2], [68] we quantify the collagen structure by using GLCM texture 
analysis and evaluate the difference between the denser and fine structure of 
collagen ﬁbrils in the not exposed sample, and the loss of the ﬁne structure and 
structural organization of the photo-exposed samples. Taken together, these 
evidences lead the Endo-HSE an effective upgraded alternative at the in vitro 
platform currently used. Indeed, here we demonstrate for the first time in vitro 
that UVA-induced cellular and extracellular senescence is reflected in the parallel 
decline of epidermal germinative potential and collagen network assembly. 
 
3.4 CONCLUSIONS 
In this chapter, we investigated the different uses and applications of our 3D 
tissue model as a responsive system that reacts to external stimuli and a useful 
platform for testing compound in a complex 3D environment. The presence of the 
cell-synthesized ECM organized in a 3D fashion represented a more suitable 
system able to mimic in vitro damages and regeneration of tissue and confirms 
that in the dermis reside the solution to contrast profound change in skin 
structure such as wrinkle and laxicity. Due to its morphological and functional 
features, our human skin equivalent is a unique tool to study effects on tissue 
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homeostasis in vitro in terms of exhaustion of staminal and proliferative potentials 
in the epidermis as well as of ECM remodeling in the dermis. We demonstrated 
that our models could be degraded by enzymatic digestion in order to quantify 
ECM components content, and that there was a gradual progressive assembly of 
ECM structural elements during the time of culture, and that long-time culture 
could establish stress phenomena and structural changes of ECM organization and 
composition. These data suggest that our system dynamically changed over the 
time. Moreover, the single oxidative stress (hydrogen peroxide and UVA 
radiations) can contribute to cellular damage and to the depletion of epidermal 
stem cell, induces ROS production in the entire tissue and through the MMPs 
action can remodel the collagenous network decreasing both the collagen content 
and its structural quality. The development of such model might as a realistic tool 
to lead to the possibility of studying in vitro the effects of variations in human skin 
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Scale-up strategy for skin models production 
4.1 INTRODUCTION  
TE products applied in pharmaceutical research as test systems offer possibilities 
for closing the gap between animal testing and administration of drugs to human 
subjects in clinical trials. The biological complexity of 3D tissue entails high 
requirements regarding applicable culture technique [1]. The development of the 
system biotechnology and its application in the industrial process open new 
horizons to industrial biotechnology. Improvements of yields and consistent 
products are the key mission in industrial process [2] and in an industrial 
prospective, the main difficult in a scale-up strategy of a bioprocess is the 
transition from the microscale to the large-scale production without 
compromising the quality and the effectiveness of products. We developed an 
accurate working plan and specific criterions to improve our bioprocess control 
and to ensure the good quality of our skin systems.  
The complexity of biological systems, from individual proteins to whole cells, 
makes it exceedingly difficult to predict their behavior under not ideal conditions. 
A bioprocess includes several unit operations, and the single complexity of a 
manufacturing scale could affect the performance of an individual operation [3], 
[4]. Concerning the scale-up of a bioprocess from bench scale to large production 
scale, the main aims are product yield and quality and both requirements are a 
“net results from several independent, but interrelated, steps” [5]. Indeed, 
bioprocess complexity increased when whole bioprocess is considered as a set of 
multiple interacting variables between individual unit operations. Microscale 
processing techniques offer the potential to speed up the fabrication of products 
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in a more controlled manner, from the numbers of products fabricated to the 
costs [4]. First of all, in a scale-up procedure of a bioprocess, it is fundamental 
determining a scale-down approach, since the only safe method is to study all 
different steps separately, but under conditions comparable with the ones in the 
production scale. [5]. In this context, two significant industrial problems related to 
a biological process can be identified: batch variations and the lack of 
reproducibility. These problems are caused by a multitude of factors and it is 
necessary to introduce an accurate methodology to support the scale-up [6]. The 
improvement of a bioprocess is developed in three fundamental stages: 
laboratory scale, where basic screening procedures are carried out; a working 
plan, where the optimal operating conditions are ascertained; and the plant scale, 
where the process is brought to economic fruition [7]. According to conventional 
scale-up strategies, in a manufacturing process, when specific parameters are 
maintained constant, others parameters cannot be controlled and may changes 
substantially in unexpected way [7]–[9] causing undesired effects on the yield and 
quality of products [7]. The productivity of a bioprocess generally depends on two 
elements: cell lines and process control. In particular, the process control is 
defined as the providing a near optimal environment to produce a desired 
product. The scope of bioprocess control theoretically includes not only the 
sequence of single steps but also product recovery including pre-incubation 
operations, sterilization, cell culture and environment [3]. Among several 
strategies employed to improve the productivity of an industrial bioprocess, one 
effective method applied to accelerate the development and the yield is the 
possibility of operating many big bioreactors in parallel working at the maximal 
capacity [4]. It is known that the parallelization and the automation of high-
throughput cell cultivations in small-scale bioreactor system is an important topic 
to increase the production controlling all process conditions [10]. In this last 
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chapter, we described an innovative scale-up strategy in order to optimize the 
production of human skin models as a platform commercially available for 
cosmetic testing and several applications. Firstly, we conducted a characterization 
of the best gold standard skin models and a comparison with our 3D human skin 
equivalent platforms to better understand the structure and the composition of 
competitive skin models commercially available. Subsequently, we described 
methods to improve the productivity of our tissue process with the prospect of 
achieving a start-up by the parallelization of our bioprocess using many 
bioreactors working at maximal capacity with the aim of increasing volumes, cells 
and number of tissues produced for month. 
Phenion Full-Thickness skin model fabricated by Henkel and EpiDerm 312X FT 
produced by MatTek Corporation, were purchased and studied by means of 
histological and morphological analysis. The Phenion Full-Thickness skin model is a 
3D tissue-construct that simulates histological and physiological properties of 
human skin. Different cell types, build up a dermal and epidermal compartment: 
fibroblasts, growing inside a spongy scaffold composed of collagen-GAGs mixture, 
form the connective tissue as basis for overlying epithelial cell layers mimicking in 
vivo conditions. This skin model is a useful in vitro test system employed for the 
study of the effects of active compounds following topical or systemic application, 
in order to study genotoxicity, corrosion and percutaneous adsorption [11], [12] 
(http//www.henkel_adhesives.de/de/content_data/247926_Flyer_Phenion_FT_S
kin_Models). EpiDerm 312X FT skin model produced by MatTek Corporation, is an 
engineered skin system composed of normal human epidermal keratinocytes 
(NHEK) and normal human dermal fibroblasts (NHFB) cultured to form a 
multilayered model of the human dermis and epidermis. The dermal 
compartment consists of a collagen matrix containing viable normal human 
dermal fibroblasts (NHDF), while the epidermal compartment was composed of 
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human keratinocytes adequately differentiated in spinous, granular and cornified 
layers analogous to those found in vivo counterpart [11], [12] 
(http//www.mattek.com/products/epidermft/). The principal applications of this 
skin system are irritation and corrosion tests, photo/genotoxicity, transdermal 
drug delivery. 
With this assumptions, after this characterization, we set up an accurate strategy 
for the realization of endogenous 3D human skin models in large scale with the 
aim to make them commercially available as a functional platform for cosmetics 
testing. Our scale-up strategy is based on i) the improvement of tissue production 
both through the parallelization of the entire bioprocess; ii) the use of higher 
instruments and devices for increasing the capacity, volumes and quantity; iii) the 
introduction of a meticulous working plan and several check points in each critical 
phase of our tissue process in order to guarantee the control on yield and quality 
products. 
Finally, we obtained a safety and standardized protocols to ensure about 200 
tissue products per month available for several tests and applications as useful 




4.2 MATERIALS AND METHODS 
4.2.1 Characterization of commercially available gold standards models 
and comparison with our endogenous 3D human skin platform 
First of all, in order to assess the characterization in terms of morphology and 
composition of the best skin models commercially available, we purchased two 
type of gold standard skin models, Phenion Full-Thickness skin model by Henkel 
and EpiDerm 312X FT (Full Thickness) by MatTek Corporation. We conducted a 
morphological analysis on Phenion by SHG imaging in order to study its 
configuration and composition. With the aim to evaluate the effective 
functionality of EpiDerm 312X FT as a screening platform for cosmetic testing, we 
performed an irritation test and a macroscopic analysis through the 
stereomicroscope (Olympus) and histological analysis in order to obtain a useful 
comparison between our endogenous 3D human skin platform and the best 
competitor skin model commercially available. 
 
Irritation test for cellular viability of EpiDerm 312X FT skin model 
With the aim to evaluate the functionality and the viability of EpiDerm 312X FT 
purchased from MatTek Corporation, an irritation test was performed according 





Basic Procedure. On the day of receipt, EpiDerm 312X FT tissues were conditioned 
by incubation to release transport-stress related compounds and debris overnight. 
After pre-incubation, tissues are topically exposed to the test chemicals for 60 
min. Preferably, 3 tissues are used per test chemical (TC) and for the positive 
control (PC) and negative control (NC). Tissues are then thoroughly rinsed, blotted 
to remove the test substances, and transferred to fresh medium. A viability test 
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MTT assay was performed by transferring the tissues to 24-well plates containing 
MTT medium (1 mg/ml). After a 3h MTT incubation, the blue formazan salt 
formed by cellular mitochondria was extracted with 2 ml/tissue of isopropanol 
(extracting solution) and the optical density of the extracted formazan was 
determined using a spectrophotometer at 570 nm. Relative cell viability was 
calculated for each tissue as % of the mean of the negative control tissues. Skin 
irritation potential of the test material is predicted if the remaining relative cell 
viability is below 50%. According to the EU and GHS classification (R38/ Category 2 
or no label), an irritant compound is predicted if the mean relative viability of 
three individual tissues exposed to the test substance is reduced below 50% of the 
mean viability of the negative controls (see Table 1). 
We tested the responsiveness of samples to irritant compound using a solution of 
SDS (sodium dodecylsulfate, Fluka) 5% in dH2O (defined as irritant substance), and 
PBS 1X (Microtech) as negative control. 
 
 
Step 1  
30 μl of the test substance were added into 0.3 ml of dH2O. The test was 
performed in a transparent, preferably glass test-tube to avoid any reaction with 
plastic during the incubation time. The mixture was incubated in the incubator 
(37°C, 5 % CO
2
, 95% RH) for 60 min. At the end of the exposure time, the mixture 
was shaken and it was evaluated the presence and intensity of the staining. 
Table 1. Criterions for irritant compounds classification. 
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Step 2  
At the end of treatment, samples were washed with PBS 1X and incubated for 3 h 
incubation in culture media with MTT (37°C, 5% CO
2
, 95% RH). After the 3 h 
incubation, the tissues were rinsed and extracted using 2 ml of isopropanol and 
the optical density (OD) was measured at 570 nm. The real MTT OD (unaffected by 
interference with the colored test materials) was calculated using following 
formula: 
𝑶𝑫 =  𝑶𝑫 𝒄𝒐𝒍𝒐𝒓𝒆𝒅 𝒕𝒊𝒔𝒔𝒖𝒆 (𝑴𝑻𝑻 𝒂𝒔𝒔𝒂𝒚) − 𝑶𝑫 𝒄𝒐𝒍𝒐𝒓𝒆𝒅 𝒕𝒊𝒔𝒔𝒖𝒆 (𝒏𝒐 𝑴𝑻𝑻 𝒂𝒔𝒔𝒂𝒚) 
 
Histological analysis 
For characterization of microscopic structure of exogenous 3D skin model, and 
comparison with our 3D skin platform, morphological analysis on histological 
section was performed both on EpiDerm 312X FT and our 3D HSE skin model. On 
the day of receipt, EpiDerm 312X FT samples were removed from agarose support 
and placed in a 12 well plate and maintained in culture medium at 37°C for 24 h. 
Subsequently, samples were fixed with 10% neutral-buffered formalin fixative for 
2–4 h at RT and rinsed twice with PBS buffer solution. After the fixation and 
dehydration procedure, samples were embedded in paraffin to be sectioned and 
stained. 7 µm transverse sections of samples were stained using hematoxylin-
eosin (Bio Optica) solutions and Picro Sirius Red (PSR) (Sigma Aldrich) following 
standard procedure and analyzed by an optical microscope (BX53; Olympus). 
Polarized light images of samples stained with PSR alone were acquired with an 
inverted microscope (BX53; Olympus) with a digital camera (Olympus DP 21). A 
linear polarizer was placed between the light source and the specimen, while the 
analyzer was installed in the light path between the specimen and the camera. It 
is known that the color of collagen fibers stained with PSR and viewed with 
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polarized light depends upon fiber thickness; as fiber thickness increases, the 
color changes from green to red [13], [14]. 
Collagen structure by Second Harmonic Generation imaging 
For the Second Harmonic Generation (SHG) imaging (see chapter 2), at the time of 
receipt, Phenion and EpiDerm 312X FT samples were removed from agarose 
support and placed in a 12 well plate and maintained in culture medium at 37°C 
for 24 h. Subsequently, samples were fixed in 4% paraformaldehyde for 30 min at 
RT, washed in PBS and observed in their 3D structure. SHG imaging were 
performed using a Confocal Leica TCS SP5 II femtosecond laser scanning system 
(Leica), coupled to a tunable compact mode-locked Ti:sapphire laser (Chamaleon 
Compact OPO-Vis, Coherent) (for details see the chapter 2). Nuclei were stained 
with Sytox Green (1:10000, Invitrogen). 
Contact angle measurements 
In order to estimate surface proprieties and wettability of our 3D endogenous HSE 
and EpiDerm 312X FT, contact angle measurements were performed on samples.  
In particular, human skin stratum corneum, (the outer layer of the epithelium) is a 
complex of proteins, water-soluble components and lipids, and it acts as a primary 
barrier to transdermal diffusion for most substances and it is responsible for the 
physicochemical properties of the human skin surface. The main function of the 
skin is to minimize water loss entry of foreign matter [15]. For these reasons, the 
study of superficial properties and their modification (for example induced by 
cosmetics or surfactants treatments) is a central focus of cutaneous, cosmetic and 
pharmaceutical research. The human skin-wetting process is the main factor of its 
protective and barrier functions: minimizing water loss and preventing the entry 
of foreign matter and chemicals [15], [16]. Contact angle measurements were 
performed by means of the static, sessile, optical contact angle drop method with 
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Attension Theta optical tensiometer (Biolin Scientific). An amount of 1.5 ml of 
MilliQ water was dropped on dry samples at 3 ml s-1 dispense rate. The plateau 
value of the contact angle was reached after 1 min and five images were recorded 
and analyzed by Young Laplace fitting method for every drop. 
 
4.2.2 Scale-up of 3D human skin equivalent multistep tissue process  
In order to obtain endogenous human skin models as effective and useful testing 
platform, responsive to external stimuli and to testing molecules and compounds 
(see Chapter 3) we set up a multistep process according to a bottom-up approach 
and we introduced several check points to ensure the good manufacture of our 
skin systems step by step, from primary extracted fibroblasts, to final 3D human 
skin models. The main phases of fabrication of 3D endogenous HSE was widely 
described in the chapter 2, performed by a multistep bottom up approach. 
3D Human skin equivalent model realization  
As widely explained in the chapter 2, 3D endogenous HSE were fabricated by 
bottom-up approach. Briefly, primary human dermal fibroblasts extracted by 
human biopsy (they were obtained by “Azienda Ospedaliera di Rilievo Nazionale e 
di Alta Specializzazione (AORN) A. Cardarelli/Santobono/Pausillipon at Urology 
and Biotechnology Centre-AORN” according to the project “Realization of human 
skin equivalent in vitro” after approval of ethical committee”) were sub-cultured 
into 1720 cm2 tissue HYPERflasks (Corning) with a density of 8x103 cell/cm2 in 
order to improve cell number and reduce risks of contamination. Cells were and 
maintained in culture medium (Minimum Essential Medium with Earle’s salts, 
Microgem) containing 20% fetal bovine serum (FBS), 100 mg/ml L-glutamine, 100 
U/ml penicillin/streptomycin (P/S), and 0,1 mM non-essential amino acids at 37 
°C, 5% CO2 and humidity 90%. Human Dermal microTissue Precursor (HD-μTP) 
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were obtained by seeding HDF (passages 5-9) on gelatin porous microcarriers 
crosslinked at 4% with D-(+)- Glyceraldehyde (Sigma Aldrich), in a spinner flask 
(Integra Bioscience) for 9 days. Each spinner flask was initially loaded with 9.5 x 
106 HDF and 172 mg of microbeads, corresponding to 10 cells/beads. Spent 9 days 
in dynamic culture, HD-µTP were transferred into the maturation chamber to 
allow their molding in disc-shaped tissue-construct such as Human Dermis 
Equivalent (HDE) (1 mm in thickness, 5 mm in diameter) as previously described in 
the chapter 2. Maturation of HDE was carried out until 6 weeks in dynamic 
conditions by placing the maturation chamber on the bottom of a bioreactor 
(Bellco) operated at 60 rpm at 37°C, 5% CO2 and humidity 90%. The medium was 
changed every 2 days and ascorbic acid (TCI) was added at a concentration of 50 
µg/ml. At the end of 6 weeks of maturation, chambers were opened and HDE 
were extracted and prepared for primary keratinocytes seeding. As described in 
the chapter 2, human keratinocytes were obtained from biopsy and cultured into 
150 cm2 tissue flasks with a density of 2x104 cell/cm2 in culture medium KGM2 
(Promocell) supplemented with 0.1% transferrin, 0.1% epinephrine, 0.1% 
hydrocortisone,0.1% insulin, 0.1% H-EGF, 0.4% BPE, 5% FBS, 1% P/S and calcium 
chloride at 0.06 μM and maintained 37 °C, 5% CO2 and humidity 90%. 3D-HDE 
were prepared for keratinocytes seeding by a human fibronectin coating for 45 
min and during this time, keratinocytes were washed and trypsinized. Cells were 
counted (150,000 cells/samples of 5 mm diameter), seeded on the human dermis 
models surface and maintained in submerged culture conditions for 6 days in 
order to allow cell adhesion and proliferation. After 6 days of submerged 
conditions, the cultures were raised to the air-liquid interface for 14 days in 
culture medium with a different composition (0.1% transferrin, 0.1% epinephrine, 
0.1% hydrocortisone, 0.1% insulin, 1% P/S, without EGF and BPE and with calcium 
chloride at 1.88 μM) in order to induce and stimulate differentiation and 
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stratification of epidermis thanks to the contact to the air and to the high 
concentration of CaCl2 [17], [18]. 
 
Quality control check point of cell cultures 
In order to evaluate the good conditions of extracted primary dermal fibroblasts, 
cells were amplified in HYPERflasks of 1720 cm2 and controlled during the 
amplification to avert any contamination and such a trans-differentiation in 
activated contractile fibroblasts [19], [20]. 
The modulation of the fibroblast into the modified fibroblast, as myofibroblasts, 
has been the object of several studies and seems to be caused by several agents 
or stimuli that trigger the evolution of the fibroblast into the proto-myofibroblast, 
and then, in activated myofibroblast [21]. Contractile fibroblasts are involved in 
wound healing and fibrocontractive disease, and they represent key players in the 
physiological reconstruction of connective tissue after injury and in generating the 
pathological tissue deformations that characterize fibrosis [19] [22]. The density of 
seeding (8x103 cells/cm2) and several external stimuli can trigger the activation of 
fibroblasts transition in contractile modified fibroblasts: it is well established that 
the first changes that fibroblasts undergo during myofibroblastic modulation are 
the acquisition of a spindle shaped thanks of stress fibers composed of 
cytoplasmic actin. Contractile fibroblasts are positive for α-smooth muscle actin 
(α-SMA) and in a first phase, they do not secrete collagen [21]. 
During the culture period, fibroblasts were controlled in shape and in time of 
cellular generation, following this formula at each trypsinization. Only if cells 
conserved a time generation of 0.46, they were used for 3D-HSE fabrication. 
𝐷𝑜𝑢𝑏𝑙𝑖𝑛𝑔 𝑡𝑖𝑚𝑒 =
log(𝑓𝑖𝑛𝑎𝑙 𝑐𝑒𝑙𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛) − log (𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑒𝑙𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛)




Quality control check point of HD-µTP  
The second quality control was performed on HD-µTPs at 9th days of dynamic 
culture in spinner flask both on 3D samples and on histological sections in order to 
evaluate collagen deposition and the expression of α-SMA as marker of transition 
in contractile fibroblasts. 
 
Collagen structure by Second Harmonic Generation imaging 
For collagen assessment, samples taken from spinner flask were washed in PBS 
and then fixed with paraformaldehyde solution 4% for 20 min at RT and rinsed 
twice with PBS. After fixation procedure, samples of 3D HD-µTP were observed to 
evaluate collagen deposition by Second Harmonic Generation (SHG) imaging as 
explained in the chapter 2. 
 
Immunolabelling 
The expression of α-SMA was evaluated performing an immunofluorescence 
directly on 3D fixed HD-µTP. Samples were washed in PBS and fixed with 
paraformaldehyde solution 4% for 20 min at RT and rinsed twice with PBS. 
Samples were incubated with histoblock solution at 3% of bovine serum albumine 
(BSA, Sigma Aldrich), 3% of FBS and 0,001 % Triton-X100 (Sigma-Aldrich) for 1 h at 
RT. Subsequently, samples were incubated with primary antibody anti α-SMA 
(monoclonal, 1:100, Abcam) for 2 h at RT. Secondary antibody used was Alexa 
Fluor donkey anti-mouse 546 (1:500, Life Technologies). Nuclei were stained with 






Quality control check point of 3D human dermis and skin equivalent 
These quality checks were performed on 3D-HDE after 6 weeks of maturation 
time culture and on the final products (3D-HSE) after 14 days at air-liquid culture 
condition. We compared good and poor quality samples in order to evaluate the 
manufacture of our product during the tissue process. For human dermis and skin 
models characterization, morphological analysis was performed on histological 
section of samples during the maturation phase in bioreactor culture system. 
Samples were fixed with 10% neutral-buffered formalin fixative for 2–4 h at RT 
and rinsed twice with PBS buffer solution. After the fixation and dehydration 
procedure, samples were embedded in paraffin to be sectioned and stained. 5 µm 
transverse sections of samples were stained using hematoxylin-eosin (Bio Optica) 
solutions, analyzed by an optical microscope (BX53; Olympus). 
 
Quality control check point of Fetal Bovine Serum and culture media by 
streaking agar plate 
FBS was one of the leading cause of bacterial contaminations [23], [24]. Since FBS 
was used at 20% in fibroblasts growth medium, in order to avoid any risk of 
contaminations, FBS purchased from Sigma Aldrich was thawed at 4°C overnight 
and an aliquot of about 2 ml were taken from the bottle. A sterile cotton bud was 
immersed in FBS aliquot and then a streaking on BHI (Brain Heart Infusion) agar 
plate (BD Falcon) was performed. The same procedure was performed also for 
culture media of extracted primary cells and of spinner flasks during the different 
phases of tissue process. The plate was leaved at 37°C for 48 h. Any bacterial 
contamination was visible on the plate by the formation of colonies distributed 




Mycoplasma detection assay 
Mycoplasmas are important tissue culture contaminants that exist in close 
association with the host cell membrane. This infection causes structural damage 
and changes in host cell metabolism which can interfere with experiments or 
result in the loss of the infected cell line [25]. In fact, the contamination of cell 
cultures by mycoplasmas remains a major problem in cell culture. Mycoplasmas 
can produce a virtually unlimited variety of effects in the cultures they infect [26]. 
Constant monitoring of cells is therefore imperative [25]. There are several 
procedures to detect mycoplasma contaminations, such as cultivation in 
appropriate media, immunofluorescence, or measurement of uridine-uracil 
incorporation ratio, and fluorescent staining by DNA-binding dyes such as DAPI 
and Hoechst 33258 [25]. We performed a mycoplasma detection assay 
(ApplyChem) based on the amplification by PCR of ribosomal subunit of RNA 16S 
on supernatant aliquots of FBS, of culture medium of primary fibroblast and 
keratinocytes extracted from biopsy, and on culture media withdraw from spinner 
flasks at each critical phase of tissue process: before HD-µTP molding, at 9th day of 
culture, and at 2 and 4 weeks of maturation phase of 3D-HDE tissues. 
Procedure. According to manufacturing procedure, samples were prepared to the 
assay transferring 0.5-1.0 ml cell culture supernatant into a 2 ml centrifuge tube. 
To pellet cellular debris, samples were centrifuged at 250 xg briefly. Subsequently, 
supernatants were transferred into a fresh sterile tube and centrifuged at 15000-
20000 xg for 10 min to sediment Mycoplasma. Carefully the supernatant was 
decanted in order to keep the pellet (not always visible). Pellet was re-suspended 
in 50 μl of the Buffer Solution (provided by the kit), mixed thoroughly with a 
micropipette and heated to 95°C for 3 min. The test sample could be stored at this 
stage at -20°C for later use. 
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For the PCR amplification, we prepared the reaction mixture in a PCR tube by 






Before of loading samples, mineral oil was added (approximately 40 μl) to avoid 
the evaporation of the reaction mixture. All tubes were placed in DNA thermal 









For electrophoresis, 2% Agarose was prepared (Sigma Aldrich), enriched with 
about 6 μl of ethidium bromide (Sigma Aldrich) as intercalating agent of DNA, 
emits a fluorescence when exposed to UV light. 20 μl of all PCR products, 
including negative control (only Buffer solution) and positive control (1 μl of 
Table 2. PCR amplification reagents  
Table 3. Thermal cycler parameters  
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Positive Template Control, provided by the kit) were added to the gel agarose 
electrophoresis. The size of DNA fragments amplified using the specific primers in 
this kit is 270 bp. Amplification products were observed with ChemiDoc XRS 
System (Biorad), and images were acquired with Quantity One software. 
 
Industrialization and working plan set up of all tissue process operations to 
allow a large-scale production 
In order to improve the bioprocess productivity and ensure endogenous 3D-HSE 
fabrication in large scale for the commercial availability, we set up an accurate 
strategy plan for the scale up of tissue process. This method allowed to guarantee 
the complete control on yield and quality products, and in the same time, to 
increase the productivity by means of the parallelization of our bioprocess 
obtaining a safety and standardized protocols to ensure about 200 tissue products 
per month available for several tests and applications. 
First of all, to increase the productivity, we employed all tools and procedures to 
improved volumes, cell numbers, amount of tissue produced using big bioreactors 
(Bellco) of 500 ml working in parallel at the maximal capacity; second, in order to 
control all steps of tissue process; we purchased both of small and big incubator 
(Esco AirFlow and Thermo Scientific, respectively) to start tissue production in 
series. We optimized our bioprocess identifying 5 phases of bioprocess and for 
each phase we characterized main critical points that could compromise the 
manufacture quality of tissue system. 
We developed a weekly program for each laboratory operation related to a single 
tissue process phase, ensuring the best organization in order to obtain a constant 




4.3 RESULTS  
4.3.1 Characterization of Phenion Full-Thickness skin model by Henkel by 
SHG imaging 
The equivalent skin samples Phenion Full-Thickness skin model were purchased 
from Henkel in order to study the characteristics and the composition of one of 
the most important skin model competitor commercially available. The dermal 
compartment is obtained starting from a mixture of reconstituted bovine collagen 
and glycosaminoglycans that formed a sponge, and human fibroblasts (Normal 
Human Fibroblast) extracted from biopsy. The epidermis is produced from a 
population of epithelial cells seeded on the dermal surface and made adequately 
differentiate into a multilayered epithelium in air-liquid interface [27]. The entire 
system is sent in a 24 well plate, and each skin models is set on a polycarbonate 
filter and embedded in a mixture solution of agarose and culture medium. At the 
time of delivery Petri dishes were filled with the ready-to-use ALI-medium 
provided with the skin models and samples were removed from the agarose, 
resting on filter paper in order to ensure the air-liquid culture condition (Figure 
1a). Samples were maintained in this culture configuration for 24 h at 37°C and 











As shown in Figure 1b and c, Phenion Full-Thickness skin model was composed of 
a spongy matrix, made of a mixture of reconstituted collagen and GAGs which 
confers a porous structure to the scaffold. Fibroblasts did not deeply penetrate 
into the spongy matrix, and they were distributed in the upper part of the dermal 
compartment (about 10 µm). Keratinocytes, distributed on the top of the dermis, 
composed a high cellularized epithelium scarcely differentiated: in fact, as better 
seen in Figure 1c, the epithelium was rich of cells in all its layers without an 
adequate stratification, since the upper stratum of epidermis were highly 
cellularized. These data highlighted the limitations of this skin model related to 
the scarce complexity both of dermal and epidermal compartment. The dermis 
was lack of an endogenous well organized ECM, and of homogeneity in cell 
distribution, while the epidermis is not adequately differentiated and stratified. 
 
Figure 1. Characterization of Phenion Full-Thickness skin model. a) Phenion skin 
models at the time of receipt laying on filter paper to recreate the air-liquid 
culture condition; tissue model composition with cells in green and scaffold in 
grey by tile scan function and conventional acquisition (b and c respectively). 
Bars are 100 µm. 
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4.3.2 EpiDerm 312X FT skin model by MatTek Corporation and comparison 
with our endogenous 3D human skin platform 
In order to assess the morphology and the composition of another gold standard 
skin model, we purchased the EpiDerm 312X FT skin model by MatTek 
Corporation. Samples were shipped in a 12 well plate and embedded in a mix 
solution of agarose and culture medium in a similar configuration of Phenion Full-
Thickness skin model. On the day of receipt, samples were removed from agarose 
and leaved in polycarbonate filter to ensure the air-liquid interface condition. 
After 24 h, we conducted an irritation test, to evaluate the effective functionality 
of model as a screening platform for cosmetic testing, and a macroscopic analysis 
through the stereomicroscope (Olympus) and histological analysis in order to 
obtain a morphological characterization and a useful comparison between our 




To test the cell viability and the models response to an irritant compound, an 
irritation test was performed using 5% SDS as irritant substance and PBS 1X as a 
control solution. Irritant compound was put in contact with samples for 60 min 
and subsequently a MTT assay to assess cell viability was conducted. As shown in 
Fugure 2b after MTT test, the purple color of control sample (treated with PBS 1X) 
denoted a higher cell viability compared to samples treated with the irritant 
compound. After solubilization of formazan with isopropanol, the absorbance of 
the supernatant was read at 570 nm and the relative cell viability was calculated: 
the relative viability of the samples treated with PBS 1X was equal to 100%; while 







Figure 2. Irritation test on 3D skin equivalent EpiDerm 312X FT. a) Absorbance 
reading of MTT test for cell viability at 570 nm; b) MTT assay after the treatment 






In order to characterize the structure and the morphological composition of 
exogenous 3D EpiDerm 312X FT skin model, histological analysis of tissue slides 
was performed. The simple composition of ECM was highlighted from H&E 
staining of 7 µm paraffin-embedded tissue slices as shown in Figure 3. In fact, the 
ECM network was less cellularized than endogenous ECM of our 3D–HSE 
counterpart. PSR staining showed several green, thin and immature collagen 
fibers, typical of reconstituted collagen used for the realization of dermal 
compartment. This structural organization was confirmed also by SHG images, 
which showed a diffuse grey signal without collagen organization in fibers or 































Figure 3. Comparison between our endogenous 3D human skin system and 
EpiDerm 312X FT skin model by MatTek Corporation. Images acquired at 
stereomicroscope (Olympus) of entire superficial features of EpiDerm 312 X 
FT (a) and 3D human skin equivalent (b); and H&E staining of paraffin 
embedded tissue of EpiDerm 312X FT and 3D-HSE (c and d respectively); 
PSR staining of embedded tissue slices of and EpiDerm 312X FT and 3D -HSE 
(e and f respectively); SHG images of collagen signal of ECM (endogenous 
3D HSE in g and EpiDerm 312X FT in h). Nuclei were stained with Sytox 
Green. Bars in c-f) are 100 µm, bars in g-h) are 25 µm.  
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Thanks to morphological and histological analysis, differences between our 3D-
skin system and EpiDerm 312X FT skin model became evident. Our 3D skin system 
appeared compact shaped, resistant to pressure and tension, with a compact 
network of endogenous ECM that primary fibroblasts assembled and secreted 
themselves spontaneously during the maturation phase in dynamic culture 
conditions. 3D EpiDerm 312X FT was made by reconstituted bovine collagen type I 
mixed with a primary fibroblasts and human keratinocytes seeded on the dermis 
surface, but the exogenous ECM is a simple system without any complexity and 
architecture. Our endogenous 3D human skin model was obtained with an 
innovative approach that allow and stimulate primary fibroblasts to produce 
endogenous ECM in a dynamic culture system. In fact, the endogenous ECM was 
rich of collagen, elastic fibers and glycosaminoglycans produced by cells: the 
dermis compartment recapitulated all features of human counterpart in term of 
morphology, function and organization. In the same time, in order to obtain the 
epidermal layer, primary keratinocytes were seeded on dermis compartment, 
mixed to a population of melanocytes that gave to our skin model the typical light 
brown color with spot of dark brown pigment (Figure 3a and b). PSR staining and 
SHG signal confirmed the presence of immature and thin collagen fibers not 
assembled in a consistent ECM for EpiDerm 312X FT skin model compared to ECM 
of our model. The ability our human skin equivalent in representing a more 
physiological and cell-instructive environment was probably due to the 
endogenous nature of HDE [28]. Indeed, HDE are composed of an intricate 
complex of cells and cell-synthesized matrix, which resembles the structure and 
the physiology of its in vivo counterpart. Histological analyses highlighted that 
human dermal fibroblasts actively produced and correctly assembled ECM 
components, and they showed a typical elongated morphology and were 
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embedded in their own ECM. Finally, we assessed that our 3D skin system mimics 
more closely the morphology of native human skin. 
 
Wettability of samples 
In order to further investigate the functionality of the model, we evaluated the 
surface wettability, which is strictly correlated with the barrier properties of the 
skin, by measuring its contact angle [29]. We found that our 3D organotypic tissue 
HDE presented a value of 83.1± 4.3, while exogenous skin model a value of 66.2 ± 
8.5 (Figure 4). Such results suggested that the physiological barrier function of the 
skin was better recapitulated on our human skin equivalent model. These data 
suggested that there is a functional crosstalk between fibroblasts and ECM 
components secreted by cells themselves and keratinocytes of epidermal 
compartment, and that the complexity of ECM and its organization could 




























We investigated the main morphological differences between our model and the 
best competitor models commercially available, Phenion Full-Thickness skin 
model and EpiDerm 312X FT skin model purchased from Henkel and MatTek 
Corporation respectively. The morphological characterization on histological 
sections revealed the complexity of our 3D human skin models, which is 
characterized by a compact endogenous ECM secreted and assembled by dermal 
fibroblasts during the culture period of the maturation phase. Thanks to loading of 
HD-µTP in the maturation chamber, tissue precursors aggregated for the 
realization of dermal compartment. In fact, the dermis of our models was 
composed of a homogenous cellular population embedded in a complex ECM 
enriched of collagen fibers and elastic components that gave support to the tissue 
system mimicking the native counterpart (as seen in Figure 3). 
Figure 4. Contact angle measurement. Wettability 
properties by contact angle measurement on EpiDerm 
312X FT skin model (exogenous skin model) and our 
endogenous 3D-HSE (Endo-HSE). (All bars are 200 mm; 
*, #p < 0.001). 
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4.3.3 Industrialization of 3D human skin equivalent models production  
The improvement of productivity and development of our 3D skin tissues was 
obtained by setting up a laboratory fully dedicated to the sole production of skin 
models. Tissue process already applied for the development of skin models in 
small-scale was achieved employing several methods and instruments useful to 
increase the cell numbers, culture media volumes, HD-µTP and 3D HSE models 
fabricated. In order to transfer the production from the small scale to the large 
scale, we purchased large instruments and devices to maximize the production. 
Figure 5. Improvement of skin models production. a) small bioreactor used for 
tissue production in small scale; b) big bioreactor employed for the fabrication of 
dermal tissues; c) small incubator for cells cultivation and amplification (d); 






In particular, the transition from the small scale to the large scale it has involved 
the use of big bioreactors (Bellco), able to accommodate 4 maturation chambers 
with a maximal capacity of 500 ml of cell culture medium, substituting small 
bioreactors (Bellco), used hitherto able to accommodate only one maturation 
chamber in a maximal volume of 120 ml, as shown in Figure 5a and b. The use of 
big bioreactor working in parallel at the maximal capacity allowed us to increase 
the production of 3D skin models, since each big bioreactor accommodated 4 
maturation chambers, containing 7 skin models draw each. In addition to the 
employment of big bioreactors, we purchased two type of incubators: a small 
conventional incubator (Esco AirFlow) of 75 L, for the maintenance and the 
amplification of cell cultures used in our tissue process (dermal fibroblasts and 
keratinocytes) (Figure 5c and d); and an industrial incubator (Thermo Scientific) of 
680 L, for the fabrication of HD-µTP and of dermal skin models (Figure 5e, f and g, 
respectively) with the possibility of start multiple tissue process in parallel to 
intensify the productivity. For the sterilization of tools and instruments, a big 
industrial autoclave (Falc), with 4 preset sterilization cycles and 1 manual 
sterilization cycle was purchased, and two different cell culture hoods (Esco 
AirFlow), were used in order to separate the cell extraction activities from others 






All these measures employed to produce skin models in large scale, were applied 
to intensity and enhance the productivity in two manners: on the one hand, by 
the purchasing of instruments with a greater capacity and higher dimensions, and 
on the other, by the production of skin tissue models in series, using big 
bioreactors working in parallel at their maximal capacity of 4 chambers and 7 
dermal tissues for chamber. In this way, we increase not only the total cell 
number for each tissue process, but also HD-µTP obtained and final 3D-HSE 
fabricated for month. 
 
4.3.4 Organization planning to improve human skin models production 
To improve the productivity of our tissue process, we introduced crucial check 
points in each critical phase of bioprocess and we defined an accurate 
organization plan of laboratory activity during the work week. This plan allowed to 
guarantee a continuous productions of tissue models in large scale, ensuring good 
manufacturing products with the maximum yield [3], [32]. The improvement of 
tissue production was obtained by defining the specific sequence of single steps of 
Figure 6. Instruments employed for the industrialization of human skin 
equivalents production. a) large autoclave for the sterilization of big bioreactors 
and big spinner flasks; b) cell culture hoods for cell extraction from human 
biopsy and all other phases of tissue process. 
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tissue process and by programming each activity and operation for each day of 
work week. This accurate program allowed to ensure a perfect activity 
organization and the production of a constant number of tissue every month, with 
the purpose of sustaining the market requirements and competing with other skin 
models commercially available. 
As shown in the first scheme, in Figure 7a, we divided the whole tissue process in 
5 main phases, which included critical steps:  
A. Fabrication of HD-µTP; 
B. Loading of HD-µTP after 9 days in dynamic culture conditions; 
C. Preparation of 3D-HDE after 6 weeks of maturation phase;  
D. Keratinocytes seeding on 3D-HDE in order to obtain final 3D-HSE; 
E. End of air-liquid interface culture condition and realization of 3D-HSE as final 
products of our bioprocess 
The subdivision of the process in these main phases allowed us to set up an 
accurate organization plan of the work week. In the second scheme, in Figure 7b, 
we set up a weekly working program with the purpose of standardizing each 
laboratory activities to better control and improve the sale-up of tissue 
production. The laboratories activities were divided by hours of work of an 
individual operator considering all operations related to every step of tissue 
process, as change culture media, (referring both to culture cells, spinner flasks 
and bioreactors), preparation of solutions and cleaning or sterilization of work 




The distribution of each laboratory activity was defined on the basis of duration 
and complexity of single operation, compatibly with the working day of an 
individual operator, in order to produce skin tissues in series, starting with a tissue 
process every week ensuring a constant tissue yield for month. In fact, as 
schematized in the Figure 7b, a tissue process, from step A to step E, was started 
and completed over the week, thanks to production in series, and bioreactors 
operating in parallel. The accurate organization of each working day activities 
Figure 7. Schematization of weekly working plan of tissue process. a) Tissue 
process division in 5 different critical steps; b) organization of laboratory activities 
during the working day of one operator who can started a whole bioprocess each 
week compatibly with the duration of each activities; c) selective check points and 
quality controls of each  preparative procedure and critical step of the bioprocess.  
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represented a powerful strategy in a view of an industrial scale-up of tissue 
production. The last schematization, in the Figure 7c, represents the check points 
and quality controls introduced in each single step of the whole bioprocess in 
order to ensure the good manufacture of our tissue products. The crucial quality 
controls were applied not only in tissue process steps but also to check reagents, 
FBS, and cell source. The main check points were: mycoplasma detection assay, 
streaking on BHI agar plate, collagen assembly evaluation by SHG imaging and 
calculation of cellular generation. These controls were made on serum aliquots, 
culture media of cells and of HD-µTP at the end of 9 days in spinner flask, and 
during the maturation phase.  
Mycoplasma and bacterial contaminations, could result from FBS [23], [26], from 
bioptical samples or acquired during the routine operation of change media. 
Collagen assembly evaluation was assessed by SHG imaging on HD-µTP before the 
loading in a maturation chamber and finally, cellular time generation was 
calculated on cell culture and on HD-µTP, during the 9 days of assembling in 
dynamic culture in order to evaluate cellular proliferation. This accurate plan had 
the purpose to intensify and improve the production of 3D endogenous skin 
models by a scale-up strategy in order to make available our products on the 
market as a competitive tissue system in the industry of equivalents skin models. 
 
4.3.5 Quality control of HD-µTP  
With the aim of guarantee the best quality of final tissue products, we introduced 
several check points in each critical step of our bioprocess. The first critical step of 
the bioprocess is the evaluation of HD-µTP after 9 days of dynamic culture in 
spinner flasks. During this period, primary dermal fibroblasts inoculated in gelatin 
microcarriers, began to proliferate, produce and assembly a collagenous matrix 
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that embedded cells and beads as a dense structural network. To verify this 
conditions, before molding of HD-µTP, an immunofluorescence for α-SMA and 
SHG imaging were performed on fixed 3D samples. As shown in Figure 8, we 
compared poor quality α-SMA-positive HD-µTP with optimal HD-µTP, negative for 
α-SMA expression. α-SMA is marker of transition from dermal fibroblasts to 
contractile fibroblasts. Poor quality HD-µTP were characterized also for the 
absence of collagen deposition evaluated by SHG signal (Figure 8a and c). On the 
contrary, optimal HD-µTP showed the absence of α-SMA signal, and an high 
deposition of collagen (Figure 8b and d, respectively) at the end of 9 day of 
dynamic culture in spinner flasks. 
The best quality HD-µTP in fact, showed a compact structure composed of cells 
and porous microbeads, totally embedded in a dense collagenous matrix. It was 
interested to observe that collagen bundles (Figure 8d in grey) were assembled 
not only around the HD-µTP, but also inner each microbeads, indicating that cells 
penetrated inside gelatin scaffolds thanks to their interconnected porosity. With 
this check point on the first phase of tissue process, it was possible to evaluated 
the best proprieties of building blocks, discarding all poor quality HD-µTP that did 
not respond to our needs. In fact, in order to obtain optimal endogenous human 
skin models in terms of morphological, structural and functional characteristics, it 




With these results, we demonstrated the effectiveness of our quality control, in 
order to identify the bad products and discard them. The expression of α-SMA is 
related to the activation of dermal fibroblasts in modified contractile fibroblasts 
[19] that, for some reasons not yet fully clarified, reduced their duplication time 
and stop producing ECM during the dynamic culture. These abortifacient products 
compromise the development of final 3D human skin equivalent models because 
Figure 8. Quality control check point of HD-µTP at the end of 9 days in 
spinner flasks. a) poor quality HD-µTP showed positivity for α-SMA 
expression (in red) with a low collagen deposition (c); b) optimal HD-µTP 
showed the absence of α-SMA expression by fibroblasts and a significant 
collagen production visualized by SHG signal in grey (d). Nuclei were 
stained with DAPI. Bars are 100 µm. 
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of cells could not support a significant collagen deposition during the maturation 
phase, basic requirements for a good development of dermal compartment. 
 
4.3.6 Quality control of endogenous 3D human dermis equivalent models  
The second check point of our tissue process was the quality control of 3D human 
dermis equivalent during the maturation phase. We assessed that by using poor 
quality HD-µTP, we obtain abortifacient dermal compartment that could not 
support keratinocytes differentiation and stratification to form a good epithelium 
comparable to native counterpart. During the maturation, HD-µTP molded in the 
maturation chamber interacts each other: cells migrate from one to another HD-
µTP producing and assembling ECM enriched of collagen, elastic fibers and 
glycosaminoglycans that confer firmness and resistance to dermal compartment. 
To verify this optimal conditions of dermis, before the development of a full 
thickness skin system, a morphological analysis on tissue sections was performed. 
As shown in Figure 9, H&E stained sections revealed several differences between 
two types of human dermis equivalent models. In the Figure 9a it was evident the 
poor quality of dermal compartment of samples examined: ECM, stained in pink, 
was disrupted, not compact and inhomogeneous. It was possible still to see traces 
of microbeads partially degraded inside dermis that did not show any continuity 
along the sample. On the contrary, the Figure 9b showed a perfect dermal 
compartment, which cells, stained in purple, were completely embedded in a 
compact, homogenous and structured matrix (in pink), with the disappearance of 







Figure 9. Morphological analysis of 3D human dermis equivalent models. 
a) H&E staining on tissue sections of 3D-HDE which showed poor quality 
dermal compartment with microscaffolds not completely disappeared 
and an ECM scarcely homogenous; b) an optimal dermal compartment 
which cells were well distributed and closely embedded in a compact 
and dense ECM with no trace of microscaffolds, completely degraded by 
cells remodeling process. Bars in a-b) are 200 µm; bars in magnified 




These data suggest that this second tissue process check point was crucial to 
verify the best quality of dermal compartment before keratinocytes seeding. As 
known from literature, dermal fibroblasts support and sustain keratinocytes 
differentiation [30], and for these reasons a good dermis is required for the 
fabrication of a functional full thickness skin systems. 
4.3.7 Quality control of endogenous 3D human skin equivalent models  
With the aim of evaluating the manufacture of endogenous 3D human skin 
equivalent models, a last quality control was carried out on samples at the end of 
tissue process. H&E staining images showed two type of samples with different 
morphological features. 
The Figure 10a showed a poor quality 3D-HSE sample, which highlighted an 
inhomogeneous ECM with empty spaces leaved by microbeads just disappeared, 
and an inadequate epithelium, characterized of a single layer of keratinocytes not 
stratified attached on dermis surface. Conversely, in the Figure 10b, it was 
possible to observe an optimal quality of 3D-HSE, which showed a compact and 
continuous ECM enriched in cells and collagen, with a continuous dermal-
epidermal junction composed of keratinocytes belonged to the germinative layer 
that reproduced a differentiated and completely stratified epithelium at the end 
of air-liquid interface. These data highlighted the powerful of check points at each 

























Finally, in the light of these results, we obtained a functional and responsive 3D 
human skin equivalent models widely characterized in previous chapters, 
composed of an endogenous ECM secreted by primary dermal fibroblasts 
themselves and a completely and well differentiated epithelium. As we have 
Figure 10. Morphological analysis of 3D human skin equivalent 
models. H&E staining on tissue sections of 3D-HSE after 14 days of 
air-liquid interface culture conditions; a) poor quality dermal 
compartment with an inhomogeneous ECM (in pink) and an 
undifferentiated epithelium on the top of dermis; b) compact 
dermal compartment and continuous ECM with a stratified 
epithelium, completely differentiated on dermis surface. Bars in a-
b) are 200 µm; bars in magnified images are 100 µm. 
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already discussed in the chapter 2 and 3, the effectiveness of our models was 
related to the endogenous dermal compartment and to the interaction between 
dermal and epidermal compartment, thanks to a complex cross-talk between 
fibroblasts and keratinocytes that communicate and interact each other during 
the assembly of dermis and epithelium [30], [33]–[35]. In particular, dermal 
fibroblasts population support human skin development [36] and, in skin 
substitutes, ensure a superior keratinocytes differentiation, and the formation of 
a functional dermal-epidermal junction, compared to acellular matrices that do 
not support an efficient epidermal stratification [37]. 
This tissue configuration made our models functional and responsive to external 
stimuli and to active compounds treatment that could be administered also in a 
topical formulation. 
With these constant check points and quality controls, we could ensure a good 
quality products, developed by standardized procedures improved during the 
scale-up of our bioprocess. Our 3D skin models represented a complex tissue 
system as a powerful testing platform for cosmetic testing which could compare 
with other existing skin models commercially available both in terms of efficacy, 
main features and yield in an industrial point of view. 
4.3.8 Scale-up of 3D human skin equivalents models 
Thanks to an accurate working plan defined to increase the large-scale production 
of our tissue models, we obtained the maximal yields during last 2 years of my 
PhD period by the application of a scale-up strategy. We ensured about 200 3D-
endogenous skin equivalent models per month. In the Table 4 we schematized all 
the operations of tissue process done step by step as final inner check control. By 
examining an ideal month and identifying each new tissue process with an 
identification number, we traced each tissue bench over the time, and the 
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percentage of successes. As shown in the Table 4, tissue processes were 
numbered and every critical step done was checked. Likewise, each failure during 
the bioprocess was identified in order to control the percentage of unsuccessful. 
An accurate costs analysis, over the ideal month of maximal production was 
estimated, with the aim of controlling not only the critical points of bioprocess but 
also the total spending for a single finished product. Table 5 was obtained by a 
costs evaluation for all reagents, components, chemicals or additives used for 
culture maintenance and finally we estimated an approximate monthly spending 
of about 10959 euro and 47,8 euro for each HSE produced. The final cost of the 
final product is related to the most expensive reagents used for the tissue process, 
as FBS and culture medium for maintenance of human keratinocytes. 
These data allowed us to better control the single step of our bioprocess, the yield 
of production, costs for a month of production and for one final tissue model. 
Furthermore, this planning allowed to estimate not only percentage of failures, 
over a month, but also to identify the most critical step more prone to failure. The 
main cause of failure was: i) the risks of fibroblasts transition from a dermal 
phenotype to an activated contractile phenotype probably due to the 
heterogeneity of cellular population extracted from biopsy; ii) bacterial and 
mycoplasma contaminations, that could affect human biopsy or acquired during 
the culture time and during the air-liquid interface culture condition, that seemed 
to be the most critical step of the entire bioprocess. 
The introduction of bioptical samples quality control allowed us to avoid the 
contaminations of extracted cells that might compromise all tissue processes 
upstream. The quality control of reagent and culture media before use 
contributed to reduce the percentage of failure during the air-liquid interface 
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29 n°26  
Table 4. HSE production plan in an ideal month. In order to control each critical 
operation, every new tissue process was numbered and traced over the time; 
every critical step done was checked. For each failure, we identified the reason.  
 
Table 5. Costs analysis for each 
month. ALI is referred to air-




4.4 DISCUSSIONS AND FUTURE PROSPECTIVE  
In this chapter, we examined our process divided in individual steps that make it 
up. The whole bioprocess is composed of 5 main steps and every step represents 
a critical phase that required a check control. In an industrial point of view, we set 
up a standardized method to increase tissue process productivity, following an 
accurate scale-up strategy. Our purpose was the improvement of human skin 
models fabrication and the realization of a start-up for sealing of 3D skin tissue, 
named “SmarTissue” as an effective platform commercially available for cosmetic 
testing that could compete with current skin model already known. To better 
control the quality of our final tissue products, several meticulous quality controls 
were introduced on the critical step of tissue process. The introduction of quality 
controls allowed not only to verify the good quality of tissues, but also to discard 
all abortifacient samples avoiding to affect subsequent steps of the bioprocess. 
The industrialization of tissue production and the working plan provided useful 
methods to optimize every activity and laboratory operations, allowing to 
estimate a percentage of failures and a costs analysis. 
The market idea is the realization of a start-up named SmarTissue s.r.l. which the 
strengths are: 
 Technological supremacy: the presence of a dermal layer provides the 
ability to study critical phenomena (as skin aging, damage from ionizing 
radiations, photo-damage), ensuring a highly predictive screening on the 
native tissue effects; 
 Expanding market: ability to make innovative new tests and create new 
highly profitable market niches (i.e. studies for the evaluation of structural 
changes that occur in the dermis); 
 Know-How: mix of knowledges and expertise in tissue engineering of 
tissues medical biotechnology of the SmarTissue team; 
 Personalized therapies: ability to test/develop drugs and personalized 
therapies from cells extracted from the patient. 
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In the same time, we identified initiative weaknesses: 
 Fundraising: the transition the current prototype to the final product 
requires a necessary and decisive fundraiser; 
 Competition: big international companies and industries which fabricated 
the principal gold standard tissue models commercially available represent 
a crucial hurdle.  
 
With the development of our complex skin equivalent system that we intend 
to implement it will be possible: 
 To assess the skin irritation, and the cytotoxicity of a compound 
simultaneously in fibroblasts (dermis) that in keratinocytes (epidermis);  
 To evaluate the ability to protect the genomic DNA, the antioxidant 
capacity, the induction of new collagen, the protection from 
degradation of new collagen, moisturizing ability, stability of the 
extracellular matrix –cell system, and skin elasticity;  
 The ability to spread through the skin of certain substances, and then 
determine the optimal doses of administration;  
 To test the properties bleaching or tanning, anti-inflammatory 
properties;  
 To study the influence of the vehicle (formulation) on improving the 








Table 6. Possible applications of 3D human skin equivalent models designed 
by us.  
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As already described in the chapter 1, there were several industries and 
companies which have developed various skin models as effective platform for 
chemical and applications in order to substitutes animal models [11]. Several 
companies such as L’Oréal, SkinEthic, Henkel and MatTek Corporation realize and 
employ skin models for pharmaceutical, cosmetic and chemical compound testing 
in order to study barrier function, drug permeability, cutaneous irritancy and 
















Table 7. Comparison of the main practicable assay carried with 
SmarTissue and those of best competitors (MatTek, L’Oréal)  
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Therefore, the competitors of SmarTissue are able to realize the skin equivalent 
models that only partially duplicate the human skin, lacking a complex stromal 
tissue and its relative cellular component. When present, the dermal 
compartment is composed of an exogenous matrix and inert proteins in which the 
cells are immersed. It follows that the limits of the models of the competitors also 
limit the quality of competitor products.  
Briefly, as shown in the Table 8 the idea of strategy was realization of a provider 
of products and services, articulating the start-up activities in two divisions: 
a) Screening Platform divided in 3 sections:  
 products/services early phase drug screening and discovery (customers 
pharma, biotech and cosmetic treatment for pre-phase of clinical tests). 
activated within 6 months from the founding of the start-up; 
 •products/services chemical and / or post-introduction tests statement EU 
REACH (customers interested in the evaluation of toxicity and / or risk the 
health of workers who handle their own products). activated from 6 
months to 1 year after the founding of the start - up to adapt to EU 
standards in this respect and properly certify the platform; 
 products/services for the Pharma industry (customers interested in phase 
1-2 clinical trials). Since it will be necessary authorizations AIFA (ITA), EMA 
(in EU), FDA (USA), the area will be activated by 2 to 3 years from the 
Foundation of the start -up. 
 
b) Therapeutics: 
 products for the pharmaceutical industry, area activated from the third 
year on the foundation of the start -up, after the necessary regulatory 
approvals for the marketing of medical-surgical Category 3 (invasive). 
 
SmarTissue is planning to implement product / service lines organizing the main 
activities in units: 
- Tissue Factory Unit (TFU): the production line that will be fully operative 
after 6 months from the start-up foundation. It will be capable of 
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producing a defined number of final products to the sale for external 
screening; 
- Tissue Testing Unit (TTU): it represents the testing service, in order to 
study of the effect of active ingredients, chemical compounds, 
environmental factors or radiation on human skin. 
 
Tissue Testing Unit will be divided into a series of platform services:  
•Cell-Test Unit. Assays on the cellular component, toxicity testing, cell viability and 
irritation and molecular profiling to be performed on the complete model or on 
the simplified model (only epidermis) activated after 6-8 months after the start-up 
foundation;  
•ECM-Test Unit. Assays on extracellular component, morphological tests using 
histological, Immunohistochemical and biochemical analysis activated after 6-8 
months after the start-up foundation;  
•Functionality-Test Unit. Assays on the products functionality in order to obtain 
information about the state of hydration, mechanical properties, permeability, 
architecture of the extracellular matrix; activated after 12-18 months from the 
start-up foundation;  
•Tissue Specific Test Unit. Assays designed specifically for customized tissues 
Table 8. Strategy for the realization of SmarTissue start-up and division of all 




In this first part of the 4th chapter, we conducted a comparison between our 3D 
human skin equivalent models and gold standard skin models commercially 
available as Phenion Full-Thickness skin model and EpiDerm 312X FT skin model 
fabricated by Henkel and by MatTek Corporation, respectively. 
The morphological and histological analysis highlighted that best skin models had 
significant limitations related to the lack of complexity of dermal compartment, 
composed, in both exogenous tissue systems, of an inert matrix (a mixture of 
collagen and GAGs or reconstituted collagen type I), which not mimic all 
characteristics and functions of native skin. In particular, in the Phenion Full-
Thickness skin model, we observed an epidermal compartment not completely 
stratified and differentiated; while, on the contrary, EpiDerm 312X FT showed a 
well stratified epithelium on an exogenous rudimentary dermal matrix. The main 
goal of best gold standard skin models is related to faster production times of 
endogenous skin systems: international companies, in fact, developed simpler 
protocols to fabricate tissue models using a mixture of exogenous matrices and 
fibroblasts as dermal compartment, obtained in about 7 days of culture. After 7 
days, dermal fibroblasts proliferate inside the exogenous matrix to form a simple 
dermis ready to be enriched in human keratinocytes, seeded on its surface, in 
order to obtain a differentiated and stratified epithelium, after 14 days of air-
liquid culture conditions. On the contrary, our 3D tissue models were obtained 
with a more complex procedure, according to a bottom-up approach, with the 
employment of cell and porous gelatin micro-carries, as support for cellular 
attachment and proliferation. After 9 days of dynamic culture, cells and 
microcarriers formed the building blocks of tissue, HD-µTP, composed of cells, 
microbeads and collagen partially assembled. HD-µTP were loaded in the 
maturation chamber in order to develop 3D human dermis equivalent models, 
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after 6 weeks in bioreactor. During this time, HDF secreted and assembled 
collagen and all proteins of ECM, forming an endogenous matrix. 3D-HDE 
extracted from maturation chamber were enriched in keratinocytes, to produce a 
fully differentiated epithelium on dermis surface. The production times of our 
endogenous skin systems are about 10 weeks, necessary to fabricate complex and 
endogenous 3D HSE that mimic all features of in vivo counterpart.  
In the second part of this chapter we tried to set up an innovative scale-up 
strategy with the aim to improve the production of 3D human skin equivalent 
model as a competitive testing platform commercially available. To better ensure 
the quality of our final products and to intensify the yield of the production, we 
introduced big bioreactors operating in parallel at their maximal capacity; a 
working plan to organize each laboratory activities and several check points in 
each critical phase of our tissue process. Finally, we obtained a safety and 
standardized protocols to ensure about 200 tissue products per month available 
for several tests and applications as useful alternative to animal testing. 
These scale-up strategy paves the way to the realization of a stat-up, 
(SmarTissue), that will be a benchmark in the European market for HSEs, focusing 
the attention on scientific excellence-technology, innovation, production and 
organizational flexibility. The start-up will take care to engineer, manufacture and 
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